incivo is used to treat the virus that causes hepatitis c infection in adults , adolescents , and children aged 1865 years and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . if you have been given a different type of hepatis - c virus , you will be given two different combinations of the sexes : - to prevent the growth of the virus . the other ingredients are : the active substance is peg interferonalfa and ribamvirin . you will also be given one of the other two ingredients . what are the active ingredient of inciva is used for the treatment of chronic hematopoietic infection . chronic he
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . - you are taking peginterferon alfa or ribavirin , based on their contraindications ( e. g . pregnancy precautions ). if any of these apply to you , tell your doctor or nurse . warnings , precautions or precautions you should tell your physician before taking the medicine : - when you are using , have recently taken or might take any of them together . the following medicines may cause severe side effects : 56 - the medicine alfuzosin may cause symptoms of an enlarged prostate , which may be caused by alpha -1 - adrenal receptor antagonists
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the appropriate dose regimen the recommended dose regimen is 3 mg once a day , 6 mg twice a week , 2 mg once every week and 8 mg once per week . your doctor may decide to increase your dose depending on how you respond to incivo . you should take efavirenz every day for as long as you feel better . it is very important that you take the prescribed dose regimen at the same time each day . this will help you to remember to take it as soon as you remember . if it is time for your next dose , your doctor will tell you how long you need to take the medicine . for hepatitis c virus infection and human immunodeficiency virus infection , it is important to take both of these two medicines together with e
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get a rash or an itchy skin rash . if the rash gets worse , talk to your doctor or nurse straight away . other symptoms may occur if your rash has a severe skin reaction , so stop taking incivo and seek medical help immediately . your doctor may decide to reduce your dose if it is too severe or too severe . you should contact your doctor as soon as possible . this is because if , in some cases , you have a skin rashes , your doctor will tell you how long you need to stay . it is important that you check with your doctor , pharmacist or nurse . these may include other symptoms , such as fever , tiredness , swelling of the face or swelling of lymph glands .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . store in a refrigerator ( 2 8 ). do not freeze . incivo tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . - each tablet contains 375 milligrams ( ml ) of the active ingredient . the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anionic ( e460 ), sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coating polyvinyl alcohol , macrogol - talc , titanium dioxide , and iron oxide yellow ( see section 2 ). what the pack looks like and contents of the pack white to off - white , round , yellow caplet- shaped tablets , each containing 20 tablets or 4 tablets . not all pack sizes may be 
zinbryta contains the active substance daclizumab beta , which is a monoclonal antibody . it is used in adults to treat multiple sclerosis ( ms ) in adults , adolescents and children aged 2 years and older . therapy is based on the results of a two - year course of therapy with other treatments to reduce inflammation of the protective sheath that protects the nerves in the central nervous system ( the brain ) and spinal cord . this loss of myelin ( also called demyelination ) can lead to the relapsing disease , repeated attacks ( relapses ), and symptoms of nerves . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not take zinbryta : - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if your doctor thinks you may have liver problems , tell your doctor or pharmacist before you are given the medicine , as this may increase the risk of a possible increase in your dose . do not use zin bryta to treat any other autoimmune disorders . you should not take any other medicines , herbal supplements or any medicines or supplements that may increase your risk of liver side effects . these medicines should not be used in children and adolescents under 18 years of age . your doctor will tell you if any of these medicines have been prescribed to you . talk to a doctor or nurse straight away if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is one 150 mg injection once a day . your doctor will do a blood test to check that your liver is working properly . if your doctor decides to increase your dose , he or she may prescribe a lower dose . the usual dose is one 40 mg injection . after this blood test , your doctor may decide to increase the dose based on the results of your liver . it is important that you do not inject yourself . you should inject zin bryta under the skin of your thigh , stomach , back , or upper arm . injections should be given at intervals of 7 to 7 days . do not stop injecting yourself unless your doctor tells you to 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need to stop your treatment : serious side effects liver problems common ( may affect up to 1 in 10 people ): unexplained nausea ( feeling sick ), vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin and your eyes turn yellow dark ( tea - coloured ) urine 41 common (may affect upto 1 in 100 people ). severe inflammation of the liver , which may lead to death . you should contact your doctor immediately . this includes any possible side effects not listed in this leaflet .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled pen in the original package in order to protect from light . if not used immediately , use a new or a re -filled pen . after first opening , the solution should be clear , colourless to slightly yellow , and should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms of daclizub beta in 1 ml of solution . - each ready - to - use pre . filled pens contain 150 microgrammes ( 0 . 5 mg / m2 ). - other ingredients : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta is a solution containing sodium '). what is the name of the product , the colour of the solution is white to off - white . the pack contains one vial in a glass vial . it is supplied as a single dose vial with or without an attached needle . not all pack sizes may be marketed
wilzin belongs to a group of medicines called metabolism products . it is used in adults to treat a rare inherited defect in copper excretion that affects the liver , the eyes and the brain . this can lead to liver damage , neurological disorders and damage of the intestine , which can cause its further accumulation in the body . if you have a history of wilson ' s disease , this treatment is not suitable for you .
do not use wilzin : - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . do not chew or crush the tablets . wilszin will be given to you by a doctor or nurse . initial therapy should be started at the same time each day . it is important that you do not stop using it unless you notice signs and symptoms of the disease . currently , you are currently taking another anti - copper agent called penicillamine . your doctor may decide to change your dose . you may need to stop using the initial treatment , or you may be given other anti . copper agents , such as penicillin , may reduce your symptoms . the treatment may be stopped if blood and urine are
what wilzin contains - the different dose regimens are listed below . each tablet contains 25 mg / 50 mg . one tablet of 1 ml contains a dose of 50 mg or less . the other tablets are : - 25 mg ( 1 tablet ) and 50 mg ( 2 tablets ). - 50 mg (2 tablets ) each containing 25 mg or more . - 1 tablet of 0 . 5 mg , containing 50 mg and 2 tablets of kilzin , consisting of 25 mg in each tablet , each tablet is divided into equal doses of 1 to 6 tablets . in each case , the other tablet contains 1 or more tablets containing 0 mg dilzin in each 25 mg tablet in each 6 , 16 , or 57 mg tablets in each 16 - day period . not all pack sizes may be marketed .
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): very rare ( affects 1 to 10 people in 100 people ). very rare : may affect up to 1 in 1 , 000 people . uncommon ( may effect up to 10 in 10 ,000 people ), very rare (1 in 10 or 10 in 10,000 people ); rare ( may impact up to one in 10 000 patients ) the frequency of the number of side effects is not known ( frequency cannot be estimated from the available data ). in patients with gastric irritation , treatment may require changes in blood tests . there may be an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . if you notice any of the side effects above , talk to your doctor or pharmacist
keep this medicine out of the sight and reach of children . do not use wilzin after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each capsule contains 25 mg of zinc ( as 83 . 92 mg zinc acetate dihydrate ) and 50 mg ( as zinc ). each capsule is supplied in a glass vial with a capacity of 167 . 8 mg zinc per ml . the other ingredients are : magnesium stearate , the capsule shell contains gelatin , titanium dioxide ( e171 ), and brilliant blue fcf ( see section 2 ). - each sachet contains 50 mg / m2 of zinc , and the printing ink is made of black iron oxide , with or without shellac , as shown on the back of the capsule . not all pack sizes may be marketed in your country . pack sizes are available in packs containing 25 capsules and 250 capsules .
biktarvy contains the active substance bictegravir . it is an antiretroviral medicine that acts as an integrase strand transfer inhibitor ( emtricitabine ). it belongs to a group of medicines called " a nucleoside reverse transcriptases inhibitor " ( nrti ) tenofovir alafenamide , which belongs to the group of drugs called " " nucleotide reverse transcriptáse inhibitor (" ntrtiti ). biktarivy is used for the treatment of human immunodeficiency virus ( hiv ) in adults and children aged 1 year and older . hiv is a type of virus that affects more than 1 in 10 people . infection with hiv can cause your immune system to stop you from developing illnesses linked to hiv infection .
do not take biktarvy : - if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . - the following medicines may be used to treat some bacterial infections : tuberculosis - saint john ' s wort , hypericum perforatum ( a herbal remedy used for depression and anxiety ). biktarivy is not recommended for use in patients with liver problems , including liver disease , such as hepatitis ( liver disease associated with chronic hematocritis b or c ) or antiretrovirals .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . antacids are used to treat stomach ulcers , heartburn and acid reflux . biktarvy contains aluminium , magnesium hydroxide mineral supplements , vitamins and minerals such as magnesium and iron . see section 2 ' possible side effects ' for more information . your doctor will tell you how to take these medicines . do not take biktarivy while you are on dialysis . it is important that you follow the advice of your doctor , pharmacist or nurse . you should not take more than one tablet at a time , as it may take longer than usual for you to take them . take these tablets at the same time each day , with or without food . this will help you remember to take the tablets . the usual dose of bi
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor immediately if you notice any of the following signs of inflammation or infection : - advanced hiv infection - opportunistic infections ( infections caused by a weak immune system ) - symptoms of inflammation - previous infections that have not been treated with hiv treatment . these symptoms are caused by the body ' s immune response , which helps the body to fight infections . obvious symptoms of autoimmune disorders ( when the immune system attacks a part of the body tissue ) when medicines are used to treat hiv infections , these are usually mild to moderate . this is because biktarvy does not work as well as it should .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine , and tenofovir alafenamide . - corresponding to the other ingredients of each biktarivy tablet , each tablet contains bictégravir sodium equivalent to 50 milligrams ( equivalent to 200 milligrammes ) of bictesgravir and encapsulated in a glass vial , while the other ingredient in the tablet core are : - tablet core microcrystalline cellulose, croscarmellose sodium , magnesium stearate , film - coating polyvinyl alcohol , titanium dioxide , macrogol and talc , iron oxide black and iron oxide red . not all pack sizes may be marketed in your country .
novonorm is an oral antidiabetic medicine that contains the active substance repaglinide . it works by helping your pancreas make more insulin to control your blood sugar and glucose . type 2 diabetes is a disease in which the pancreatic system does not make enough insulin . the sugar in your blood is stored in the body , and the body does not produce enough of the insulin it produces . if you are taking any of the above , you should tell your doctor , pharmacist or nurse , or nurse straight away . this is called diabetes , which occurs when you are treated with treatment with exercise and weight reduction . your doctor will tell you how long you need to stay on the diet and exercise programme that you should follow . you may also take novonlorm with metformin . diabetes is not a condition where your doctor has prescribed it .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have type 1 diabetes . your doctor will check the acid level in your blood ( diabetic ketoacidosis ). you have a severe liver disease . you are taking gemfibrozil , a medicine used to lower increased fat levels 47 you have liver problems . if any of these apply to you , tell your doctor or pharmacist . novonom is not recommended for use in patients with moderate liver disease ( see section 4 ). your doctor may need to adjust your dose if your doctor considers that you may be at risk of developing a serious liver disease or have kidney problems before you are given novonlorm 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . your doctor will tell you how many tablets to take and how long you should take them . do not take more than 30 tablets . take the tablet at least 4 hours before or at least 30 minutes before or 16 hours after your meal . if your blood sugar is too low or you have a hypo , your doctor may decide to reduce your dose . this will help to control your diabetes . it is important that you follow your doctor ' s instructions for your treatment with this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is a common side effect that may affect up to 1 in 10 people . if you have a hypo in section , your doctor may decide to reduce the dose of novonorm to a lower dose , which may be more appropriate or less appropriate for you . the frequency is generally mild / moderate , but can be severe and may be life - threatening ( coma ). allergy allergy ( rare , affects more than 1 user in 10 , 000 people ) which may cause symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating . anaphylactic reaction has also been reported . other side effects tell your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . each tablet contains iron oxide yellow ( e172 ) in 1 ml of solution and iron oxide red in 2 % of the solution . what novoorm looks like and contents of the pack novonomtablets are white to off - white , round , oval shaped tablets , each containing 0 . 5 mm , 1 mm or 2 mm in diameter . they are available in four blister pack sizes containing 30 , 90 or 120 tablets . not all
pumarix is a vaccine given to children and adolescents aged 18 years and older against pandemic flu ( influenza ) in the United States . it is given to adults , adolescents and children from 10 years of age and older . the vaccine is not intended to be used in adults . however , it is intended to protect against the disease that causes flu . all vaccines should be given with pumarx .
pumarix will not be given to you if you have ever had a sudden life - threatening allergic reaction to any of the ingredients of this vaccine ( listed in section 6 ): chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction include itchy skin rash , shortness of breath and swelling of the face or tongue . your doctor will decide if the vaccine is suitable for you or your child . medical treatment is not recommended if your child develops an allergy reaction . the duration of the vaccine will depend on how well your child responds to the vaccine . 33 your doctor or nurse will monitor you closely for any allergic reaction , if any of these apply to you or you are not sure , talk to your doctor , pharmacist or nurse before you are given this vaccine , as it may take up to 6 weeks before your child
pumarix will be given to you by a doctor or nurse who is experienced in administering a similar h5n1 as03 vaccine to a child under 18 years of age . pumarx will be administered as a single dose . the recommended dose is one ml of vaccine per day . it is given to children aged 3-9 years and adolescents aged 3 months and above . children aged 10-17 years : if you are not sure , talk to your doctor , pharmacist or nurse before you are given pumarix . if your child is younger than the age of 18 years , it is recommended that you do not need to inject it into a muscle in your upper arm . do not give this vaccine to children younger than three months of age or older .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions can lead to dangerously low blood pressure and shock . you may need emergency treatment . the following side effects may occur with pumarix : very common ( may affect more than 1 in 10 people ) pain after the injection : headache tired aching muscles joint pain common : may affect up to 1 in 100 people : redness or swelling at the site of the injection fever sweating shivering diarrhoea , feeling sick uncommon ( may effect up to 2 in 100 patients ): dizziness , tingling or numbness . very common side effects are : - rash , swelling of the face , lips , tongue , mouth , nose , throat , eyes , eye irritation , redness of the skin , skin
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the original package in order to protect from light . the suspension should be used immediately after administration . if not used immediately , the vaccine may be stored at room temperature ( up to 24 hours ) for up to 30 days .
what pumarix contains - the active substance is split influenza virus 5 / 2005 . each vial contains pr8 - ibcdc- rg2 , 0 . 5 mg of haemagglutinin ( a substance produced during the pandemic ). when the vaccine is given , it is given as an ' adjuvant ' as03 , which contains squalene ( e421 ), dl  - tocopherol , polysorbate 80 , and phosphate . the other ingredients of the vaccine are : sodium chloride , disodium hydrogen peroxide , potassium dihydrogen peroxidase and potassium chloride and water for injections . what pu marsix looks like and contents of the pack the suspension is white to off - white , colourless to pale yellow
somakit toc is a radiopharmaceutical product that contains the active substance called edotreotide . the powder contains the radioactive substance called gallium ( 68ga ) chloride , which is similar to a chemical in nature . it is used to replace the phosphate in the body by removing gallium from the body . this procedure involves the removal of gallium , causing it to be absorbed into body areas . a medical imaging procedure called positron emission tomography ( pet ) of a pet . during this medical procedure , images are taken of the abnormal cells and tumours in your disease . somat toc will be used in combination with the procedure . your doctor will discuss with you the benefits and risks of the radiopharmacedural .
do not take somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . allergic reaction is rare ( may affect up to 4 out of 10 people ). if this applies to you , tell your doctor straight away . if your doctor tells you to stop taking somat toc because you have kidney or liver problems , or have renal or hepatic disease . children and adolescents ( aged 18 years and older ): - dehydration during the examination 28 - other medical conditions that affect other parts of the body such as cushing syndrome ( inflammation ) or thyroid disease , tumour ( of pituitary gland , lung , brain , breast , immune system , thyroid 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of somakit toc is 29 mg once a day . after the start of the procedure , your doctor will give you 100 mg or 200 mg of megabecquerel . how much to use the dose you will be given will depend on how you respond to the radiolabelling . your doctor , nurse or nurse will decide how many doses to use . if the procedure is repeated , it is important that you do not miss a dose . you will receive the dose as soon as you remember . do not stop the procedure without first talking to a doctor . radiolabeling , somatat toc may be given as an intravenous injection . it is usually given as a single injection , followed by the test
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site or ionising radiation . this can be a sign of cancer or hereditary abnormalities . reporting of side effects click here to discuss the side effects that may affect you . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . radiopharmaceuticals should not be disposed of via wastewater or household waste . these measures will help protect the environment . somakit toc should be used immediately after first opening in order to protect from light . from a safety point of view , radioactive materials should be stored in a refrigerator ( 2 - 8 ). do not refrigerate , refrigerated or stored above 25 for a single period of up to two weeks . if not used immediately , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use , as they may cause deterioration or damage to radioactive products .
what somakit toc contains - the active substance is edotreotide . each ml of powder contains 40 mg / m2 dna . the other ingredients are : - 10 phenanthroline ( gentisic acid ), mannitol ( e421 ), formic acid , sodium hydroxide , water for injections and sodium for radiolabelling ( see section 2 ). the solution contains hydrochloric acid and water for radiopharmaceutical preparation . - a glass vial with black flip - off cap containing a white powder , which is a clear and colourless solution . it is supplied as a single - use vial containing one vial of white to off - white , colourless , clear to slightly opalescent to pale yellow flip
afinitor is an anticancer medicine , which contains the active substance everolimus . everyolimus works by blocking the growth of cancer cells in the tumour , preventing the growth and growth of new cells . afinitr is a type of hormone receptor , used in the treatment of positive advanced breast cancer in postmenopausal women . it is used in combination with non - steroidal aromatase inhibitors to keep the disease under control . pouritor belongs to a medicine called exemestane , also known as a sterolyse inhibitor . hormonal anti cancer therapy is used to treat advanced tumours , including neuroendocrine tumours that affect the stomach and bowels .
do not take afinitor - if you are not sure , talk to your doctor , pharmacist or nurse before you start cancer treatment . pouritor should not be used if : - you are allergic to everolimus , sirolimus or temsirolim or any of the other ingredients of this medicine ( listed in section 6 ). if any of these apply to you , tell your doctor immediately . - vous may be allergic . warnings and precautions talk to a doctor or pharmacist before you are given this medicine . your doctor will tell you if vous have any problems with your liver or any disease that affects your liver . you will be given a different dose of afinitor to treat diabetes or high level of sugar in your blood . vousitor may increase blood sugar levels , which may worsen diabetes mellitus , if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . pouritor is used to treat liver problems . your doctor may prescribe a lower dose of afinitor : 5 mg , 5 mg or 7 . 5 mg depending on how you respond to certain side effects . you should take afinitor at the same time each day , with or without food . if your doctor tells you otherwise , your doctor will tell you how long you need to take it . it is important that you take the tablet with food , drink and water . do not take a double dose to make up for a forgotten tablet . this will help you remember to take the next dose as soon as you remember . don ' t stop taking this medicine without talking to your
like all medicines , this medicine can cause side effects , although not everybody gets them . afinitor can cause an allergic reaction , which may include difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , a red rash or raised bumps . the following side effects have been reported with Afinitor : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ), fever , coughing , difficulty breathing , wheezing and inflammation of the lung ( pneumonitis ). the most common side effects were : may affect up to 1 in 100 people increased temperature ( chills ) and infection , fever . coughing and difficulty breathing and wheezeing . these could be signs of inflammation of your lung , such as pneumonia . not known ( frequency cannot be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister tightly closed in order to protect from light . after opening the blister , the tablets should be used immediately . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . pouritor 2 . 5 mg : each vial of 2, 5 mg contains 2 , 5 milligrams ( iu ). pouriitor 5 ml : every 10 mg , each 10 mg tablet contains 3 , 000 milligrammes / u . the other ingredients are : butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , and crospovidone ( e421 ), which is a clear , colourless to slightly yellowish powder . what pouritor looks like and contents of the pack quintacle - coated tablets quennacle are white , light yellowish , round , oval shaped tablets . each pack contains 2
laventair ellipta contains two active substances : umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what lavent air ellivta is used for : chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties . copd causes tightening of the muscles in your lungs . this medicine reduces the tightness of these muscles , thereby reducing the number of airways that your breath can take in and out . if you have any of these problems , talk to your doctor .
do not take laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine is not intended for the treatment of asthma . if this applies to you , tell your doctor straight away . tell the doctor or nurse immediately : - asthma - heart problems - high blood pressure - an eye problem called narrow - angle glaucoma , an enlarged prostate , difficulty passing urine - a blockage in your bladder ( epilepsy ), thyroid gland problems , diabetes , severe liver problems . immediate breathing difficulties such as tightness of the chest , abdominal pain , chest pain or swollen limbs , muscle spasms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inhale the recommended dose is one inhalation every 24 hours . the dose of laventair ellipta depends on how you respond to it . your doctor will tell you how long you need to use the inhaler . do not use more than your doctor tells you to use . if your symptoms do not improve , contact your doctor immediately . you may need a sudden attack of breathlessness or wheezing . it is important that you use a quick - acting reliever inhalers ( such as salbutamol ). if this happens , your doctor may prescribe you a rapid - action reliever ( like a syringe ) for this type of attack . when using a fast -
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions : if you experience any of the following symptoms while taking laventair ellipta , contact your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ) skin rash ( hives ) redness rare side effects (1 in 1 , 000 patients ) swelling of the face and mouth ( angioedema ) very wheezy , coughing , difficulty in breathing , feeling weak or light headed , or collapse . reporting of side effects that you get , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each inhalation dose contains 55 micrograms ( ml ) of umeklidinium . - each dose is for inhalers aged 65 years and over . the other ingredients are : 55 milligrams of umeridiane , 22 millilitres / m2 /m2 of the body , and 63 milliliters , which is equivalent to a tablet , as well as a single dose , inhaler , a dose counter , lactose monohydrate ( see section 2 under ' laventaire ellibta is a powder '), magnesium stearate and water for injections . what la ventair ellpte looks like and
tremfya contains the active substance guselkumab , which is a monoclonal antibody . this medicine contains il - 23 . psoriasis is an inflammatory condition that affects the skin and nails . it helps to improve the condition , such as the appearance of nails , and reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not take tremfya - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you are given the medicine . if your doctor thinks you may be allergic , ask your doctor for advice . you should not be given this medicine if : you have an active infection , or you have active tuberculosis warnings , and you should be warned before you start . your doctor will tell you if any of these apply to you or your child ' s doctor , pharmacist or nurse . children and adolescents the risk of developing an infection is not known . it is important that you have a history of an infection known as tuberculosis . tuber
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given under the skin ( subcutaneous injection ) every 4 to 8 hours . the usual dose is one injection once a day . your doctor will tell you how many doses to use . do not use more than your doctor tells you to . if any of the above applies to you , talk to your doctor , pharmacist or nurse . it is important that you read the instructions for use carefully and follow the instructions of the package leaflet . you can also use a different dose to make up for a forgotten dose . what to do if a dose is too high or too low , contact your doctor as soon as possible .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may be at increased risk of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . some side effects are uncommon ( may affect up to 1 in 10 people ): upper respiratory infections . the most common side effects were : very common : may affect more than 1 in 100 people : headache , joint pain , difficulty breathing , and difficulty swallowing ( e . g ., difficulty sleeping , cough , abdominal pain ). reporting of side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 to 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , this medicine should not be disposed of if it is cloudy or contains large particles . if the solution is not clear or contains particles , it should be used immediately . use the refrigerator to store the tremfya vial . once reconstituted , store it in the refrigerator at room temperature ( up to 30 ) for as long as it is clear , colourless , and free of particles 
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg / 0 . 5 ml of guslkumarab ( as 1 mg of histidine ). - this is a clear , colourless solution for injections . the other ingredients are : polysorbate 80 , sucrose , water for injection , solvent for injection and water for oral use only . what the package solution looks like and contents of the pack solution for trempya is presented as a carton pack containing one single - dose glass single - dosing device , or a multipack containing 2 , 2 or 1 single , single – dose pre . not all packs may be marketed .
trepulmix contains the active substance treprostinil , which is a type of medicine called prostacyclins , a hormone that helps to control blood pressure by relaxing blood vessels . treprplm is used in adults to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adults , adolescents and children . it is used for the treatment of persistent or recurrent chest pain after surgical treatment and exercise capacity . symptoms of the disease are similar to those of adults whose blood pressure is too high because the blood vessels in the heart and lungs are not working properly .
do not take trepulmix : - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a disease called " pulmonary veno - inclusive disease " ( pvoe ). - you are a person whose blood vessels ( the lungs ) become swollen , resulting in a higher pressure in the blood vessels between the heart and the lung . you have severe liver disease , you have had a heart problem , or you have ever suffered a cardiac attack ( myocardial infarction ) in the last six months severe changes in heart rate severe coronary heart disease or unstable angina ( e . g . heart defect or a 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion under the skin via a small tube ( cannula ) in the abdomen or thigh . you will be given tepulmix with or without a portable pump . your doctor will give you your treprostinil at the same time each day . the pump will be inserted into the infusion line to prevent accidental overdose . in general , the recommended dose is 1 , 2 . 5 mg , 5 mg or 10 mg per minute . depending on your condition , your doctor may recommend special dose adjustments . patients with liver or kidney disease , you may need to be given an infusion rate that is appropriate for your condition and / or a special dose adjustment .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - widening of blood vessels pain at the infusion site reaction , at the site of infusion bleeding , bruising or at the injection site . - headaches , nausea , diarrhoea jaw pain . common : may affect up to 1 in 100 people - dizziness , light - headedness or fainting , low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgio ) - swelling of feet , ankles - tingling of hands , legs , arms , back pain , abdominal pain and / or abdominal pain ( common ) may affect as many as 1 in 1 , 000
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep a trepulmix vial in the outer carton in order to protect from light . after first opening , it should be used within 30 minutes of continuous subcutaneous infusion . if not used immediately , a single reservoir ( syringe ) of dilution will be stored at room temperature for up to 72 hours . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this medicine if you notice damage , discolouration or other signs of deterioration .
what trepulmix contains - the active substance is treprostinil . each ml contains 1 mg ( equivalent to 1 mg ) teprostiginil in sodium salt . - each 10 mg / 10 mg vial contains 10 mg or 10 mg ( equal to 2 . 5 mg tu ). - every 2 , 5 mg or 25 mg , t . 2 mg of trepst inil ( as sodium salt) in a vial . the other ingredients are : 10 mg and 25 mg in water . how to prepare the tablets the tablets are white to off - white , colourless to pale yellow tablets , with or without sodium salt on one side and a white to pale pink tablet on the other side . one tablet contains one tablet containing one tablet with one tablet of the same colour as the other .
thorinane contains the active substance enoxaparin sodium , which is a low molecular weight heparin ( lmwh ) which is used to prevent existing blood clots . it is used in adults , adolescents and children aged 1 year and older , to prevent , stop or stop blood coagulations in your blood . the active ingredient in thlorinan consists of two active substances : 1 : to prevent the formation of new , old , or re - used substances . 2 : stopping blood , and your doctor will test your blood regularly to make sure that the blood is clear , clear and clear . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may decide to change the dose if it is not suitable for you .
do not take thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if any of these apply to you , tell your doctor immediately . signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . you may also be allergic to other low molecular weight heparins such as nadroparin , tinzaparin or dalteparin . your doctor may decide that you have a reaction to the active substance , which may lead to a severe drop in the number of your clotting cells ( platelets ). this reaction may be a sign of 
thorinane belongs to a group of medicines called " other similar medicines ". medicines that help to prevent blood clotting are medicines used for the treatment of bleeding . you should not take thlorinana if you experience any bleeding event . excessive bleeding , exceptional weakness , tiredness , paleness or dizziness or headache , or unexplained swelling , tell your doctor immediately . if this happens , stop taking your medicine and contact your doctor straight away . your doctor may decide to reduce the dose of your medicine if it is not possible to prevent a severe allergic reaction ( such as difficulty breathing , swelling of the lips , mouth , throat or eyes ) or blockage of a blood vessel , which may lead to the clot or cramping pain . this may be accompanied by a feeling of weakness or tiredness or paleness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after dilution the solution should be used within 8 hours . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of the thorinane pre - filled siringes . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 0 . 2 ml / 2 , 000 micrograms / milligram / l . the other ingredients are sodium , water for injections , and chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size : 2 x 10 pre . filled vials . not all pack sizes may be marketed .
senstend contains the active substances lidocaine and prilocaine , which are local anaesthetics used to treat lifelong premature ejaculation in the head of the penis . this is a condition where the body ' s natural defences are not working properly . senstende is used in adults , adolescents and children aged 6 years and over .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have a history of allergy or sensitivity to local anaesthetics , especially amide - type local anesthesias . - this is a genetic disease , or other condition that affects your red blood cells , glucose or phosphate deficiency , anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor or pharmacist . medicine sensitivities ( sensitivity ) have been reported in patients with severe liver problems . this medicine is not recommended for use in children and adolescents . it is not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . senstend should be used within 3 hours after first opening of the pump . the recommended dose is 1 ml in the head of the penis . this dose is for use within 3 days . if not used within 24 hours , use within 4 hours of opening the spray container . use the pump mechanism and the valve should not be used if contact with eyes , nose , mouth and ears is not possible . when the pump is opened , the pump should be pushed into the foreskin , head and penis must be removed from the valve . in this case , it should be applied within 1 hour of opening it . it should
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with senstend : very common ( may affect more than 1 in 10 people ): inability to develop or maintain an erection in the penis , feeling of burning in your penis ( very common , may affect up to 1 in 100 people ). headache local irritation of the throat , irritation , or the skin redness , failure to ejaculate during sexual intercourse , abnormal orgasm tingling , a feeling of pain or discomfort . if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the metal container in order to protect from light . if not used immediately , the product may be stored at room temperature ( up to 25 ) for a maximum of 12 hours . from a microbiological point of view , senstend should not be used if it is damaged or if there is a risk of puncture or burn . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg of lidocaine and 50 mg pvp . the other ingredients are : - solution for spraying 50 micrograms , corresponding to 7 . 5 mg / kg / m2 / cm2 , lidocasine and 2 . 4 mg of pvie . - each spray container contains 6 . 6 mm in diameter and 20 microns in length and each spray containers contains 5 or 12 m3 of light yellow cutaneous spray in an aluminium spray container with metering valve . pack sizes of 1 , 6 , 5 and 5 sprays . not all pack sizes may be marketed .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ). it is used in adults , adolescents , and children to treat adult patients with advanced melanoma . complete resection in adults ( treatment with surgery or adjuvant therapy ) for the treatment of advanced non - small cell lung cancer ( lung cancer ) in adults advanced renal cell carcinoma , advanced kidney cancer , adults classic hodgkin lymphomas , previously treated with previous therapies , an autologous stem - cell transplant or a transplant . it is also used in adult patients who have advanced cancer of the head and neck ( adults advanced urothelial carcinoma ), bladder and urinary tract cancer . nivolumab , a monoclonal antibody , has been shown to reduce the amount of protein in the blood .
do not take opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your heart has a change in the rhythm of the heartbeat , or an abnormal heart rhythm , your lungs may have breathing difficulties , cough , inflammation of the lungs ( pneumonitis ), interstitial lung disease , diarrhoea , watery , loose or soft stools . tell your doctor or pharmacist if any symptoms occur , including : inflammation of your intestines ( colitis ) or stomach pain . your doctor may decide to change your dose , depending on the severity of your condition . you may experience breathing difficulties or cough . this may be
what opdivo contains the active substance is nivolumab . each ml of solution for treatment of skin cancer contains 1 mg / kg of your body weight . if you weigh more than 4 kg , your doctor will prescribe the right dose for you . the recommended dose for adults and children is 240 mg , 2 mg or 480 mg per day . your doctor may prescribe a higher or lower dose if needed . how much to take the recommended daily dose is 4 mg . what to take when to take a dose of ipilimumab the treatment of advanced kidney cancer is given by your doctor or nurse . you will be given a total of 3 doses . not all pack sizes may be marketed in your country .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . opdivo can be stored at room temperature ( up to 25 ) for up to 48 hours . the infusion solution should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg ( 0 . 5 mg ) of nitvolumаb , corresponding to 40 mg / 4 g / 10 g of concentrate . - each vial contains 240 mg of concentrate ( equivalent to 24 mg ). - in addition , the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 ) and mannitol ( e421 ), pentetic acid , polysorbate 80 - sodium hydroxide , hydrochloric acid and water for injections . not all pack sizes may be marketed in your country .
clopidogrel tad is a medicine that contains the active substance , clopidost . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets that form in these structures , the body ' s natural defences prevents this clumpeding , and so prevents the clots from forming ( thrombosis ) and prevents them from growing again . what is the purpose of this medicine , why is it important that you read the leaflets of the leaflet for more information on the benefits and risks of taking antiplatelets medicinal products ( such as thrombocytes ) in your body . this helps to prevent blood coagulations ( called thrombi ) from
do not take clopidogrel tad - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , you should tell your doctor immediately . precautions you should follow the advice given to you by your doctor or nurse . warnings , precautions your doctor has taken , have recently taken or might take any other medicines that are not listed in this leaflet . it is important that you read the leaflet carefully before taking the tablet , as this may increase the risk of bleeding . your doctor will tell you what to do if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . you should take clopidogrel tad for the treatment of a condition called ' atrial fibrillation ' ( an irregular heartbeat ). your doctor will tell you how many tablets to take . your doctor may prescribe a lower dose of 75 mg / m2 daily . take the tablet with or without food . patients with severe chest pain ( unstable angina ) or heart attack , the usual starting dose is 300 mg . if your doctor prescribes you , your doctor might prescribe you a higher dose . however , you may need to take the 75 mg dose , depending on how you respond to treatment . it is recommended that you take 75 mg daily , every day
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel tad and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth . - skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . tell your doctor straight away if any of the following side effects get serious , stop taking this medicine and seek medical help immediately . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
what clopidogrel tad contains - the active substance in each film - coated tablet , contains 75 milligrams ( ml ) of clopidosrel ( as hydrochloride ). the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil ( see section 6 ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide [ e172 ), talc and macrogol 3000 ( see also section 3 ). what oblong tablet size : tablets are round and slightly convex . they are supplied in boxes of 7 , 14 or 28 tablets . not all pack sizes may be marketed .
tacforius contains the active substance taccrolimus , which is an immunosuppressant . it is used to prevent your organ transplant from affecting your liver or kidney . your body ' s immune system will not respond well to the treatment of your transplanted organs . tacfordius will be given to you by your doctor if you have been told that your organ has been rejected , i . e . that you have previously been treated with liver , kidney , heart , or any previous treatment before your transplantation .
do not take tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor or pharmacist . warnings are the responsibility of the doctor . children and adolescents do not give this medicine to children under the age of 18 years . you should not be given a prolonged - release capsules . your doctor will tell you how long you should wait for the immediate release capsule . the duration of the delayed release is the same as for adults . it is important that you do not have to wait until the next extended - released capsules to be taken . tacfordius is not intended for use in children under 18 years of age . this is because it is not known
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . transplant patients should take the same tacforius medicine every day , with or without food . if your transplant is delayed , your doctor may prescribe a different taccrolimus medicine . this medicine is for oral use only . your doctor will tell you how many tablets to take and how often to take . it is important that you take the right medicine for the rejection of your transplanted organ , depending on your body weight . the usual starting dose is 0 . 10 mg / kg of body weight on day 35 of transplantation . these same doses will be given to you based on your general condition , immunosuppressive medication , and the duration of your treatment with tacforinius
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : infections . infections can be serious . tacforius can cause severe effects such as allergic and anaphylactic reactions , benign or malignant tumours . if this happens , your doctor will decide if it is appropriate for you to continue to receive the medicine . pure red cell aplasia is a very severe reduction in red blood cell counts ( agranulocytosis ), a severely lowered number of white blood cells ( haemolytic anaemia , decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( decrease in the number of these cells , which helps to fight infection ) may occur . this may be a sign of a reduction in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions . after opening the aluminium wrapping , tacforius should be used immediately .
what tacforius contains - the active substance is tacrolimus . each capsule contains 0 . 5 mg or 1 , 5 mg of tacrolimimus ( as monohydrate ). each capsule of tac forius 1 mg contains 1 mg of stratospheric acid . the other ingredients are : capsule content : 3 mg / ml : the other ingredient is tacforimus ( ag ). capsule contents : hypromellose , 2910 , ethylcellulose , lactose and magnesium stearate . capsule shell tacforimius is supplied in a blister containing a 0.5 mg capsule containing 1 capsule . not all pack sizes may be marketed .
clopidogrel zentiva belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets that form in these structures , the body ' s natural defences prevents this clumpeding , and by preventing the clots from forming ( a process called thrombosis ) from accumulating in the arteries ( thrombi ) forming in hardened blood vessels ( arteries ) and thus reduces the risk of atherothrombosis and reduces a certain number of a number of atheothrombotic events ( such as stroke , heart attack , or death ) that occur in patients who are not able to take the medicine . cloprino
do not take clopidogrel zentiva - if you are allergic ( hypersensitive ) to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have a medical condition that is currently causing bleeding , such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . precautions : if your doctor thinks you may be at risk of bleeding . your doctor will monitor you closely for signs of a health condition that causes internal bleeding ( for example , your stomach ulcer ) or a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues , organs or joints . this is especially important if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of clopidogrel zentiva for adults with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is 75 mg once a day . your doctor may prescribe a different dose , depending on your condition . if this applies to you , your doctor will prescribe the right dose . you may be given a higher or lower doses . patients with severe chest pain ( unstable angina ) or heart attack , the usual starting dose is 300 mg once daily . for patients who have had a history of heart attack or stroke , you will be given 300 mg twice a week for 4 weeks . however , if your doctor prescribes you a lower or higher dose of 75 mg per day ,
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel zentiva and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth . - skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . these may be signs of a cold or flu - like symptoms . tell your doctor straight away if any of the side effects get serious . this includes any possible side effects not listed in this leaflet . you can also report side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . clopidogrel zentiva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel zentiva contains - the active substance is clopidostrate . each vial contains 75 mg of cloponigrel ( as hydrogen sulphate ). the other ingredients are : ( see section 2 ' cloprincipal contains lactose '), mannitol ( e421 ), hydrogenated castor oil , microcrystalline cellulose , macrogol ( 6000 ), low - substituted hydroxypropylcellulose . ( ml ). ( pfizer ) ( cbs ) - milk sugar , hypromellose , triacetin , red iron oxide , titanium dioxide , carnauba wax . not all pack sizes may be marketed .
yttriga is a radioactive medicine . it is used in combination with another medicine to reduce the amount of radiation . tiny radiation doses are used for the treatment . the radiolabelled medicinal product must not be disposed of via wastewater or household waste .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using this medicine . if any of these apply to you , tell your doctor or nurse straight away . pregnant women should not be given . pregnancy and breast - feeding do not take a radioactive medicine or another medicinal product ( called radiopharmaceuticals ). if this applies to you or your child , ask your doctor for advice before you are given the medicine , as this medicine contains radioactive material . radioactive medicinal products must not be used in children under 2 years of age . children under 16 years should be supervised by a doctor or pharmacist . other medicines and this medicine is not recommended for use in children below the age of 16
always use yttriga exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the treatment should be started by a doctor experienced in the use of radiolabelling of medicinal products . if specific diseases occur , your doctor will monitor you closely for signs of overdose . it is important that you receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep out of the reach and sight of children . do not use yttriga after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from local regulations , radioactive substances should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of waste material .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid . each vial contains 3 mg of solution . - it is supplied in a v - shaped bottom and a colourless type i glass vial . it is available in packs containing 10 vials with a flat bottom , a silicon stopper and an aluminium seal . not all pack sizes may be marketed .
ciambra is a medicine used in the treatment of cancer . it is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a type of cancer that affects the lining of the lung , to patients who have received prior chemotherapy and whose cancer has spread to other parts of the body . the combination is used in patients with lung cancer whose disease does not respond to treatment or has not responded to other initial chemotherapy . what are the benefits and disadvantages of using the product you will get , how long you will be given , and how much you will receive . your doctor will decide on the most appropriate combination , depending on the type of lung cancer that you have . you will also be given the medicine by a doctor , nurse or nurse .
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of the vaccine ( listed in section 6 ) or breast - feeding . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . - do not breast feed unless your doctor has told you to . your doctor may decide to increase your dose . tell your doctor or nurse if any of these apply to you . children and adolescents this medicine is not recommended for children under 6 years of age . it is recommended that you breast feed at least once a day for at least one hour before or during treatment . you should not breast- feed , as this may increase the risk of developing yellow fever . before you receive a vaccine , your doctor will tell you if : you have problems with your kidney
ciambra will be given to you by a doctor or nurse . the recommended dose is 500 mg / m2 of your body ' s surface area , based on your height and weight . this body surface area will be determined by your doctor . your doctor will check your blood cell counts during treatment . if you are not sure , ask your doctor for advice . mixed the cimbra powder 9 mg with 9 mg sodium chloride solution to make sure that you are given the right dose . infusion into your veins , the infusion will last approximately 10 minutes . you will receive the medicine in combination with cisplatin , depending on your weight and how well you respond to the dose , and how often you should be infusion . it is recommended that you have been given the dose that is right for you , or if your doctor prescribes c
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : 52 fever , signs of infection , a temperature of at least 30oc , sweating , sign of infection and a decrease in the number of white blood cells than normal . infection ( sepsis ) can lead to death . chest pain , with a fast heart rate , pain or redness , swelling or sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever and skin reactions . not known : frequency cannot be estimated from the available data .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the infusion solution of pemetrexed in the original package in order to protect from light . after reconstitution , the reconstituted solution should be used immediately . ciambra may be stored for up to 24 hours at 2 to 8 , up to 15 minutes at 25 . any unused solution should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of any medicines no longer required . these measures will help protect the environment .
what ciambra contains the active substance is pemetrexed . each ml contains 100 micrograms ( 0 . 100 g ) of pemetreexed ( as pemetrexxed disodium hemipentahydrate ). each vial ( vial ) contains one vial of one 500 microgram / litre solution containing one 500 milligram syringe ( equivalent to one 500 g dose ). after reconstitution , the solution contains one 25 g solution . after further dilution , mannitol ( e553 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further pharm adjustment ). see section 2 . what you need to know before you are given , what you should do if you have any further questions on the use of 
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam is used to treat certain infections in your blood . immunogam can be used to reduce the levels of human hepatitis b immunoglobularins , as well as the amount of immunoglobuin g ( igg ) in the blood plasma of screened patients . if you are not sure , talk to your doctor , pharmacist or nurse before you are given immunogam . it is used in combination with immunogam to prevent the spread of a type of virus known as haemodialysed patients who have not been vaccinated . the use of immunogam has been shown to increase the number of measurable and measurable hb antibodies . vaccination is also used for continuous prevention of infected patients who are in the treatment of someone who has a virus called ' 
immunogam may cause an allergic reaction to human immunoglobulins or other blood products . immunogam is used to treat an iga deficiency in adults . if you have ever had a reaction to iga containing products , or to any of the other ingredients of immunogam ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given immunogam . children and adolescents ( 18 years of age and older ) immunogam can cause adverse reactions such as chills , headache , fever , vomiting . allergic reactions include nausea , arthralgia , joint pain , low blood pressure , moderate low back pain . antibodies can also be produced against hepatitis b immunisation regularly . this is because humans are not able to produce human iga immunoglobularin injections . however ,
immunogam is used for vaccination against hepatitis b virus . the first vaccine dose will be given by a doctor or nurse who is experienced in the use of human , human and animal vaccines . immunogam will be administered as a single dose . it is used in adults , adolescents and children of all ages . administration prevention : the recommended dose for adults with a high risk of developing a form of a virus is 500 mg / ml . in haemodialysed patients , a dose of 500 mg is given within 24 hours and 72 hours . if you have a higher risk of contracting a recombinant form , your doctor may decide to increase the dose to 500 mg in 2 weeks . seroconversion : your doctor will decide on the right dose for you . you will be vaccinated with he
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogam : very common ( may affect more than 1 in 10 people ): very rare ( affects up to 1 in 100 people ). very rare : may affect up to one in 10 or 1 in 1 , 000 people . uncommon ( may effect up to a maximum of 1 in a 10 or 10 in 10 ? ) undesirable effects in clinical trials immunogam may cause muscle pain , nausea , fatigue , induration , swelling and bruising . not known ( frequency cannot be estimated from the available data ). if you notice any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v .
keep this medicine out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . immunogam should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / 5 ml solution for injection contains human plasma protein ( hpp 96 ) and polysorbate 80 ( e421 ). what immunegam looks like and contents of the pack immunogam is presented as a clear to slightly opalescent , colourless to pale yellow liquid . each vial contains 1 vial .
remicade contains the active substance infliximab , which belongs to a group of medicines called ' tnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis ( ankylosing spondylitis , bechterew 's disease ) and p . remikade is used in adults , adolescents , children and adolescents aged 6 years and older with crohn' s disease or ulcerative colitis . in a small number of patients , it blocks the activity of the protein that is involved in tumour necrosis factor alpha . it works by blocking its action .
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine if : you or your child is allergic ( hypersensitive ) to tuberculosis ( tb ) or another serious infection ( e . g . pneumonia , sepsis , heart failure ). if any of these apply to you , tell your doctor or pharmacist . children and adolescents the use of remikade is not recommended in children below the age of 6 years . your doctor will tell you how long you will be treated . it is important that you continue to be treated for the first few weeks of treatment . you should not be given , however , your doctor may
remicade is used to treat rheumatoid arthritis in adults , adolescents and children 3 years of age and older , based on body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) and soriasis , ulcerative colitis , crohn 's disease in adults and children 5 years and above . the recommended dose is one ml of water for infusion with the medicine . it is given as an infusion ( drip ) over 2 hours in the veins of the upper arm . after the third treatment , the doctor will give you the next dose . you will be given two doses . your doctor will tell you how long you need to be given . this will be able to give the medicine over a short period of time .
like all medicines , this medicine can cause side effects , although not everybody gets them . the majority of side effects are mild to moderate . serious side effects may occur during or after treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor immediately : - an allergic reaction , such as swelling of your face , lips , mouth or throat , difficulty in swallowing or breathing , skin rash , hives or swelling of the hands , feet or ankles . these reactions may be serious and may be life - threatening . you should contact your doctor as soon as possible if any of these reactions occur . your doctor will tell you how long you need to take the medicine . allergic reactions are uncommon ( may affect up to 2 in 10 people ): allergic side effects 12 : pain in the muscles , fever 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . remicade can be stored at room temperature ( up to 25 ) for a single period of up to 3 months . after infusion , the product should be used immediately . it should be stored in the original package in order to protect from light . from a doctor or nurse , it should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what remicade contains - the active substance is infliximab . one vial contains 100 mg of remuin . - each ml of solution contains 10 mg / m2 of infusion . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , and dibasic salt ( e421 ). what retinol looks like and contents of the pack remikade is supplied as a glass vial containing a powder for solution for infusion and the powder is white to off - white . each pack contains 1 , 2 , 3 , 4 and 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults . it belongs to a group of medicines called levodopa , which is another medicine used for the treatment of parkinsons ' disease . parkinon 's disease is caused by a loss of cells that produce dopamine in the brain . this is a substance that is produced by the brain and is important for movement control . a high level of dopa is produced in the body , causing it to be released into the bloodstream . the active substance is called a neurotransmitter called neuropathic receptor .
do not take rasagiline mylan : - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe liver problems . your doctor may prescribe the following medicines : rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors . it is used to treat depression in patients with parkinson ' s disease . medicinal products are natural products , such as st . john 's wort , pethidine , a strong pain killer . children and adolescents this medicine should not be used in children less than 14 years of age . you should tell your doctor or pharmacist if any of these apply to you or your child .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . rasagiline mylan should be taken with or without food . if necessary , your doctor will tell you how many tablets to take and how often to take them . do not take more than the recommended daily dose of 1 tablet per day . you can take up to 1 tablet at the same time each day , by mouth or by injection . your doctor may prescribe a higher or lower dose , depending on how you respond to the dose you are taking . it is important that you do not forget to take the next dose as soon as you remember . take the rasagil mylan capsules with you , and then take the tablet with you straight away . this will help you remember to take it . however ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan : very common ( may affect more than 1 in 10 people ): very rarely , may affect up to 1 in 100 people . uncommon ( may effect up to one in 1 , 000 people ), may affect as little as 1 in 10,000 people very common abnormal movements ( dyskinesia ) headache common abdominal pain ( fall allergy ) fever flu ( influenza ) feeling of being unwell neck pain , chest pain ( angina pectoris ) common : not known ( frequency cannot be estimated from the available data ) if you notice any of the following : low number of neutrophils in the blood , tell your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly
what rasagiline mylan contains - the active substance is rasagiline . - each tablet contains a single - use tablet containing rasagilin tartrate equivalent to 1 mg rasagillin . the other ingredients are : tablet core : microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( e460 ), talc , stearic acid and water for injections . what rasamil mylan looks like and contents of the pack rasagile tablets are white to off - white , round , biconvex tablets , each containing 1 tablet . they are available in blister packs of 7 , 10 , 28 , 30 , 100 or 112 tablets in perforated blister packs . not all pack sizes may be marketed .
do not take hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have a severe infection ( tuberculosis ). symptoms of infections include : fever , wounds , feeling tired , dental problems . - you have moderate or severe heart failure or a serious heart condition . allergic reaction allergic reactions can include symptoms such as chest tightness , wheezing , dizziness or swelling , and a rash . these reactions may be signs of infections , such as an infection or localised infection . you should tell your doctor or pharmacist if any of these reactions occur . your doctor will tell you how long you should take 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . hulio is used to treat polyarticular juvenile idiopathic arthritis in adults , adolescents and children from 2 years of age and older . the recommended dose is 10 mg once a day for children and adolescents aged 30 years and above . your doctor may prescribe a higher dose if your child ' s doctor prescribes a lower dose , or if he / she will prescribe the right dose for them . this will depend on how much he or she will need to take . it is important that you read the leaflet carefully before you take it . you should also read the instructions for use in the box at the end of this leaflet . do not take more than one tablet at the same time each day . for enthesitis
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . if you notice any of the following side effects you may need urgent medical treatment : tell your doctor or nurse straight away : very common : may affect more than 4 people after the last hulio injection : allergic reaction , heart failure , severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever or bruising or bleeding . signs and symptoms of infection include : fever , feeling sick , bleeding , signs of infection such as fever and feeling sick ( vomiting ), nausea , vomiting , stomach upset , abdominal pain , difficulty sleeping , pain in the legs , headache , constipation , nausea
what hulio contains the active substance is adalimumab . the other ingredients are : monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , water for injections . what helio looks like and contents of the pack heilio 40 mg / ml solution for injection in a sterile solution . each 40 mg vial contains 0 . 8 % solution , colourless to slightly opalescent , with a rubber stopper . hülio is available in packs of 1 , 2 or 3 vials , each containing 1 or 2 syringe , 1 steril injection vial with 1 sterile needle , one vial adapter and 2 alcohol pads .
yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ). it is used to treat inflammation in adults , adolescents and children aged 12 years and older . yellax is used for the treatment of eye inflammation in adult patients who have had cataract surgery .
do not take yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have asthma , skin allergy or intense inflammation in your nose . you are taking other nsaids such as acetylsalicylic acid ( e421 ), ibuprofen , ketoprofent , diclofennac . this medicine is also used in combination with topical steroids , such as cortisone , which can cause unwanted side effects . bleeding problems such as haemophilia have been reported in the past , or you have taken other medicines to reduce bleeding time such as warfarin . your doctor will tell you if any of these apply to you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop of yellox per eye ( s ) once a day . your doctor will tell you how many drops to use . you should use the drops at least 2 hours apart . the drops should be used the next day after your cataract surgery . method of administration you should keep the bottle cap tightly closed in order to protect your hands from the drops . do not use the bottle if your thumb or fingers are firmly attached to your head , back , eyelid , finger , and the bottle tip to keep the eye closed . if this happens , contact your doctor immediately . it is important that you keep the dropper close to your eye until it is clear , clear and colourless . this will help to protect the
what yellox contains - the active substance is bromfenac . - each ml of solution for solution for injection contains the following ingredients : sodium sequihydrate ( equivalent to 33 mg / m2 ). - yellx contains boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride ( e464 ), tyloxapol , povidone ( k30 ), disodium edetate , and sodium hydroxide ( to reduce acidity levels ). the other ingredients are : a clear yellow liquid ( solution ) supplied in a carton containing 5 vials with a screw cap . not all pack sizes may be marketed .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain .
do not take dzuveo : - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a serious lung or breathing problem . if this applies to you , tell your doctor straight away . you may also be more likely to get sick . your doctor may decide to reduce your dose if necessary . do not stop taking a dose unless your doctor tells you otherwise . this is because you may have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). if any of these apply to you or you are not sure , ask your doctor or pharmacist for advice before starting treatment . it is important that you inform your doctor as soon as possible
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . the single - dose administration device should be used immediately . your doctor will tell you how much dzuveo to take and how often to take it . do not take this medicine with strong painkillers ( such as sufentanil ) for more than 30 days . take the sublingual tablet with or without food . if the tablet is swallowed , the tablet should be taken with a glass of water . you can take the tablet with the disposable single dose applicator on your tongue . once the tablets dissolve on the tongue , you can feel pain relief . swallow the tablet whole with water , for 10 minutes , until the maximum daily dose is 720 mg 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you notice any of the following side effects you may need immediate medical attention : severe breathing problems , slow and shallow breathing . if any of these side effects occur , stop taking dzuveo and contact your doctor . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick or feeling hot . commonside effects ( could affect up to 1 in 100 people ), inability or difficulty sleeping . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects by country , you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufentenil ( as citrate ), mannitol ( e421 ), dicalcium phosphate , hypromellose , criscarmellose sodium , indigo carmine , and stearic acid . - each tablet is a single - dose applicator ( labelled [ sublingual tablet ]) . the application is for use in children and adolescents aged 3 years and older . it is available in a blister pack containing one sufenil 30 mg tablet . pack sizes of 5 or 10 tablets . not all pack sizes may be marketed .
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body after surgical treatments . if you have sensitive prostate cancer , it may not be able to be treated with surgical treatment . your doctor will test your body for the presence of testosterone . you will also be given a medicine to treat resistant prostate cancer in which the body does not produce enough androgens to stop the cancer from spreading . the medicine works by reducing the amount of the number of prostate cancer cells in your body .
do not take erleada : - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you are pregnant , think you may be pregnant or are planning to become pregnant . if this applies to you , ask your doctor for advice . contraception section is not recommended . this medicine is not intended for contraception use . do not give this medicine to children under 18 years of age . you should tell your doctor or pharmacist if any of these apply to you or your child . children and adolescents this medicine may cause seizures . your doctor may prescribe any medicines to prevent blood clots ( such as warfarin or acenocoumarol ) to treat any heart or blood vessel conditions . heart rhythm problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take them . you can take erleada with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . take the tablet with food or drink . it is very important that you take the tablets at the same time each day to make sure that your doctor knows how to take it . if it is too strong or too weak , talk to your doctor , pharmacist or nurse . taking this medicine should be taken by mouth . this will help you to remember to take your tablet with other medicines you have taken . how long you need to take the medicine , take it as soon as you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you notice any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may include fever , flu -like symptoms ( toxic epidermal necrolysis ). serious side effects may include : fit or seizure . uncommon ( may affect up to 1 in 100 people ) when a patient is taking the medicine , it may cause a reaction called a swollen rash . if these side effects get serious , talk to your doctor or pharmacist . this includes any
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutamede , which belongs to a group of ingredients called colloidal anhydrous silica , croscarmellose sodium ( e464 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystalline cellulose . the film coating is iron oxide black ( see section 2 ). the other ingredients are macrogol , polyvinyl alcohol and talc , and titanium dioxide [ e171 ]). what erin looks like and contents of the pack erin erin is a clear , colourless to slightly yellowish - coloured , tablet - coating . it is available in packs containing 8 . 7 x 60
axumin is a radiopharmaceutical product that contains the active ingredient fluciclovine . it is used to perform a scan of a pet , if previously treated for prostate cancer . other tests have shown that the prostate specific antigen ( psa ) is present in the body . if the cancer has spread to other parts of the body the doctor will perform an acumin pet scan to check that the cancer is gone . the scan will be performed by a doctor , nurse or nurse . your doctor will discuss with you the benefits and risks of this procedure with you . you will be asked to take your own radiation dose and the risk of exposure to radiation .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor straight away . children and adolescents : if your doctor thinks you may be allergic , ask your doctor or nurse for advice . do not give this medicine to children under the age of 18 years . other medicines tell your pharmacist , nurse or pharmacist before you receive , or have recently taken any other medicines . the images may not be accurate . pregnancy and breast - feeding should not be given to children or adolescents under 18 years of age . your doctor will tell you how long you should take the test . it is important that you do not have a low sodium diet .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of radiopharmaceutical products is one dose of axumin per day . your doctor will tell you how many doses of this medicine to inject . during the procedure , you will be given 370 mg of megabecquerel . how much to inject the dose you will receive the dose that is right for you and will depend on how well you respond to the treatment . if your doctor tells you otherwise , your doctor may decide to increase or decrease the dose . it is important that you follow the instructions for the procedure carefully , and that you do not inject more than once a day , if necessary , or if the dose is too high or too low , then the dose may be too low or too high . do not use
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects have been reported : very common ( may affect more than 1 in 100 people ) side effects of the medicine are listed below . the most common side effects reported with axumin are : common : may affect up to 1 in 1 , 000 people : pain , rash , altered taste in the mouth and altered sense of smell . this radiopharmaceutical uses ionising radiation to treat cancer and hereditary abnormalities . reporting of side effects tell your doctor or pharmacist if you get any side effects not listed in this leaflet . you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . radiopharmaceuticals should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of radioactive materials . these measures will help protect the environment .
what axumin contains - the active substance is fluciclovine . one tablet contains one tablet containing 1600 mg / ml . - each tablet contains 1 . 600 mg flucclovine in 1600 / 16000 iu . the other ingredients are : tablet core : tablets : 3200 mg , 3200 micrograms , containing 3200 and 32000 Iu , sodium citrate , concentrated hydrochloric acid , and sodium hydroxide . see section 2 for more information on how to take the tablet . tablet core: tablets 1 - 10 tablets , 1600 - 16000 Iu tablets each tablet is supplied in a multidose of 1 or 10 tablets and tablets . tablets of 1600 and 16000 are also available in multidoses of 3200 . not all pack sizes may be marketed .
azopt contains the active substance brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . it reduces pressure within the eye by reducing the amount of water in the eye . the active substances are : salt , water , and adopt eye drops . this helps to reduce high pressure in the eyes . if you have an illness called glaucoma , the pressure in your eye can be too high , causing damage to your sight .
do not take azopt - if you have severe kidney problems . - are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine if : - you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes , infections , diuretics ( water tablets ). if any of these apply to you , tell your doctor or pharmacist . your doctor will check that you are taking the same allergy . you have too much acidity in your blood ( hyperchloraemic acidosis ). your doctor may decide to reduce the dose if it is appropriate for you . it is important that you do not receive adopt . kidney or liver problems , such as dry eyes and cornea problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one glass of azopt per day . your doctor will tell you how many glasses to use . the usual dose is 1 glass of water per eye . if your doctor tells you not to use your eyes , your doctor may prescribe a different dose . do not use more than once a day , unless your doctor advises you to . it is important that you do not change the dose if the dose is too much , or if it is too small , contact your doctor , pharmacist or nurse . children and adolescents do not take more than the prescribed dose , but the dose should be adjusted by your child ' s doctor . this will help you to remember to take your medicine . you should take a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) in the eye : blurred vision , eye irritation and eye pain . eye discharge : itchy eye or dry eye , abnormal eye sensation , and redness of the eye ( see section 2 ). other side effects include : bad taste . uncommon side effects that may affect more than 1 in 100 people - effects that have been observed in patients treated for eye infections , which have been associated with eye discharge ( e . g . itchy eyes , dry eye and abnormal eye senssation ) and sensitivity to light , especially in the upper eye and / or a feeling of bad taste ( see also section 4 ). very common : may affect less than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . a pack containing a single bottle should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg / m2 of brinzolide . the other ingredients are benzalkonium chloride , carbomer 974p ( edetate disodium ), mannitol , purified water , sodium chloride and tyloxapol , hydrochloric acid and sodium hydroxide ( used to control acidity levels and ph levels ). what if i get a high level of acidity , i . e . in a study , it is important that you read the label carefully before you take agopt , which is a milky liquid ( a suspension ) which contains 5 mg of solution . it is supplied as a 10 mg plastic ( droptainer ) bottle with a
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " medicines taken by mouth ". it is used to treat diabetes in adults , adolescents and children aged 18 years and over . the active ingredient is forxika . diabetes is a condition in which the body does not make any insulin . for xiga is used for the treatment of type 1 diabetes in adult patients who are overweight or obese . type 2 diabetes occurs when the body is not making enough insulin to control diabetes . your doctor will test your blood and your urine to make sure that the insulin is working properly . if you have diabetes , your blood may not work as well as it should . this will help to control the level of sugar in your urine . you will also be given a test to check your urine regularly to check how well you are doing .
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking : feeling sick or sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , sweet smell to your breath or a sweet or metallic taste in your mouth , odour to your urine , sweat , rapid weight loss , or any combination of the above symptoms . " diabetic ketoacidosis " is a condition in which your body produces increased levels of " ketone bodies " in your urine and blood . if any of these apply to you , tell your doctor or pharmacist . your doctor will monitor you closely for signs of diabetes . you may experience increased levels
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet once a day . forxiga is used to treat type 2 diabetes in adults , adolescents and children from 10 years of age and older , with or without food . your doctor may prescribe a dose of 10 mg once daily . if your doctor decides that your dose is too high , your doctor will adjust the dose based on your liver problem . you may need to take one tablet every day to make up for a forgotten tablet . do not take more than one tablet per day , unless your doctor tells you to . take your tablet with food , drink or snack . this medicine swallow the tablet whole with some water . it is important that you take it at the same time each day to reduce the amount of sugar
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with forxiga : angioedema ( may affect up to 1 in 10 , 000 people ) if you get angioendema , you may experience swelling of the face , tongue or throat , which may cause difficulties swallowing , hives or breathing problems . diabetic ketoacidosis ( type 1 diabetes ) has been reported in adults and in children aged 1 to 10 years . type 2 diabetes has been seen in adults , in patients aged 2 to more than 1 in 1000 people , and in patients with diabetes , there have been reports of increased levels of " ketone bodies " in your urine . if this happens , your doctor will check you for signs of diabetes . this includes any possible side effects not listed in this leaflet
what forxiga contains - the active substance is dapagliflozin . - a single - use , film - coated tablet ( tablet ) contains 5 mg of : - tablet core , containing the following ingredients : dapagllif lozin propanediol monohydrate equivalent to 5 mg / ml : the other ingredients are microcrystalline cellulose , lactose ( see section 2 ' for more information '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film  - coating , polyvinyl alcohol , titanium dioxide , macrogol 3350 , yellow iron oxide , colourless to pale yellow , round , oval , tablet , and / or ' 5 ' on one side and ' 0 . 7 
mepact contains the active substance mifamurtide . it works by inhibiting the growth of certain bacteria in the immune system , preventing them from multiplying . mepakt is used to treat osteosarcoma ( bone cancer ) in adults and adolescents 2 and 30 years of age , who have had surgery to remove the tumour or have received chemotherapy to kill cancer cells . this helps to prevent cancer from spreading and getting back to normal .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . this includes medicines containing ciclosporin , other calcineurin inhibitors , non - structurally active substances ( nsaids ) that can damage your heart or blood vessels , causing blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). your doctor will monitor you for signs of this . it is important that you tell your doctor or nurse if any of these apply to you . you should not be treated with this medicine for long - lasting , worsening symptoms . mepac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepact is 2 mg of mifamurtide once a day for 12 to 24 hours . your doctor will adjust your dose based on your dose and on your chemotherapy schedule . you will be given your chemotherapy 36 hours after your last dose . do not stop treatment with a dose that is too high or too low . how much to take you should tell your doctor , pharmacist or nurse if your doctor tells you to . if the dose is too low or too high , you may need to take the next dose at the same time each day . it is important that you follow your doctor' s instructions carefully , and that the dose you receive is the same as you should . treatment with mepacat may cause an interruption of the freeze 
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients treated with mepakt , which are transient and may be treated with paracetamol . if you experience fever , stop treatment and contact your doctor immediately . stomach problems , such as nausea , vomiting and loss of appetite , may occur after chemotherapy . tell your doctor or pharmacist immediately if continuing fever or chills persists for more than 8 hours . you should tell your healthcare professional straight away if any of the following happens : - you have an infection such as rash , any problems breathing or wheezing . your doctor will tell you how long you should be treated . it is important that you tell your health care professional immediately , as this may be a sign of an infection , rash or any problems whe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle in the outer carton in order to protect from light . reconstituted suspension contains sodium chloride 9 mg / ml . after reconstitution , mepact should be used within 9 days . this medicine should not be used if you notice any visible signs of deterioration .
what mepact contains - the active substance is mifamurtide . each ml contains 4 mg , corresponding to 0 . 08 mg . after reconstitution and suspension , each vial contains 1 . 0 mg / m2 . the other ingredients are : - 1 - palmitoyl - 2 - oleoyn- sn - glycoresoro - 3 phosphocholine ( see section 2 ) and - 2- dioleayn ' s glycero -3 phospho ' and l . sodium monosodium salt ( see page 2 for more information on the contents of this leaflet ), white homogeneous cake for solution for infusion . mepace 50 mg : pack of 50 vials with a grey buty
mirvaso contains the active substance brimonidine , which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness caused by rosacea . redness in the face is a sign that you have high levels of blood flow in the facial skin . this can lead to enlargement ( dilation ) of the small blood vessels of the skin , and thus reduces the amount of blood in the blood vessels , thereby reducing the excess blood flow and resulting in redness .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine , as this may increase the risk of side effects . the medicine should only be used under the skin . certain medicines used to treat depression in patients with parkinson ' s disease are monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( imipramine ), tetracyclic antidepressants such as maprotiline and mianserin , and mirtazapin . you should tell your doctor or pharmacist if any of these medicines are not suitable for you . your doctor will monitor you closely . tell you to take mir
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso will be given to you under the skin ( face ) by your doctor . this medicine is for oral use only . it does not have to be applied to other parts of the body , such as your eyes , mouth , nose or vagina . your doctor will tell you exactly how much to take and how often to take it . how to take the recommended dose is one tablet a day . you can take the tablet at any time of the day , with or without food . the usual dose is 1 gram of gel ( a pea - sized amount ) once daily . if your symptoms get worse , your doctor may prescribe the maximum daily dose of 1gram ( 5 pea size amounts ) twice daily on the face or on your hands 
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects include : severe skin irritation , inflammation , skin rash and skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects are : worsening of rosacea . the treatment should be stopped immediately if symptoms do not improve . see section 2 " mirvaso can cause contact allergy " for more information . allergic reaction , including rash , rare angioedema ( a serious allergic reaction that can cause a rash of the skin ). tell your doctor or pharmacist if you notice any of the following : - a severe allergic reaction which may cause skin irritation or inflammation . - skin pain , discomfort or dry skin and / or cold skin sensation ( 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . tube and pump do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimoniidine ( as 5 mg / m2 ) in the syringe ( e421 ). the other ingredients are : gel : carbomer : methylparahydroxybenzoate ( see section 2 ), phenoxyethanol , glycerol , titanium dioxide , propylene glycol , sodium hydroxide , purified water . see also section 2 for more information . - inactive substances ( see also " mtb ' in section 2 " in section 3 ). - mercaptoid ( brimidine ) is a white to off - white , opaque gel . it is available in packs containing 2 , 10 or 30 m
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that attaches to the immune system of your body ) and is used to prevent infection and cancer . mvai binds to a protein called human vascular endothelial growth factor ( vegf ), which is produced in the lymph vessels in your body and is produced by a process called recombinant stem cell transplantation . the veggf protein helps to increase the amount of blood vessels and oxygen that are needed . it is used as a medicine to treat advanced cancer in the large bowel ( colon ) that has spread beyond the colon .
do not take mvasi : - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents 6 years of age and older if your doctor thinks you may be allergic , hypersensitive or allergic to chinese hamster ovary ( cho ) cell products . if any of these apply to you , tell your doctor or pharmacist . pregnant or breast - feeding , do not give this medicine to children or adolescents under the age of 18 years . do not have a baby , unless your doctor tells you otherwise . your doctor will tell you if : you are not sure . it is important that you read the leaflet carefully before you are given 
administration the dose of mvasi depends on your body weight and the type of cancer you have . the recommended dose is 5 mg , 7 . 5 mg or 10 mg once a day . your doctor will decide the dose that is right for you . depending on how much you weigh , your doctor may decide to increase your dose to 15 mg . if you are not sure , talk to your doctor or nurse straight away . how much to give the doctor will tell you how many infusions you will receive . you will be given the medicine for 2 or 3 weeks . it is important that you continue to receive treatment with this medicine for as long as your tumour is growing . do not change the dose until your tumour grows back . administration mvai is given as an infusion into a vial containing sodium chloride solution , which is diluted with water . this diluted m
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with mvasi : very common side effects ( may affect more than 1 in 10 people ) if the side effects get serious , talk to your doctor , pharmacist or nurse straight away . if you notice any of the following serious side effects while you are taking the medicine , tell your doctor immediately : - side effects related to chemotherapy . these side effects may be serious and may be life - threatening . allergic reactions : an allergic reaction may cause difficulty in breathing , chest pain , redness or flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include : severe side effects such as : mild to moderate side effects that can be life
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion solutions should be used immediately after dilution . mvasi can be stored for up to 24 hours at 2 to 8 oc . from a microbiological point of view , in - use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours in the refrigerator and should be disposed of via wastewater or household waste . ask your pharmacist how to dispose of the medicine you no longer use . these measures will help to protect the environment .
what mvasi contains - the active substance is bevacizumab . each vial contains 25 mg of : - each ml contains 1 . 4 mg , 16 . 5 mg or 4 mg of 100 mg . - one vial containing 100 mg is a single - use solution for infusion . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 , water for injections and water for food and drink . what if you have any further questions on the use of this product , ask your doctor , pharmacist , or nurse . pack size : the vial is supplied as a clear , colourless to slightly yellow liquid in a glass vial with a rubber stopper . it is available in packs of 100 vials , each containing 4 or 400 mg of bevac
tecartus is a gene therapy medicine used in the treatment of mantle cell lymphoma . it belongs to a group of medicines used to treat refractory mastectomy , in which your own white blood cells ( autologous anti - cd19 - transduced cc3+ cells ) are destroyed by the body ' s own immune system , b - lymphocytes . if you have ever had a cancer that affects your immune system ( called a type of b lymphocyte ), you may have a higher number of these cells . when you have been told by your doctor or nurse that you have an uncontrolled way in which they are being destroyed , the b cells have been destroyed in the lymph tissue , bone marrow or blood . this helps to increase the number of the whiteblood cells in your blood ,
do not use tecartus - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . your doctor will check the number of white blood cells in your blood ( lymphodepleting chemotherapy ). children and adolescents 3 years of age and older : if this number is not enough , your doctor may decide to reduce your dose . tests and checks are performed to check your lungs , heart , kidney , blood pressure , infection , inflammation , or your cancer is a sign of graft - against - host disease . you have had a transplant and you have symptoms such as rash , nausea , and vomiting . tell your doctor or nurse if any of these apply to you
tecartus will be given to you by a doctor or nurse who is experienced in the use of your own white blood cells . your cells will be injected into a catheter placed in a vein . a procedure call leukapheresis will be performed to remove your whiteblood cells from your blood . this will take about 3 to 6 weeks , depending on how well your blood is circulating . the amount of your white blood cell count will be increased by 2 to 3 times a day . medicines will be prescribed to you during the course of treatment , such as lymphodepleting chemotherapy , to make sure that the modified blood cells remain in your body for at least 30 to 60 days . you may also be given other medicines to prevent infusion reactions such as fever . these other medicines should not be used if you have any further questions on these medicines .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the side effects listed below . if your side effects get serious , you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness and fluid in the lungs . all symptoms may be due to a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness and confusion , memory loss . common : may affect up to 1 in 1 , 000 people : headache , tremor , nausea , vomiting , diarrhoea , constipation , abdominal pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep infusion bag in the original package in order to protect from light . from a microbiological point of view , liquid nitrogen should be used immediately . tecartus 150 micrograms / ml : this medicine contains genetically modified human blood cells and human - derived material . this medicine must not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what tecartus contains - the active substance is autologous anti - cd19 - stimulated CD3+ cells . each ml contains a specific single infusion bag containing a dispersion of anti . 68 - CD19 car t cells ( 2 x 106 ) - anti , sodium chloride , human albumin ( see section 2 ) and water for infusion . the other ingredients are : - infusion in a plastic bag , a metal cassette , and a single infussion bag with 68 cells of cell diffusion . not all pack sizes may be marketed .
januvia contains the active substance sitagliptin . it belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase -4 inhibitors ). it is used to lower blood sugar levels in adults with type 2 diabetes mellitus . this medicine lowers the levels of insulin in your blood . if you are taking this medicine , your doctor will check your blood sugar to see if it is right for you . your doctor may decide to change the dose of this medicine to lower your type2 diabetes . you may need to take this medicine in combination with certain other medicines , such as insulin , metformin , sulphonylureas or glitazones . these are used to reduce blood sugar , helping to control your diabetes and prevent it from getting worse .
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : - you have inflammation of the pancreas , which can lead to pancreatitis . if this applies to you , tell your doctor straight away . you should contact your doctor as soon as possible , if there is blistering of the skin ( bullous pemphigoid ). if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist before taking a dose . it is very important that you tell the doctor if your doctor tells you to stop taking janusvia , as this may increase the risk of developing , or worsening of a disease
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg / 63 mg coated tablet taken by mouth . for patients with kidney problems , the usual dose is 25 mg or 50 mg of this medicine . this medicine can be taken alone or in combination with certain other medicines to lower blood sugar . your doctor will tell you how much januvia to take and how often to take it . if your blood sugar is too high or too low , talk to your doctor , pharmacist or nurse immediately . take a tablet with or without food . swallow the tablet whole with a glass of water . do not crush , crush or crush the tablet . it is important that you take the tablet at the same time each day . you should not take more than one tablet at a time . taking jan
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) of your back , nausea or vomiting . you may have an inflamed pancreas ( pancreatitis ). this is a serious allergic reaction ( frequency not known ). rash , hives , blisters on the skin or peeling skin , swelling of the face , lips , tongue , and throat , difficulty in breathing or swallowing . if any of these side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet .
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains a single - - use tablet called " symbiosis ". it is a clear , colourless to pale yellow powder . the other ingredients are : - tablet core : silicon dioxide ( e171 ). - tablets : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . tablet coating : poly ( vinyl alcohol , macrogol 3350 ), talc , titanium dioxide , red iron oxide and yellow iron oxide . - each tablet contains one tablet . not all pack sizes may be available in pvc / plastic bottles .
xultophy is used to control blood glucose in adults with type 2 diabetes mellitus . diabetes is a condition in which your body does not make enough insulin . the insulin that your body produces does not work well enough to control the level of blood sugar . insulin degludec , a long - acting basal insulin , helps to control your blood sugar levels . liraglutide ( glp - 1 ) is used when you are not using insulin during meals . you should not take xkultophy alone or in combination with oral medicines to treat diabetes . it is important that you take oral medicines for diabetes such as metformin , which are used for the treatment of diabetes in adults .
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 - you are taking a sulfonylurea such as glimepiride or glibenclamide . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine , as this may affect your blood sugar levels . your doctor will monitor you closely for type 1 diabetes mellitus ( also known as ' ketoacidosis '), which is a condition in which you are being treated . you may also be at risk of developing inflammatory bowel disease or delayed gastric emptying ( diabetic gastroparesis ). x
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . xultophy should not be used in patients who are blind or have poor eyesight . your doctor will check your blood sugar level regularly to make sure that it is not too high . the recommended dose for adults is 41 mg / kg of body weight once a day . you should not exceed the recommended daily dose for children and adolescents of 8 years of age and older . how much to use the dose you should take the recommended starting dose is one tablet . it is recommended that you use the tablet in a pre - filled dial - a - dose pen with the dose counter . 1 tablet of insulin degludec ( 0 . 036 mg ) and liraglutide is recommended . however , the maximum daily dose is 50 mg twice a
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar . very common ( may affect more than 1 in 10 people ): if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia , which can cause brain damage , can be life - threatening . if you notice that your blood glucose level is too low , you may be at increased risk of hypogycaemia ( see section 2 ). if this happens , talk to your doctor or pharmacist straight away . you may experience serious allergic reaction ( anaphylactic reaction ) with frequency not known ( frequency cannot be estimated from the available data ). your doctor may decide to reduce the number of local reactions . this is because xultophy can cause allergic reactions , such as severe allergic reaction . local reactions
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . xultophy may be stored at room temperature ( up to 30 ) for up to 8 weeks . after that , it should be used within 21 days . this medicine does not require any special storage conditions . however , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains - the active substance is insulin degludec . each vial contains liraglutide equivalent to 100 mg insulin . - each ml contains 3 . 6 mg of insulin d / l , corresponding to a dose equivalent to 300 mg . the other ingredients are : glycerol ( e421 ), phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 ). - sodium : 1 , 3 or 5 tablets - a multipack containing 10 tablets , each containing 2 vials . not all pack sizes may be marketed .
giotrif is a medicine that contains the active substance afatinib . it belongs to a group of proteins called egfr [ epidermal growth factor receptor ] . these proteins are called erbb1 , her2 [ herbb2 ] and her3 . by blocking these proteins , cancer cells multiply and multiply . this medicine works by reducing the number of cancer cells in your body . the effect of this medicine is similar to that of other medicines used in the treatment of cancer of the lung ( non - small cell lung cancer ). if you are not sure , talk to your doctor , pharmacist or nurse . your doctor will prescribe gio trif for you as your first treatment . prior chemotherapy treatment for patients of squamous type who have not received previous chemotherapy treatment , this medicine may not be suitable for you .
do not take giotrif : - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . children and adolescents 6 years of age and older , low body weight 50 kg , kidney problems . side effects include : lung inflammation , interstitial lung disease , liver problems , and some liver tests . this medicine is not recommended for patients with a severe liver disease . eye problems : severe dry eyes , inflammation of the transparent layer of the eye ( cornea ) and ulcers in the eye . tell your doctor or pharmacist if any of these apply to you . your doctor may need to monitor you more closely before you are given the medicine , as this may increase the risk of side effects . lung inflammation (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how much giotrif to take and how often you should take it . take the tablet with a glass of water . do not crush or chew the tablet . swallow the tablet whole with some food . you can take the tablets at any time of the day , with or without food , at the same time each week . this will help you remember to take the medicine . it is important that you do not take more than this medicine than you should . if it is too strong or too weak , talk to your doctor , pharmacist or nurse straight away . taking this medicine , take it at least 1 hour before or 3 hours before you start taking it , and then take the next dose
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may occur with treatment : diarrhoea : very common ( may affect more than 1 in 10 people ): if you have a mild or moderate form of diarhoéa ( see section 2 ' common '). - if your doctor has told you that you may be suffering from severe diarrhea or fluid loss . common : may affect up to 1 in ten people , low blood potassium and worsening kidney function . if this happens , you should contact your doctor immediately . it is important that you continue to receive appropriate antidiarrhaeal treatment . you should also receive antidistributive medicine prior to and after taking the medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking 
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg / 0 . 5 ml ( corresponding to 20 mg in a tablet ). - other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 . what the pack looks like and contents of the pack giotricf 20 mg film . giotrigif is supplied in blisters containing 1 , 2 or 4 films . the tablets are supplied in packs containing blisters of 7 and 1 films , each blister contains 7 tablets . not all pack
orkambi contains the active substance lumacaftor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults , adolescents and children ( aged 6 years and older ) with f508del mutation , a protein in the cystic fibrillation transmembrane conductance regulator that controls the flow of air through the lungs . the mutation causes the body to produce a different type of protein , called an abnormal fftr protein . i .e ., the protein is mainly made by the body ' s own proteins , which is important for the normal function of the f508del protein and is essential for the growth of new cells , and for the development of new ones . your doctor will work out how to make lum a caffeft
do not take orkambi - if you are allergic to lumacaftor , ivacafter or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . tell your doctor or nurse if : - you are not sure , or if your doctor thinks you may be allergic , ask your doctor for advice . if any of these apply to you , it is important that you read the leaflet carefully before you take it . the f508del mutation is not known . warnings , precautions or advice is not recommended . you should not take , have liver or kidney disease . your doctor will tell you if the dose is too high or too low . abnormal blood tests of the liver may be necessary before you start taking or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 6 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take them . orkambi tablets should be taken at least 6 hours apart . children and adolescents 12 years of age and older : the usual dose is 11 mg / kg of body weight . if your doctor prescribes a higher dose , your doctor may prescribe a lower dose based on your child ' s age . it is recommended that you take at least one tablet at the same time each day , at least two tablets in the morning and one tablet in the evening . do not take more orkimambi than your doctor tells you to take . you can take the tablet at any time of the day or at the usual time .
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi and ivacaftor are usually mild to moderate . if you experience any of the following serious side effects you should stop taking the medicine and contact your doctor immediately : - raised levels of liver enzymes in the blood - liver injury - pre - existing severe liver disease - the worsening of liver function - common side effects ( may affect up to 1 in 100 people ) - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes - loss of appetite - nausea , vomiting , diarrhoea - vomiting - stomach pain - difficulty breathing - bloating - increased levels of uric acid in the urine - decreased levels of creatine phosphat
what orkambi contains - the active substance is lumacaftor . each tablet contains two active substances : ivacafter , or 100 mg and 125 mg . one 100 mg tablet contains 100 mg / 0 . 5 ml solution . - each 125 - mg solution consists of one 0 and one 200 mg tablet , corresponding to one 200 mb2 solution , which is equivalent to two 200 mg tablets , each containing a total of 200 mg , respectively . the other two are : the other half of the pack , the other side of the 100 mg or a , and the other part of the 200 mg ( adolescent ), the other containing one 125 micrograms ( analogues ) of the ivacafta . orkabambi 100 micro
lynparza contains two active substances , olaparib and adriamycin . o laparib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it is used to prevent mutations ( changes ) in brca ( breast cancer gene ) that cause cancer . parp inhibitors can cause death of cancer cells , which are damaged by an enzyme that helps to repair dna . what is the purpose of the medicine , and how it works , is to treat ovarian cancer , in which brca is mutated and the cancer has not responded to previous treatment with standard pllatinum . this medicine is used in adults , adolescents and children . it is also used to treat adult patients with brca ,
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents 6 years of age and older should not take this medicine after the expiry date which is stated on the carton and on the blister after exp . if this applies to you , tell your doctor or nurse immediately . do not give this medicine to children under the age of 2 years . you should not give your child more than the prescribed dose . before you start taking the medicine , your doctor will check your child ' s blood cell counts before and during treatment . in testing , low counts of red or white blood cells ( low platelet counts ) may occur . see section 4 " possible side effects " for more information .
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg capsule once a day . your doctor will tell you how many 150 mg capsules to take . depending on the dose you take , your doctor may increase or decrease the doses of lyrase capsules or tablets . a capsule is a tablet that contains the active substance . it is used to treat side effects in adults 8 years of age and older . you can take the tablet by mouth or in the evening with or without food . swallow the capsule whole with a glass of water . do not crush , crush or chew the capsule . take the capsules with food , drink , or snack . children and adolescents the dose should not exceed the recommended daily dose . adults the dose may be taken with
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat , symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( could affect up to 1 in 100 people ), allergic reactions , hives , difficulty breathing or swallowing , dizziness . these may be signs and symptoms of hypersensitivity reactions . other side effects have been reported in patients taking lynparza . the following side effects may occur with this medicine : very common : may affect as many as 1 user in 10 , 000 people , being sick , having a cold or being sick ( e . g . feeling sick ), feeling tired or pale skin or fast heartbeat . symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep any lynparza capsules in the outer carton in order to protect from light . after first opening , the capsules should be used within 30 days . if not used within 3 days , do not throw away any capsules via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg / ml . the other ingredients are : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( see section 2 ). what linparza looks like and contents of the pack the capsule is a white , opaque , hard capsule containing the word ' ' on one side . it is printed with the astrazeneca logo on the other side of the capsule . lilparza is available in packs containing 112 or 448 capsules . not all pack sizes may be marketed .
nyxoid contains the active substance naloxone , which belongs to a group of medicines called opioids , such as heroin , methadone - fentanyl , oxycodone , buprenorphine and morphine . the other ingredients are : this medicine is used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children 14 years of age and older , who are at increased risk of having an overdose due to breathing problems , severe sleepiness , and if you have ever had or might have had an opioidoverdose , talk to your doctor , pharmacist or nurse .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if this applies to you , you should contact your doctor or go to the nearest hospital emergency medical care or emergency services immediately . an opioid overdose is a serious and serious event . your doctor will tell you how to treat the signs and symptoms of an opioidoverdose . this nasal spray should be used within 2 to 3 hours after you have used it . you should use a new nasal spray . it is important to use this medicine when you are physically dependent on opioids such as heroin , methadone , fentanyl or oxycodone , buprenorphine or morphine .
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one spray a day . your doctor will tell you how many sprays to use . the dose is based on your symptoms : shoulders , ears , breastbone ( sternum ), ear , fingernail . clear the mouth and nose of any blocksages . if your mouth or nose is not clear , talk to your doctor , pharmacist or nurse . 1 . breathing is the chest moving . in this case , your chest may hear breathing sounds or breath on the cheek . overdose can cause a response to touch or sounds , slow uneven breathing . do not use this product unless your doctor tells you to . it is very important that you tell your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine . nyxoid can cause acute withdrawal symptoms in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps feeling sick ( vomiting ), diarrhoea , sweating , fever , goose bumps , shivering and trembling changes in behaviour such as violent behaviour , nervousness and anxiety . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . - each nasal spray contains 1 . 8 mg / ml ( equivalent to one g - solution containing n - chloride dihydrate ), trisodium citrate dihydrate ( e421 ), sodium chloride , hydrochloric acid , sodium hydroxide and purified water . each vial contains 0 . 1 g of neoprene in a pre - filled nasal spray and a single dose container . the contents of the pack are white to off - white , colourless to pale yellow , opalescent , round , oval - shaped spray , with or without a lidded , single dose bottle , and / or a carton containing 2 nasal sprays in
this medicine contains the active substance follitropin alfa . ovaleap is a gonadotropin , a type of hormone called " fsh ", which is involved in the growth and development of the sacs ( follicules ) in the ovaries and in the production of sperm ( a mature egg cell ). treatment with a medicine known as " clomifene citrate " is used in assisted reproductive technology procedures ( procedures used to get pregnant ). this medicine is used to treat women who are not able to have a baby . it is also used in combination with : - one medicine called " lipopinalfa ", - another gonadopin " or " luteinising hormone ", and - the combination of two different types of hormones called " human chorionic gonadotropic " in women who
do not use ovaleap : - if you are allergic to follitropin alfa or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine if : you have a tumour in your hypothalamus or pituitary gland ( part of the brain ). - you have large ovaries ( sacs of fluids ) in the ovary ( ovarian cysts ). you have unexplained vaginal bleeding . you have cancer in your ovates , womb or breasts or any condition that makes normal pregnancy impossible . it is important to tell your doctor as soon as possible . - your doctor will check that you have any condition which may make normal pregnancy possible , such as ovarian failure 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much ovaleap to use the recommended dose of this medicine is one injection into a tissue under the skin ( subcutaneous injection ). it is recommended that you inject this medicine within the first 7 days of your menstrual cycle . your doctor will tell you how many doses to use . the usual starting dose is 75 mg / m2 body surface area . this medicine will be given to you by a doctor or nurse . in women , your doctor may prescribe a higher or lower dose of 150 mg per day . you will receive this medicine for 7 days to 14 days at 37 . 5 ml . if your doctor prescribes you this medicine , you should inject the medicine at least 225 mg of hcg once a week . laboratory testing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 common ( may affect up to 1 in 10 , 000 people ) type of reaction . if you notice any of the above , stop your ovaleap injection and contact a doctor immediately . you may experience serious side effect in women lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian hyper - stimulation ( ovulation ). if any of these occur , talk to your doctor , pharmacist or nurse straight away . this includes any possible side effects not listed in this leaflet .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the pen cap after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine can be stored for up to 3 months at room temperature ( up to 25 ). this medicine should be used within 3 months after first opening of the cartridge . if not used immediately , the cartridge can be used immediately after opening , preferably within 28 hours of opening of 25 . the cartridge cap must be removed from the ovaleap pen if you notice that the medicine is cloudy , or if the solution is clear , colourless or opalescent . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines
what ovaleap contains - the active substance is follitropin alfa . each cartridge contains 300 mg / 0 . 5 ml of solution for injection . - one cartridge of 300 mg or 22 mg dna for injection contains a total of a single - dose of ferocin . the other ingredients are : - acetate , in a glass vial , containing a trace amount of st . martinibose ( e421 ) and adolescent ( sc ). - anaesophagus ( fc ) in one vial of ff . in the other , the smallest dose is 450 mg in one . 75 mg in two vials . 33 % of the total dose is 33
voriconazole accord contains the active substance vorikonazole , which is an antifungal medicine used to treat the fungi that cause infections . it is used in adults and adolescents ( aged 2 years and older ) to treat invasive aspergillosis ( a fungal infection caused by scedosporium sp ) and candidaemia , a type of fungal illness caused by candida spp . in non - neutropenic people with abnormally low white blood cells count . candidasp. infections are caused by the flora . fluconazol is a combination of two antibiotic medicine to treat serious fungal infections , caused by two different fungus species , such as a spore sc . f . and fusarium .
do not take voriconazole accord - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine accord . this includes any other medicines , including herbal medicines . your doctor will tell you what the medicines are and when to stop the treatment . 46 terfenadine ( used to treat allergy ), astemizole ( for allergy ) and cisapride ( used for stomach problems ) pimozide ( for mental illness ) quinidine ( used in patients with irregular heart beat ) rifampicin ( for tuberculosis ) or efavirenz . tell your doctor or pharmacist if any of these apply to you . children and adolescents this medicine is not recommended for children and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much voriconazole accord to use the dose depends on your weight and the risk of infection . the usual dose is 40 mg once a day for 24 hours . your doctor will prescribe a dose of 400 mg once per day for 12 hours , 24 hours after the first dose . if the dose is too low , your doctor may increase the dose to 200 mg once every day , 12 hours after a single dose of 200 mg , or 100 mg per day . after treatment , the recommended dose is 300 mg once daily for mild to moderate cirrhosis . children and adolescents 2 - 12 years of age and adolescents 12 - 14 year of age , 50 mg twice daily for 12 weeks and 14 years , and a maximum of 50 mg once weekly for
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any side effects not listed in this leaflet . serious side effects of voriconazole accord include : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects common ( may affect up to 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision or nightblindness or swinging vision . these may be signs of eye disorder such as : halos ( night vision ) and night blindness ( swiping vision ). these may also occur in children and adolescents . the frequency of these effects is not known .
what voriconazole accord contains - the active substance is vorikonazole . each 50 mg film - coated tablet contains a single dose ( equivalent to one tablet ) of vermiculite . - one tablet contains 200 mg of vermirulite ( the other ingredient being lactose monohydrate , pregelatinised starch ), croscarmellose sodium , povidone , magnesium stearate , hypromellose , titanium dioxide ( e171 ). the other ingredients in the tablet core are : laucine , lactoses monohydrate and triacetin . the film  - coating contains the active ingredient in the film and contains the tablet coating . voricole accord is supplied in a glass vial . not all pack sizes may be marketed .
mvabea is a vaccine to prevent ebola virus disease in the future . it is given as a single dose . the recommended dose is 1 dose , containing the active substance ( zabdeno ) per day . a 2 dose course of vaccinations is given to help protect you against the zaire , leukococcus and filovirus . this vaccine protects against the whole , unadulterated form of the zebrafish virus , which can cause you to develop a severe form of a virus . you will be given a dose of the whole virus to help prevent you from developing a new form . your doctor will decide how long you need to be vaccinated . vaccinations will usually be given in a hospital or clinic for 8 weeks later than usual . in addition , your doctor may decide to give you
always use mvabea exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the vaccination course and the dose of the vaccine will depend on whether you have had a severe allergic reaction ( see section 6 ). if your doctor thinks you may have a serious allergic reaction to an antibiotic ( such as ' gentamicin ') or to any of the other ingredients in the vaccine , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may decide to change the dose , depending on the severity of the allergic reaction . if the vaccine is given to you , you should contact your doctor immediately . you may need to stop the vaccine from working properly . it is important that you follow the instructions for use in this leaflet . do not give m
mvabea is a vaccine that is given by injection into a muscle ( intramuscular injection ) in either the upper arm or the lower thigh , through a blood vessel . vaccination with zabdeno vaccine is given 8 weeks later . if you are not sure , talk to your doctor , pharmacist or nurse . your doctor will decide on the best dose for you . the second vaccine will be given as a single dose . primary vaccination first vaccination , given in a red cap vial , is given in two doses . second vaccination is administered in the form of a white to off - white - coloured vial and is given to children aged 8 years and older , who are not able to carry on the first vaccination in the first dose , and a booster vaccination . you will receive one dose each week . do not take more
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects have been reported with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth or swelling after the injection . very tired muscle ache joint pain common : may affect up to 1 in 100 people : sick ( vomiting ) itching after receiving the injection uncommon : can affect up , 1 to 100 people redness or skin hardness following the injection generalised itching . other side effects include : headache , nausea , vomiting , diarrhoea , numbness , and tingling of the skin . if you get any side effects not listed in this leaflet , talk to your doctor , pharmacist or nurse . this includes any possible side effects listed in appendix v . by
what mvabea contains the active substance is zaire ebolavirus 29 . the other ingredients are : tai forest ebavirus nucleoprotein marburg , 0 . 7 mg / 108 ml , chicken embryono fibroblast cells . this vaccine contains trace residues ( e . g ., gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid , for ph adjustment ). this is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . each vial contains 20 vials . not all pack sizes may be marketed .
bondronat contains the active substance ibandronic acid , which belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer in adults , adolescents and children with ' bone ' metastases ' where your bones are damaged , breaking ( fractures ) or other bone problems that may need surgery or radiotherapy bondronate can cause a raised calcium level in your blood , a tumour that has spread to other parts of your body , or which is lost from your bones , making your bones weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low levels of calcium in your blood . this medicine can cause side effect called osteonecrosis of the jaw ( onj ). bone damage in the jaw may occur after taking bondronate . - you have cancer or related conditions . your doctor may decide to stop treatment . onj is a painful condition that can increase the risk of developing osteoonecrosus of the wrist . some precautions you should take before starting treatment , especially if your mouth or teeth are damaged . you may have poor dental health or gum disease , a planned tooth extraction or routine dental examination . tell your doctor immediately if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bondronat will be given to you by a doctor experienced in the treatment of cancer . it is given as an infusion into a vein . your doctor will carry out regular blood tests before you are given this medicine . the recommended dose of this medicine is one infusion in your vein once a day . if your illness is severe , your doctor may decide to reduce your dose . breast cancer that affects the bones , it may take 3 to 4 hours . you will receive a single dose of 3 to -4 days . this is based on how well your doctor tells you to . however , if the dose is too low , you will be notified by your doctor as soon as possible . in case you have a higher calcium level in your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : very common ( may affect more than 1 in 1 , 000 people ): persistent eye pain caused by inflammation new pain , weakness , discomfort in your thigh , hip or groin , unusual fracture of the talus ( common ) ( rare ) : may affect up to 1 in 10,000 people : pain or sore in your mouth or jaw . severe jaw problems caused by necrosis ( dead bone tissue ) in the jaw or bone . ear pain accompanied by discharge from the ear . this may be a sign of an ear infection . bone damage in the ears . not known : frequency cannot be estimated from the available data .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after dilution the infusion solution should be used immediately . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg of concentrate for solution for infusion . the other ingredients are : sodium monohydrate ( e460 ), sodium chloride , acetic acid , sodium acetate , water for injections and water for administration in a glass vial with a bromobutyl rubber stopper . not all pack sizes may be marketed .
zeposia belongs to a group of medicines called white blood cells and lymphocytes . what zeposia is used for the treatment of relapsing remitting multiple sclerosis ( rrms ) in adults . it is used to treat adults with active disease called multi-organ failure . ms is a disease that affects the body ' s immune system , which helps the body to fight off infections . this helps to increase the number of these cells , especially in the nerves of the brain , spinal cord and nerves , and reduces symptoms such as numbness and difficulty in walking .
do not take zeposia : - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zeposia if : you have a severely weakened immune system . you have had a heart attack ( angina ), stroke , mini - stroke ( transient ischemic attack ), tia or severe heart failure in the last 6 months . - you have irregular or abnormal heartbeats ( arrhythmias ) in your heart . your doctor will monitor you closely during treatment , if any of these apply to you or your child ' s doctor will check you for signs of severe infection ( hepatitis ), tuberculosis , cancer , severe liver problems or if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zeposia is based on your heart rate . your doctor will give you a ' treatment initiation pack ' with instructions on how to start treatment . you will be given 4 capsules of 0 . 23 mg of ozanimod once a day for 1 week . after 4 weeks of treatment , your doctor may increase your dose to 3 capsules , each day , for 3 weeks , at a lower dose of 0.46 mg / ml . if your doctor tells you otherwise , you will receive 5 capsules ( 6 capsules per day ) and 7 capsules each day for 8 weeks . it is important that you follow the instructions for a maintenance pack containing orange capsules with a dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need immediate medical attention : very common ( may affect more than 1 in 10 people ): slow heart rate , urinary tract infection , blood pressure common : may affect up to 1 in 100 people allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist , or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects they mean you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice any damage to the pack , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg / ml . - each capsule is filled with 0. 23 mg of oznimod ( as hydrochloride ). - one capsule contains 0. 46 mg , ozaimod in a single solution . the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous ( e460 ), croscarmellose sodium , magnesium stearate . capsule shell contains 0.23 mg iu , gelatin , titanium dioxide , yellow iron oxide red ( encoding ink ). not all pack sizes may be marketed in your country .
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . the other ingredients are : - flutaxelonefuroate belongs to a group of medicines called corticosteroids and steroids . - umeklidinium brmide belongs to the group called bronchodilators and is used to treat breathing difficulties in adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties . in copd the muscles and / or breathing difficulties are affected . when copd occurs , the muscles may stop breathing normally . this is because copd affects the ability of breathing in the airways . it is important for copd to be able to breathe properly . cop
do not take temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . do not chew or chew the tablets . warnings : children and adolescents do not give this medicine to children under the age of 6 years . temibric alprazolam is not recommended for use in children under 6 years of age . tell your doctor or pharmacist if : you have asthma , heart problems , high blood pressure , liver problems or tuberculosis ( tb ) of the lung or any long standing or untreated infections . you have an eye problem called narrow - angle 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inhale the recommended dose is one inhalation every 24 hours . your doctor will tell you how much temybric ellipta to use . do not use more than your doctor tells you to do . take the dose as prescribed by your doctor , pharmacist or nurse . the usual starting dose is two inhalations a day . inhaling a single inhaler every day for up to 24 hours depending on how long you need to use it . it is important that you do not take more . if it is too strong or too weak , contact your doctor immediately . you may experience symptoms of a sudden attack of breathlessness or wheezing . this may be caused by an attack . use a quick -
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing starts to get wheezing , stop taking this medicine and contact your doctor immediately . pneumonia is an infection of the lung ( copd ). this is a very common side effect of temybric ellipta . symptoms of a lung infection include fever , chills , increased mucus production , change in mucous colour and increased cough . increased breathing difficulties common side effects ( may affect more than 1 in 10 people ): sore , sore throat , tingling or numbness . these may be symptoms of an infection , such as fever or chills or increase in blood pressure . if you get any of the following , talk to your doctor or pharmacist . this includes any possible side effects not listed in this
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each inhaler contains 92 mg of fluticsone fumoate ( for inhalation in adults 65 years of age and older ) and 65 mg of umeklidinium brmide . the other ingredients are : 55 mg / ml , inhaling inhalers containing 55 mg or 00 % , and 22 mg , respectively , vilantrol , trifenatate , lactose monohydrate ( see section 2 under ' how to inhale milk '), magnesium stearate and water for injections . what the heck is the name of the pack the ellibta inhalator is a light grey plastic body
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. zinfordo is used to treat infections of the skin and the tissues under the skin . if you have an infection of the lungs ( ' pneumonia '), your doctor or nurse will prescribe the right dose for you . your doctor , nurse or pharmacist will work with you to determine the best treatment for your condition . this medicine works by killing certain bacteria and preventing serious infections .
do not take zinforo : - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have been allergic to other cephalosporin antibiotics , or previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . if any of these apply to you , tell your doctor or pharmacist before taking the medicine . your doctor will check that you are not sure . you should not take the medicine without first talking to a doctor . before you are given the medicine it is important that you read the instructions carefully and follow the instructions . it is also important to read the information carefully before you start taking it . children and adolescents do not give this medicine to children under the age of 18 years
always take zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 600 mg once a day . your doctor will tell you how many tablets to take and how long to take . you should take the tablets at least 12 hours apart . take the tablet at about the same time each day , with or without food . for some infections , the dose may be increased to 600 mg every day for up to 8 hours . if this is not enough for you , your doctor may prescribe a higher or lower dose . this will be given to you by a drip into a vein . it is recommended that you take a dose of 5 mg , 60 mg or 120 mg . in case of an increased dose , treatment should be continued for 5 to 14 days . skin infections should be treated within 5 to 7 days 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of these symptoms and you need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . if this happens , you may be at risk of a serious or severe allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinforo may be stopped . medicines may slow bowel movement . very common ( may affect more than 1 in 10 people ): a blood test ( a ' coombs test ') or antibiotic . this test may be repeated if necessary . your doctor will tell you how long you will be treated . talk to your doctor if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 to 8 ). do not freeze . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine and ethylhexylglycerol ( e421 ). what znforo looks like and contents of the pack zafroo is a pale yellowish , light yellow powder for solution for infusion in a vial . each vial contains 10 ml of powder .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathy pain is long lasting pain caused by damage to the nerves . it is caused by a variety of diseases , including peripheral neuropathy in adults with diabetes and shingles . pain sensations such as burning or throbbing , shooting , stabbing or sharp , cramping or aching or tingling or numbness are common .
do not take pregabalin pfizer : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine . if any of these apply to you , tell your doctor or nurse straight away . before you are given the medicine you may experience symptoms of an allergic reaction . these symptoms may include swelling of the face , lips , tongue , and throat , diffuse skin rash . your doctor may decide to reduce the risk of these reactions . you may also experience dizziness or somnolence , which may lead to accidental injury or fall . when you are taking the tablet , your vision may become blurring , loss of vision or other changes in eyesight . talk to a doctor or pharmacist about any changes in your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is used for the treatment of peripheral and central neuropathic pain in adults with epilepsy or generalised anxiety disorder . the usual dose is 150 mg once a day . your doctor may prescribe a different dosing schedule depending on how you respond to the medicine and on how well your body responds to it . it is recommended that you take one tablet in the morning or two tablets in the evening . you should not take more tablets than you should if your doctor tells you to do so . 59 - if the dose is too low , talk to your doctor , pharmacist or nurse as soon as you remember . do not change the dose unless your doctor advises otherwise . in the unlikely event that your kidneys are not working
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . uncommon ( could affect up to 1 in 100 people ), increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , disturbance in clumsiness and memory impairment , loss of memory . tremor , difficulty with speaking and tingling feeling . the most common side effects are : - a feeling of weakness , inability to concentrate , lack of concentration , increased sensitivity to light , low self - control , decreased sense of taste , reduced sense of smell , poor taste . other side effects include : common : may affect
what pregabalin pfizer contains - the active substances are : 25 , 50 , 75 , 100 , 150 , 200 , 225 , or 300 mg / ml . the other ingredients are lactose monohydrate , maize starch ( e464 ), talc , gelatine , titanium dioxide , sodium laurilsulphate , anhydrous colloidal silica , black ink with black iron oxide , propylene glycol , potassium hydroxide ). the 75 - mg capsules are white to off - white , oval - shaped , with ' m ' printed on one side and ' 100 ' on the other side . each bottle contains 200 or 225 capsules . not all pack sizes may be marketed .
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this helps the brain to work more efficiently . it is used for the treatment of parkinson ' s disease in adults , adolescents and children aged 2 years and older . the use of x - 0 . 5 ml is not recommended because of the risk of sudden switches in the way you are able to move . if you have difficulties moving , talk to your doctor , pharmacist , or nurse . how xdogo works the medicine with levodopa and other medicines used to treat parkinsons ' disease are listed in section 2 .
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . - you are taking one of the following medicines : monoamine oxidase ( mao ) inhibitors ( selegiline , rasagiline ), moclobemide , phenelzine ( isocarboxazid ), tranylcypromine ( used in treatment for parkinson ' s disease and depression ). - pethidine ( used as a strong pain killer ) should not be used in children and adolescents less than 7 years of age . your doctor may decide to reduce your dose if he or she is not sure .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of xadago is one 50 mg tablet once a day . the usual dose is one 100 mg tablet taken by mouth . your doctor will tell you how many tablets to take . if your doctor tells you that you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take the tablet with a glass of water . do not take more tablets than your doctor told you to . you should take your tablet at the same time each day , with or without food . it is important that you tell your doctor , pharmacist or nurse , or nurse as soon as you remember . warnings and precautions talk to a doctor or nurse straight away if : you have raised blood pressure ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis , very high blood pressure , collapse ( neuroleptic malignant syndrome ), confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). confusion ( hypertension ), muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with xadago : parkinson ' s disease , safinamide and levodopa . if you get any of the side effects listed above , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v .
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg of s . the other ingredients are : tablet core : methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ) and iron oxide red ( see section 2 ). what is x - containing the active substances are as follows : tablets are white to off - white , biconcave film - coated tablets of 7 mm diameter with metallic gloss . tablets are supplied in blisters containing 50 mg , 100 mg tablets . not all pack sizes may be marketed .
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer in adults , adolescents and children , who are not able to control their own levels of testosterone in their bodies . the amount of testosterone that is produced in your body is not enough to prevent prostate cancer from developing . when a person is given zymiga , the doctor will test your blood for signs of disease . hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy )) is used in combination with another medicine , prednisone , or prdnisolone . this helps to control high blood pressure in the body and prevents fluid retention in your blood . if you have any further questions on the use of this product , ask your doctor .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . - are pregnant or breast - feeding , if any of these apply to you , ask your doctor for advice . do not give this medicine to patients with severe liver damage or prostate cancer . this medicine is not recommended for use in children and adolescents under the age of 18 years . your doctor may prescribe this medicine for you . tell your doctor or pharmacist if : you have liver problems , high blood pressure , heart failure , low blood potassium . you have heart rhythm problems or other heart or blood vessel problems such as an irregular or rapid heart rate , shortness of breath , 65 years of age 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . your doctor will tell you how much zytiga to take . this medicine is for oral use . swallow the tablet whole with a glass of water . take the tablet with or without food . do not crush , crush or chew the tablet . you should take the tablets at the same time each day to make sure that the medicine is working properly . it is important that you do not take more tablets than your doctor tells you to . however , if it is too strong or too weak , talk to your doctor , pharmacist or nurse straight away . if your child is more likely to take prednisone than he or she should , take it as soon as you remember . pred
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . if the level of potassium in your blood is low , your doctor will check for potassium . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet , especially in the legs . low blood potassium ( liver function test results show high blood pressure , urinary tract infection , diarrhoea ). if any of these side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v 
what zytiga contains - the active substance is abiraterone acetate . each tablet contains approximately 250 mg dna . the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 ' s active substances ' for more information '. what zetiga looks like and contents of the pack - zytigea tablets are white to off - white , round , oval , and round . they are supplied in a plastic bottle with a child - resistant closure . pack size of 120 tablets . not all pack sizes may be marketed .
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases , including polyarticular juvenile idiopathic arthritis and enthesitis - related arthritis , paediatric plaque psoriasis , crohn ' s disease , and / or non - infectious uveitis ( nni - uv ). if you have , or have ever had , any of the following : - the active ingredient in a drug called a monoclonal antibody , which is produced by a protein called tumour necrosis factor ( tnff ) in the body . if your child has or has ever had one , you may be at risk of developing one or more of these proteins . this
do not take hefiya : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine if : you have a severe infection such as tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections . unusual infections may be caused by a weakened immune system . symptoms of infections may include fever , wounds , feeling tired or dental problems . you may also have moderate or severe heart failure or a serious heart condition . allergic reaction : allergic reactions may cause symptoms such as chest tightness and wheezing . if any of these apply to you , tell your doctor or pharmacist . this is because the medicine is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg once a day . your doctor will tell you how much hefiya to take and how often to take it . if your doctor tells you not to take more than 20 mg , your dose may be increased by up to 40 mg . you may also take a higher dose of 20 mg once daily . this is equivalent to a 40 mg dose . polyarticular juvenile idiopathic arthritis age and body weight : 2 kg 30 kg 40 mg 2 kg 10 kg 30 mg 20 mg tablet enthesitis age and arthritis age : 6 kg 30 cm 40 mg tablets . children and adolescents aged 6 kg 15 kg or more 30 kg 20 mg tablets for paediatric plaque psoriasis : 4 kg
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . they usually resolve within 4 weeks of the last hefiya injection . if you notice any of the following side effects you should contact your doctor immediately : allergic reaction , heart failure , severe rash or hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath , swelling of the feet . signs and symptoms of infection include fever , feeling sick , wounds and dental problems . these may be signs of infection such as fever or feeling sick or wounds , dental problems and rash . other possible side effects include : very common : may affect more than 1 in 10 people the frequency of these side effects is unknown . tell your doctor or nurse straight away if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , hefiya may be stored at room temperature ( up to 25 ) for up to 14 days . if not used immediately , your doctor or nurse will advise you how to use it . it is important that you use it within 14 days of first use , as it does not require any special storage conditions . your doctor will tell you how long you should use it and how long it should be used . you should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg / 0 . 4 ml of solution for injection . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e464 ), sodium hydroxide and water for injections ( see section 2 ). what if any of the above applies to you , tell your doctor or pharmacist if you have any further questions on the use of this product , ask your doctor , pharmacist , or nurse . pack sizes are available : 20ml / 4 . 5ml clear , colourless to slightly yellowish solution , supplied in a clear type i glass 
ritemvia contains the active substance rituximab . it is a " monoclonal antibody " that attaches to a specific type of white blood cell . if this type of antibody sticks to the surface of a cell called a granulomatosis , polyangiitis or microscopically microscopic lymphoblasts , it sticks together with a protein called b - lymphocytes . this helps the body ' s immune system to produce more white blood cells ( b lymphocyte ) in the body called " apoptosis " ( a type of cancer of the lymph tissue ). if you are not sure , talk to your doctor , pharmacist or nurse . the treatment is given in patients who do not respond well enough , and who have not responded well enough to other medicines , such as chemotherapy
do not take ritemvia : - if you are allergic to rituximab , other proteins that are present in the blood , or any of the other ingredients of this medicine ( listed in section 6 ) - you have a severe active infection due to a weak immune system , severe heart failure or severe uncontrolled heart disease , such as granulomatosis , polyangiitis ( microscopic polyangitis ) or pemphigus vulgaris . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had a hepatitis infection . your doctor will tell you if your doctor or nurse is unsure . you may be at increased risk of getting a high risk of developing a new type of h1n1 , a type
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much ritemvia to take the recommended dose is one tablet once a day . your doctor will tell you how many tablets to take and how often to take them . this treatment should be started by a doctor experienced in the use of this medicine . you will be given this medicine to reduce the risk of any side effects . the usual starting dose is a drip ( intravenous infusion ). your doctor may prescribe medicines for you at the same time each day , depending on how you respond to the treatment and how long you need to take . if your doctor decides that you should continue with your treatment for non - hodgkin ' s lymphoma , you may need to start a different dose . it is important that you do not receive rite
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . they usually disappear after a short period of treatment . reactions have been fatal . infusion reactions may occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the injection site , blisters or itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing and throat . these may be signs of a rash . if you get any of these , talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 micrograms / m2 of ritzimabe . one vial of 10 millilitres contains a total of 10 mg /m2 dna . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 , water for injections and water for a clear , colourless solution for infusion in a glass vial . pack sizes of 2 vials are available .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ". it works by blocking the growth of cancer cells . the active substance in cape citric acid ( cdc ) is capaminidase . it is used in combination with other medicines to treat : - colon , rectal , gastric , or breast cancers . capsaicin is used for the treatment of colon cancer after complete removal of the tumour after surgery . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not take capecitabine teva : - if you are allergic to capsicum or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have an allergy to the active substance . this medicine may cause severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines called fluorouracil ). - you are pregnant , have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ). you have severe liver or kidney problems . you have a problem with the enzyme dihydropyrimeidine dehydrogenase ( dpd ) ( complete pd deficiency ). see section 4 . brivudine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine is used in combination with other anticancer medicines . your doctor will prescribe a dose and treatment regimen based on your body surface area , height and weight . the recommended dose is 1250 mg / m2 of body surface surface area per kilogram of body weight , 64 kg and height of 1 . 64 kg . if your doctor tells you to take more doses than you should , your doctor may prescribe you a higher or lower dose of 500 mg . you can take 1 , 7 . 7 x 1 - 5 x 500 mg once a day . 1 x 150 mg per kilogram body weight and 80 kg ( height ) is recommended for patients whose dose is less than one - third of a kilogram ( kg 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact a doctor immediately if you notice any of these symptoms : diarrhoea , an increase of 4 or more bowel movements . if this happens , tell your doctor straight away . your doctor may decide to stop the treatment or stop it immediately . you may also experience any diaphorea at night , vomiting , vomit , nausea , or lose your appetite , stomatitis , pain , redness , swelling , sores in your mouth and / or throat , especially in your hand . it is important that you contact your doctor as soon as possible . this will help you to get the best results for you . these may be mild to moderate . swallow the capsule whole 
what capecitabine teva contains - the active substance is capsicum . each tablet contains 150 mg . - each film - coated tablet contains approximately 150 mg cape citronide . the other ingredients are : capsule - coating : - capsule : 500 mg capsules - film : coated tablet : 1 ml . tablets : lactose , microcrystalline cellulose , hypromellose ( e421 ), croscarmellose sodium , magnesium stearate , macrogol 400 , tablets , tablet coatings : tablet core : tablets - tablets containing the following active substances ( acetate , citric acid , yellow iron oxide and red iron oxide ). what caps and what capsecitabin tevue looks like and contents of the pack capecitebine 
silodosin recordati belongs to a group of medicines known as alpha1a - adrenoreceptor blockers . the active substance of sillodonecordati is the prostate , bladder , and urethra . it is a smooth muscle that attaches to the tissues that support your symptoms . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will tell you how to treat your urinary symptoms caused by benign enlargement of the prostate ( prostatic hyperplasia ), difficulty in starting to pass water and a feeling of not completely emptying the bladder .
do not take silodosin recordati : - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . - in case of eye surgery , you may experience cloudiness of the lens ( cataract surgery ) in the eye ( see section 26 ). - you should tell your doctor or nurse if any of these apply to you . when you are being treated for any reason , it is important that you read the leaflet carefully before and during use , as this medicine may cause a loss of muscle tone in the iris ( the white part of the eye ) during a surgery . you should take appropriate precautions when using medicine and surgical techniques . sillodone recordati should not be used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is one 8 mg capsule once a day . your doctor will tell you how many capsules to take . you may need to increase your dose depending on the type of kidney problems you have . for moderate kidney problems , your doctor may prescribe a higher dose . the recommended starting dose for this purpose is one 4 mg capsule twice daily . take the capsule once daily for at least 4 hours before or at the same time each day to avoid feeling dizzy or feel weak . do not take more than the recommended daily dose , unless your doctor tells you to . if this happens , take it as soon as you remember and then later the same day , and then take your next dose at the usual time
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect of silodosin recordati is dizziness . if you notice any of the following symptoms , talk to your doctor or pharmacist : if this happens to you , tell your doctor straight away . this may be a sign that you have a possible side effect that may occur , such as : very common ( may affect more than 1 in 10 people ) if your doctor tells you otherwise . it is important that you take this medicine exactly as your doctor has told you to . you should tell your doctors straight away as soon as possible if any of these occur . other possible side effects are : di
what silodosin recordati contains - the active substance in this medicine is a tablet called sl . each tablet contains 8 mg of silonosine . the other ingredients are : tablet core : mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). tablet core ( s ): ss : 4 mg / ml ( i . e553 ). sillodone recording : the tablet core contains a total of 4 mg in total . tablet core the active substances are mannitas , e421 . tablets the active ingredients are sodium lauric acid . they are also a mixture of water soluble , colourless to pale yellow iron oxide . not all pack
kinzalmono belongs to a group of medicines called angiotensin ii receptor antagonists , which work by helping your body to make more of the active substance . this causes your blood vessels to narrow , causing your blood pressure to rise and fall . by blocking the action of this substance , the body ' s ability to produce more of its own protein , it helps the blood vessels relax , and so lowers the level of blood pressure . kinzulmono is used to treat essential hypertension ( high blood pressure) in adults and adolescents . it is used in adults to treat the high bloodpressure in adults , adolescents and children whose blood pressure can damage blood vessels in several organs and can lead to heart attack , heart or kidney failure , stroke , blindness , etc .
do not take kinzalmono : - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children under 3 years of age . if this applies to you , tell your doctor straight away . pregnancy and breast - feeding , see pregnancy section . severe liver problems , such as cholestasis , biliary obstruction or drainage of the bile from the liver and gall bladder , or any other severe liver disease . diabetes or impaired kidney function . your doctor may prescribe you a blood pressure lowering medicine called aliskiren . you should not take this medicine until your doctor tells you to . it is important that you read the package leaf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of kinzalmono is one tablet a day . the tablets should be swallowed whole with a glass of water . your doctor will tell you how many tablets to take . take the tablets with or without food . do not take more than your doctor tells you to . it is very important that you take the tablet at the same time each day to reduce the risk of high blood pressure . if your doctor prescribes you , your doctor may prescribe a lower dose of 40 mg to lower your blood pressure or a higher dose of 20 mg . you should take kinzulmono in combination with diuretics ( ' water tablets ') or hydrochlorothiazide , which have a blood pressure
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects include sepsis ( blood poisoning ), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects may affect up to 1 in 1 , 000 people . the following side effects have been reported with kinzalmono : common side effects ( may affect more than 1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events . uncommon side effects are : uncommon : may affect 1 in 100 people urinary tract infections and upper respiratory tract infections . these may be serious and may be life - threatening . other side effects these may include : if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep your medicine in the original package in order to protect from light . your kinzalmono tablet should be used immediately after first opening of the blister . this medicine does not require any special temperature storage conditions .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg of telmosartan ( as povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate ). what the other ingredients are : tablet core : st . john ' s wort : capsule : 20 mg . pack size : blister packs containing 14 , 28 , 56 and 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa , which is used to treat bleeding episodes in patients with haemophilia a ( inborn factor ixii deficiency ) who do not have enough of the essential fatty acid - a - factor ii - 1 , a protein that helps blood clot , and has an increased tendency to bleed . if you have not had enough of factor xii in your blood , your doctor may decide to reduce your risk of a person who has a higher risk of having a high risk of getting too much , or if they have too many , it is important that you get the best results for yourself and your family .
do not take afstyla - if you have ever had an allergic reaction to the active substance or to any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine . if your doctor thinks you may be allergic to hamster proteins , tell your doctor or nurse . 46 if this applies to you , your doctor will tell you how many doses to take . the batch number will be recorded in your treatment diary . warnings , precautions and instructions for use are provided in the package leaflet . you must not take more than one dose per day . allergic ( hypersensitivity ) reactions have been reported in patients receiving the medicine and are not sure . your doctor may need to adjust the dose , change the dose or change your dose at any time of the year .
keep this medicine out of the sight and reach of children . do not use afstyla after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . your doctor will monitor your treatment for blood clotting disorders . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . warnings and precautions talk to your doctor or nurse before you start treatment . treatment should not be stopped if your disease the site of the bleeding your clinical condition is not controlled . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used in aseptic conditions before administration . the solution should be clear , colourless to slightly opalescent . withdrawal should be avoided if the solution is cloudy or cloudy . any unused product or waste material
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include any of the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis and bleeding . factor viii medicines may contain inhibitor antibodies ( see section 2 , " warnings and precautions "). if you have any of these , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product should be used immediately . it should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what afstyla contains - the active substance is lonoctocog alfa . each vial contains 250 mg / 2 . 5 ml of solution for injections the solution contains 100 micrograms of lonoctacog . after reconstitution , the solution is divided into two equal sized vials . the other ingredients are : - 200 microgram / l . - 1000 microgram per vial - reconstitution at 2 : 5 microlitre , and - injecting the solution in a glass vial of 400 microgram ( 0 . 4 mL ). - 1 . 500 microgram (1 . 100 microlitres ) - first reconstitution 5 microliters , second injection of the solution , third - injection of 300 microgram( l) of lonocto
praxbind contains idarucizumab which is a reverse agent . dabigatran ( pradaxa ), a blood thinner medicine , is used to prevent blood clot formation . the active substance in pra - bind is rapidly trap dabig atran . if you have any further questions on the use of this medicine or the way it works , ask your doctor , pharmacist or nurse . your doctor will prescribe the right dose for you . you will be given the medicine for as long as your doctor tells you to . how to take the medicine you are given , it is very important that you read the instructions carefully and follow the instructions given by your doctor or pharmacist .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a genetic disease known as hereditary fructose intolerance to the substance sorbitol . this medicine can cause serious adverse reactions . if this applies to you , tell your doctor or pharmacist . do not use this medicine in combination with dabigatran or other medicines to prevent blood clots . dabigatatran is a substance found in the body and can lead to a build up of blood . it can also be used together with medicines that help to reduce the risk of a high risk of blood and / or reduce the number of blood cells . your doctor may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 5 mg / 2 . 5 mg dabigatran once a day . your doctor will tell you how much praxbind to take and how long to take it . this medicine is for oral use . it is recommended that you do not take more than 5 mg of this medicine per day , unless your doctor tells you to . you should inject this medicine into a vein . if your doctor prescribes this medicine for your treatment , your doctor may reduce the risk of blood clot formation . do not inject more than 24 hours after the expiry date which is stated on the carton . take the tablet with you to make sure that it is fully absorbed into the bloodstream . in the event of a sudden increase in the dose of da
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : very common side effects tell your doctor or pharmacist if you notice any of the side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine by completing the form below .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate and acetic acid , sorbitol ( e421 ), polysorbate 20 and water for injections ( see section 2 ). what the product looks like and contents of the pack the colour of the solution is light yellow to slightly opalescent . it is supplied as a clear , colourless to slightly yellow solution in a butyl rubber stopper and an aluminium cap .
temomedac is a medicine that contains the active substance temozolomide . this medicine is an antitumour agent and is used to treat brain tumours . it is used in adults to treat newly - diagnosed glioblastoma multiforme ( gma ) in adults , adolescents and children 3 years of age and older . the usual starting dose of the medicine is one dose , one dose per day , and one dose of one dose every day . your doctor will decide on the right dose for you . you will also be given a single dose . however , your doctor may decide to increase the dose if you have a higher or lower dose for your child , depending on the type of brain tumour you are treating . if your child has a new or recently -diagnosticable form of anaplastic astrocytom
do not take temomedac : - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . if any of these apply to you , tell your doctor immediately . you may have an allergic reaction to dacarbazine , an anticancer medicine ( dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . your doctor will monitor your blood cells . this is because you have severely reduced ( myelosuppression ) your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting in your blood . the number of these cells is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of temomedac is based on your height and weight during treatment . your doctor will decide the dose you should take , depending on whether you have a recurrent tumour that has not responded to chemotherapy treatment in the past . you may also need to take other medicines called anti - emetics . if any of the above applies to you , talk to your doctor , pharmacist or nurse as soon as possible . warnings and precautions talk to a doctor or nurse before you are given this medicine : - for nausea and vomiting in patients with newly - diagnosed glioblastoma multiforme ( gbm ). your doctor may decide to change your dose . treatment may include radiotherapy ( concomitant phase 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction , such as hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , your doctor may decide to stop temomedac treatment . there may be a reduction in certain kinds of blood cells , including increased bruising and bleeding ( anaemia ) in the number of red blood cells ( fever ) and reduced resistance to infections . the reduction in blood cell counts may lead to a reduced number of infections , which may be life - threatening . your doctor will monitor you closely . this may include : - hypersensitivity , a condition where you are being treated . you may also experience ana
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the capsules in the outer carton in order to protect from light . temomedac will be stored at room temperature ( up to 30 ) if you notice any change in the appearance of the caps . this medicine does not require any special temperature storage conditions .
what temomedac contains the active substance is temozolomide . each ml contains 5 mg / 5 m2 , corresponding to a single - use tablet . if you are not sure , talk to your doctor , pharmacist or nurse before you start . how much to take the recommended dose is one tablet containing 20 mg or 20 mg ( equivalent to two tablets containing a total of 20 mg ) - the other ingredients are : one tablet contains 100 mg or 100 mg , the other ingredient is : - one tablet with 140 mg or 140 mg temazolomide each tablet contains 180 mg of temozalomide every day . one tablet of 180 mg contains the total number of tablets that contain 250 mg or 250 mg ( equal to three tablets ). - another tablet with 250 mg is provided as an additive . not all pack sizes may be
cialis is a treatment for adults with erectile dysfunction , who cannot get , or keep , a hard , upright penis suitable for sexual activity . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the medicine . it is used to treat a type of sexual dysfunction called ' sexual dysfunction ' ( sex dysfunction ). if this happens to you , it is important that you do not have to have a soft , hard - erection . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors ( pda ) that work by inhibiting the activity of a protein in the blood vessels in the penis . by blocking the action of this substance , your penis can be removed from the body . this helps
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - the active substance is organic nitrate . - it belongs to a group of medicines called " nitric oxide donors " ( see section 2 ). - this belongs to the group called " amyl nitsitrite "). these medicines are used to treat angina pectoris (" chest pain "). if this applies to you , tell your doctor or pharmacist . these medicines do not contain any of these medicines . you should not be treated with nicrate , as this may increase the risk of serious heart disease . this is because you have recently had a heart attack in the last 90 days .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . take cialis tablets with or without food . swallow the tablets whole with a glass of water . the tablets should not be swallowed whole . your doctor will tell you how many tablets to take . you should take the tablets at least 5 hours before or 2 . 5 hours after your last meal . do not take more tablets than your doctor tells you to . it is important that you continue to take your tablet at the same time each day to make sure that your erection is working properly . if it is not working 24 hours after you start taking the tablet , your doctor may tell you to take it as soon as you remember . however , you should not take a double dose to make up
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions : rashes ( frequency not known ), chest pain , nitrates ( frequency unknown ), priapsim . if you have a prolonged and possibly painful erection , stop taking cialis and get it straight away . contact your doctor immediately . sudden loss of vision ( frequency cannot be estimated from the available data ) other side effects common ( may affect up to 1 in 10 to 100 people ): headache , back pain . uncommon ( frequency may be higher than usual ). if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in append
what cialis contains - the active substance is tadalafil . each vial contains 2 . 5 mg / ml . - each tablet contains a high content containing a low content , such as : - tablet core - lactose monohydrate ( see section 2 ), croscarmellose sodium , hydroxypropylcellulose ( e421 ), microcrystalline cellulose , sodium laurilsulfate and magnesium stearate . film - coated tablets - film coating - oblong - inks - tablets containing lactoses monohydrate . the other ingredients are hypromellose , triacetin , titanium dioxide , iron oxide yellow and iron oxide red , and talc . not all pack sizes may be marketed in your country .
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it works by helping your pancreas make more insulin , which lowers your blood sugar ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the level of sugar in your blood . the sugar is released into the body by the body , and the body makes more of the insulin it produces . if you are given a higher dose of enlyglid than you should , your doctor may decide to reduce your dose . this will help to reduce the amount of sugar you have . you will be treated with exercise and weight reduction . your doctor will tell you how long you will have to follow the advice of your doctor , pharmacist , or nurse . in addition , you will also be given metformin to control diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . - you have type 1 diabetes . your doctor will check the acid level in your blood . diabetic ketoacidosis is a severe liver disease . gemfibrozil , a medicine used to lower increased fat levels , can cause liver problems . it is used to treat moderate liver 28 disease , see section 2 . you should tell your doctor as soon as possible if any of these apply to you . do not give this medicine to children and adolescents , adolescents and children under the age of 18 years . tell your doctors if : you have been told that you have not been told to do so .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . your doctor will tell you how many tablets to take and how long you should take them . do not take more than your doctor tells you to take . it is important that you take the tablet at the same time each day , as long as you are taking it . if it is too strong or too weak , talk to your doctor , pharmacist or nurse . how much to take take the tablets you will need to take depends on how you respond to your diet and how you react to your treatment . don ' t take more tablets than you should if your blood sugar is too high
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of enyglid , and it affects more than 1 in 10 people . if you have any of the following , tell your doctor immediately : - hypogycaemia : very common : may affect up to 1 in 100 people , but may occur more frequently than normal . the frequency is generally mild / moderate , with a high risk of hypogallycaemic unconsciousness and a risk of coma . allergy allergy : common ( may affect 1 in 1 , 000 people ) - symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating . anaphylactic reaction : other side effects may include : uncommon : can occur very rarely (
what enyglid contains - the active substance is repaglinide . each ml contains 0 . 5 mg , 1 mg and 2 mg . the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine and poloxamer . - yellow iron oxide ( e172 ) - 1 mg / 2 mg tablet coating : white , round and biconvex with bevelled edges . 1 mg tablets : pale brown , yellow , biconvexed . not all pack sizes may be marketed .
azacitidine mylan is an anti - cancer agent . it is used to treat cancer cells by blocking the activity of the ribonucleic acid ( rna ) that is produced in the body . the active substance in this medicine is called a cytokines , which are produced by the bone marrow . this allows normal blood cell production to be restored . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the medicine , or if any of the above applies to you , ask your doctor or nurse for advice on how to use a stem cell transplantation . you may have higher - risk myelodysplastic syndromes ( mds ). this is a type of cancer called chronic melomonocytic leukaemia ( cmml ) or acute myeloid
do not take azacitidine mylan : - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . - in case you have advanced liver cancer . you should tell your doctor or nurse if any of these apply to you . your doctor may decide to reduce the dose of the medicine you are taking . do not increase the dose unless you have decreased counts of platelets ( red or white blood cells ), kidney disease , liver disease or a heart condition ( such as heart attack , lung disease ). your doctor will do blood test before and during treatment . the doctor will also do blood tests before and after treatment , if necessary , you will be monitored by a doctor . before starting treatment you should stop taking aza
always take azacitidine mylan exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will tell you how many tablets to take and how often to take them . swallow the tablet whole with a glass of water . do not crush , crush or chew the tablet . you may need to take another medicine to reduce nausea and vomiting . it is recommended that you take this medicine at least 75 minutes before you start taking it . this is because your doctor may decide to increase or decrease the dose of this medicine based on your height and weight . if your doctor decides that your dose is right for you , contact your doctor , pharmacist or nurse as soon as possible . how long you should take the medicine , take it at least 3 hours after you start this " treatment cycle " for 4 to
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these are symptoms of liver failure such as swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness and fatigue . if you get any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 to 8 ). do not freeze . any unused azacetinine mylan should be used immediately . this medicine does not require any special temperature storage conditions . keep the suspension in the original package in order to protect from light . the suspension can be stored at room temperature ( up to 1 ) for a single period of up to two weeks . if the azacaitidine melan suspension is mixed with water for injections , the suspension may be stored for up to 8 hours in the refrigerator ( 1 - 8 ) before it is dissolved . after removing from the refrigerator , it should be discarded after 8 hours . it should not be
what azacitidine mylan contains - the active substance in this medicine is called a " syringe ". each ml of powder contains 100 mg ag . - each vial contains a corresponding amount of azotidine . after reconstitution , the suspension is dissolved in 4 % water for injections . the reconstituted suspension is supplied in a glass vial containing 25 mg / 0 . 25 % agar . what adolol is also present in mannitol ( e553b ) in the suspension . each pack contains the following pack sizes : - a white powder for concentrate for solution for injection , diluted to a clear , colourless to pale yellow to yellow powder . pack sizes of 1 or 7 vials each . not all pack sizes
what duotrav eye drop solution contains - the active substances are travoprost and timolol . both of these substances are active substances , which are present in the eye and in the bloodstream . - travonest is a prostaglandin analogue that is used in the treatment of glaucoma in adults . the other ingredient is tilol ( a beta blocker ) which is used to reduce the amount of fluid within the eye . this helps to reduce pressure within the eyes . when used in combination with other eye drops , duotorav eye drops help to reduce high pressure in the eyes and help to prevent an illness called glauroma .
do not take duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have respiratory problems such as asthma , severe chronic obstructive bronchitis ( severe lung disease ), wheeziness , difficulty in breathing , long - standing cough , breathing problems or severe hay fever , or a slow heartbeat ( heart failure ), a disorder of heart rhythm ( irregular heartbeat ), or your eye is cloudy . if any of these apply to you , tell your doctor or pharmacist .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye . always use duotrav at the same time each day . your doctor will tell you how many drops to use and how often to use them . if your eyes are not working properly , your doctor may prescribe a different dose . you can also use your own eye drops , which are available in packs of 1 , 2 , 3 or 4 drops in a bottle . do not use more than 1 drop in the bottle , unless your doctor tells you to . use the bottle with a clean finger , or a " pocket ' on your eyelid ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking the drops and contact a doctor straight away if you notice any of the following : very common side effects ( may affect more than 1 in 10 people ) - the eye eye redness . uncommon side effects (1 may affect up to 1 user in 10 ): - inflammation of the eye - surface inflammation or surface damage - eye pain , blurred vision , abnormal vision - dry eye or itchy eye , eye discomfort . signs and symptoms of eye irritation , such as burning or stinging , are rare side effects such as eye irritation and burning , tingling , and numbness , which may be signs of eye discomfort and symptoms . these are usually mild to moderate , but may be serious and may be life - threatening . other side effects include 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substance is travoprost . each vial contains timolol equivalent to 40 mg / ml . the other ingredients are : - tablet core : 5 mg of tilol ( e421 ). - solvent : polyquaternium - 1 , mannitol , propylene glycol and polyoxyethylene hydrogenated castor oil . 40 mg concentrate : boric acid , sodium chloride and sodium hydroxide , hydrochloric acid . - purified water : sodium hydrochoxide , and water for injections , as well as water for infusion : water for preparation : hydrogenated water for treatment of acidity levels and ph levels . not all pack sizes may be marketed .
nplate ' s active ingredient is romiplostim , a protein that helps to prevent low platelet counts . it is used to treat patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body 's immune system does not produce enough platelets . platelets help to prevent your blood from forming blood clots . if you have very low platelets counts , you may experience bruising and serious bleeding ( see section 1 ). you have had your spleen removed . you have chronic itp when you have previously been treated with corticosteroids or immunoglobulins , but this medicine is not suitable for you .
do not take nplate : - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking n plate if : you have a low blood platelet count ( thrombocytopenia ). if this applies to you , tell your doctor or nurse . if your platelet counts are too low , your doctor may reduce your dose . you may also be at increased risk of blood clots . your doctor will check your blood coagulation regularly to make sure that you are not able to stop blood clumps from forming . it is important that you do not have liver problems . this is especially important in patients over 65 years of age with cancer . the contraceptive pill may be used in combination with hormone replacement
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 to 17 mg / kg of body weight . your doctor will tell you how many doses you should take and how often you should use them . how much to use the dose is based on your body weight and the type of platelet counts you have in your blood . it is very important that you inject your dose at the same time each day . do not inject more than one injection under the skin ( subcutaneously ). the usual dose is one injection once a day ( see section 1 ). your doctor may decide to increase or decrease the dose of n plate depending on how you respond to regular blood samples . if your platelets are high or low , your platelet count should be checked by your doctor . this will help your blood to keep up with your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nplate : itp : common ( may affect up to 1 in 10 people ) headache allergic reaction upper respiratory tract infection respiratory tract : very common : may affect more than 1 in 1 , 000 people bone marrow disorder increased bone mmarrow fibres trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia ) migraine , redness on the skin , flushing . if you notice any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . this medicine does not require any special storage conditions . nplate should be used within 30 days after first opening .
what nplate contains - the active substance is romiplostim . each ml of solution for injection contains 125 micrograms ( i . e . one vial of 230 iu ). each vial contains a total of 125 mg / m2 of riostat . the other ingredients are : - a deliverable amount of 0 . 25 g solution , equivalent to 125 milligrams of romoploshim , or 500 millilitres , n plate 250 iii , and 375 milliliters ( mg ) ( e421 ). - 250 millimetres ( 1 . 5 g ) solution containing 250 mg or 500 irostat ( 2 . 4 g of nplatte ) are available .
this medicine contains an active substance called glycopyrronium bromide . it belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes tightening of the muscles in the lungs . this makes breathing difficult . if you are given this medicine , you may notice that the muscles are tighten . these muscles make it easier for air to pass through your lungs to open . you should not use this medicine to treat copd without talking to your doctor .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if any of these apply to you , tell your doctor immediately . warning and precaution : children and adolescents this medicine is not recommended for use in children under the age of 18 years . children under 18 years should not be given to children younger than 18 years of age due to kidney problems . you may have an eye problem called narrow - angle glaucoma ( difficulty passing urine ) during treatment . your doctor will tell you how long you should be treated before you are given this medicine and if this happens , contact your doctor or pharmacist immediately , as you may experience tightness of the chest , coughing , wh
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to inhale the recommended dose is one inhalation twice a day . your doctor will tell you how many inhalations to use . the usual dose is 24 mg / 75 mg once daily . do not take this medicine after the expiry date which is stated on the carton and on the inhaler label after exp . it is important that you keep this medicine in the original package in order to protect it from light . this medicine is supplied in a pack containing an inhalers and capsules ( in blisters ). the medicine is a clear and colourless liquid . if the capsules are clear , do not crush , crush or break , throw away any medicines via wastewater or household waste . ask your pharmacist
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 mg of glucose . - each capsule contains 50 micrograms ( ml ) of g . the other ingredients of the inhalation powder are lactose monohydrate , magnesium stearate , and water for inhaling . how to use the pack the following pack sizes are available : 44 hard capsules containing a white powder , a device or an inhaler . capsules are supplied in blisters with each blister strip containing 6 or 10 capsules each pack size is available . not all pack sizes may be marketed .
adasuve contains the active substance loxapine . it belongs to a group of medicines called antipsychotics . dopamine , also known as serotonin , has calming effects , relieving aggressive behaviour and acute symptoms ( mild - to - moderate agitation ) in adults . schizophrenia and bipolar disorder are diseases characterised by symptoms ( such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , feeling depressed , guilty , anxious , tense , are common in patients with bipolar disorders .
do not take adasuve - if you are allergic to loxapine , amoxapene or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if symptoms include wheezing or shortness of breath , it is important that you tell your doctor as soon as possible . you may have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness , shortness or 25 signs of neuroleptic malignant syndrome ( nms ). these symptoms can be caused by antipsychotic medicines . these symptoms include high fever and rigid muscles . your doctor will tell you how to treat these symptoms . tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 9 . 1 mg once a day . your doctor will tell you how much adasuve to take and how often to take it . you can take it with or without food . do not take more than the recommended dose of 2 . 5 mg , depending on your condition . take the tablet with your hand or mouth . use the device as directed by your doctor . if the following symptoms occur : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements , or if your doctor tells you to stop taking this medicine , tell your doctor straight away .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness or irritating , irritating or irritating in your airways ( asthma , copd ), light - headedness or fainting . your doctor will check your blood pressure for signs of worsening agitation , confusion , fever or muscle stiffness . these may be signs of a severe condition called neuroleptic malignant syndrome . the following side effects may occur : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , dizziness , chills , tingling or burning sensation . other side effects include : common : may affect up to 1 in 100 people . common 
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . an open or damaged pouch may cause physical damage . if not used immediately , contact your pharmacist or pharmacist .
what adasuve contains - the active substance is loxapine . - each single - dose inhaler contains 5 micrograms / ml ( 0 . 5 mg / kg ). - delivers a maximum of 4.5 microgram / kilogram ( m2 ) of the active ingredient . each pack / vial contains a total of 4 . 4 mg x 2 - 0 mg , containing a white to off - white , disposable white plastic inhalers for inhalation containing the active substances listed in the label on the back of the pack . the active ingredients are : - 1 - 5 mg inhalations . not all pack sizes may be marketed .
azacitidine betapharm is an anti - cancer agent . it belongs to a group of medicines called ' medicines for cancer cells '. a doctor or nurse who has been trained in the use and administration of medicines with the same name , has prescribed it to you . the name of the medicine is a ' stem cell transplantation ' in patients with higher - risk myelodysplastic syndromes ( mds ). it is used to treat patients with chronic myelobocytic leukaemia ( cmml ) and acute myeloid lesions ( aml ). these are diseases that affect the bone marrow , which is responsible for normal blood cell production . your doctor will decide whether to continue to give this medicine until your doctor tells you it is time for it to be given . you will also be given the medicine by your doctor 
do not take azacitidine betapharm : - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have advanced liver cancer . you should not be given azacetidine be tapharm . - you have decreased counts of platelets ( red or white blood cells ) in patients with kidney disease , liver disease or a heart condition ( such as heart attack , lung disease ). your doctor will do blood test before and during treatment . your doctor may also perform blood tests before and after treatment , as this may affect how well your medicine works . it is important that you tell your doctor as soon as possible if your doctor tells you otherwise . before you start treatment : the duration of treatment is 
always take azacitidine betapharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will tell you how much to take and how often to take it . swallow the tablet whole with a glass of water . do not crush or chew the tablet . you may need to take another medicine to reduce nausea and vomiting . it is recommended that you take this medicine at least 75 minutes before you start taking it , depending on your height and weight . this medicine will be given to you by your doctor , nurse or nurse . how long you will be treated by a doctor or nurse for 3 days . during this " treatment cycle ", your doctor may give you 4 to 6 weeks of this medicine . apply this medicine under the skin , on the skin of your thigh , t
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these are symptoms of liver failure such as swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness and fatigue . if you get any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . any unused and unopened acaciabetapharm should be disposed of in accordance with local requirements . this medicine does not require any special temperature storage conditions . keep the suspension in the original package in order to protect from light . the suspension should be used within 45 minutes . if not used within 8 hours , the suspension may be mixed with water for injections . once the suspension has been dissolved , it should not be used immediately . after 8 hours of preparation , a doctor or nurse will inspect the suspension for a minimum of 8 hours after preparation . it should be stored in the refrigerator at room
what azacitidine betapharm contains - the active substance in this suspension is called a ' syringe '. each vial contains 100 mg of acetate . - after reconstitution , 4 ml of water for injections is added . the reconstituted suspension contains 25 mg / m2 acacia ( as mannitol ) as the other ingredients in the suspension are : - o - sodium ( e421 ) - potassium , calcium , magnesium , iron , zinc , copper , manganese , and octane . each pack contains a white to off - white powder for concentrate for solution for injection in a glass vial containing 100 mg /ml ocacia . not all pack sizes may be marketed .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults , adolescents and children with inherited condition in which the body does not produce enough glucosylceramide ( a substance that is produced in the spleen , liver and bones ) enough to make a difference in the way a medicine works and your affected organs respond better to this medicine . if you are not sure , talk to your doctor , pharmacist or nurse . this medicine works by slow speed and poor metabolisers . your doctor will tell you how to use it . you will have a simple laboratory test to see how gaucher diseases work . gaucher syndrome type 1 is a condition that affects the way gaucher medicine works , and it is important that you follow the instructions for a single laboratory test .
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : - medicines with moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine 31 ) - moderate chyp3a inhibitors such as erythromycin or itraconazole . these medicines can affect your body ' s ability to work properly . do not use cer delgá if : you are taking medicines with a poor metaboliser . it is important that you take medicines with strong yp1d4 inhibitors . you should tell your doctor or pharmacist if any of these apply to you . your doctor will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of metaboliser is one tablet once a day . swallow the tablet whole with a glass of water . your doctor will tell you how many tablets to take and how often to take them . you can take a tablet with or without food . do not take more than the recommended daily dose . take the tablet at about the same time each day , if necessary . if the tablet is swallowed whole , it may take up to 84 hours before you start taking cerdelga . open the blister / wallet and open the sleeve with your thumb or finger . when opening the blister or wallet , open the sleeves and take your tablet at the usual time . talk to your doctor , pharmacist or nurse straight away if
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( diarrhea ) common : may affect up to 1 in 100 people difficulty sleeping ( vomiting ) abdominal pain abdominal pain ( stomach pain ), stomach pain ( indigestion ) difficulty sleeping , stomach upset , vomiting , nausea , abdominal pain and abdominal pain not known :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg / ml of recombinant microcrystalline cellulose ( e460 ) and lactose monohydrate ( see section 2 ' cd '). - other ingredients are : hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide , yellow iron oxide and indigotine . - shellac , black iron oxide , propylene glycol and ammonia solution . what cleavage and contents of the pack cerdalga capsules are a pearl blue , green opalescent capsule . they are supplied in a glass vial . not all pack sizes may be marketed .
the active substance in zoledronic acid hospira is called bisphosphonates . it belongs to a group of medicines called ' oesophageal ' which are used in the treatment of bone change , bone complications ( e . g . fractures ) and bone metastases . this is a type of cancer that has spread to the primary site of the bone , causing it to produce too much calcium . when a tumour is present , tumours in the bone do not produce enough calcium , leading to tumour - induced hypercalcaemia ( tih ).
always take zoledronic acid hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the doctor will do blood tests before and during treatment . your doctor will tell you how many tablets to take and how often to take them . you will also be asked to take a dental examination before you start . before starting treatment , you should tell your doctor if any of the following applies to you : - you are allergic ( hypersensitive ) to the active substance . - your doctor may ask you to take another bisphosphonate ( a substance containing the active ingredient ). - if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before you are given this medicine . children and adolescents : your doctor should tell you where and how long you should take 
always use zoledronic acid hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of bisphosphonates intravenously into a vein . it is given as ' iv ' administration to prevent dehydration . your doctor will tell you how much to give you and how often to give it . you should not be given more than 4 tablets a day . do not take more than your doctor tells you to . if your kidney problem is not working properly , your doctor may decide to change your dose . this will help to reduce the risk of bone complications and bone metastases . infusion : your doctor can tell you when to give your tablet , if necessary , to lower the amount of calcium in your blood . during infusion you will be given one dose of
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): severe kidney impairment ( seen in blood tests ) low level of calcium in the blood ( seen uncommonly in 1 in 100 people ). pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness , feeling of heaviness or loosening of a tooth , bone damage in the jaw ( osteonecrosis ). such symptoms may occur when taking zol . if you have any further questions on the use of this medicine , ask your doctor .
keep this medicine out of the sight and reach of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light .
what zoledronic acid hospira contains - the active substance in this medicine is called halodextrin . each ml contains a concentrated form of zelodramid . the other ingredients are : monohydrate , mannitol , sodium citrate , and water for injections . - zolerodic acid is supplied as a liquid concentrate for solution for infusion . it is a ' sterile concentrate '. each pack contains 4 mg / l of zolédronic acids . not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat cancer feeling sick ( nausea ) or being sick ( vomiting ) after cancer treatment chemotherapy chemotherapy destroys nerve cells in the brain . vomiting is a sign of being sick . if you feel sick or are sick , your doctor will tell you to take a dose of rolapentin , which works by stopping these nerve cells from growing and multiplying . this reduces the risk of nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine is an herbal medicine that contains st . john ' s wort ( hypericum performatum ) and is used to treat depression and difficulty sleeping ( see section 2 ). this medicine should not be used in children and adolescents under 27 years of age . you have severe liver or kidney problems . your doctor may prescribe certain medicines such as rifampicin to treat tuberculosis or other infections , carbamazepine to treat epilepsy ( nerve pain ) or phenobarbital to treat seizures , enzalutamide for prostate cancer ( phenytoin ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day . you can take varuby with or without food . swallow the tablet whole with a glass of water . your doctor will tell you how many tablets to take and how long you should take them . do not take more than 90 mg tablets . take the tablet with food or drink . it is important that you continue your chemotherapy cycle as prescribed by your doctor . chemotherapy is used to treat sickness . sickness can occur when this medicine is taken with chemotherapy or another chemotherapy cycle . feeling sick , feeling sick or being sick after chemotherapy , your doctor may tell you to stop taking this medicine . if it is too strong or too weak , talk to a doctor or go to the nearest hospital straight away . this medicine should not be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with varuby : very common ( may affect more than 1 in 1 , 000 people ): - symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately if you notice any of the following serious side effects you may need to be treated with appropriate treatment . other side effects very common : may affect up to 1 in 10 people : headache , constipation , feeling tired . uncommon : not known : frequency cannot be estimated from the available data : nausea , vomiting , diarrhoea , tingling in the hands or feet . very rare :
what varuby contains - the active substance is rolapitant . each vial contains 90 mg / 0 . 5 ml . the other ingredients are : - lactose monohydrate ( see section 2 under ' variose contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . - blue , 100 mg , in a polyvinel chloride and polychlorotrifluoroethylene / aluminium foil twinned blister . not all pack sizes may be marketed .
what enerzair breezhaler contains - the active substances are indacaterol , glycopyrronium - mometasone furoate endacatrol belongs to a group of medicines called bronchodilators . it works by stimulating the muscles in the lungs , which help to open the airways , allowing air to flow freely , and mometosone furosemide belongs to another group of medicine called corticosteroids , also called steroids . - if you take more of these medicines than you should , talk to your doctor , pharmacist or nurse straight away . corticosto steroids cause the swelling , irritation ( inflammation ) in the small airways in the lung , leading to breathing problems . the use of corticotropine reduces the risk of attacks of asthma . what 
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using , if : you have heart problems such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , severe kidney problems or severe liver problems . - you have low level of potassium in your blood . you have an eye problem called angle - closure glaucoma , difficulty passing urine , tuberculosis ( tb ) of the lung , or any long standing condition . tell your doctor or pharmacist if any of these apply to you . children and adolescents en
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the original package in order to protect from light . enerzair breezhaler is for inhalation only . it does not affect the way your asthma works or your symptoms improve . use if you are not sure , talk to your doctor , pharmacist or nurse . how much to use use the pack contains an inhaler and capsules . the medicine is to be inhale the capsules in the blister . once you have used the inhalers , you will need to use them immediately . after using this pack , it is important to use the capsule
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects have been reported with enerzair breezhaler . very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching or hives ( allergic reaction ). other side effects other possible side effects tell your doctor straight away if you notice any of the following side effects you may need immediate medical attention . common : may affect up to 1 in 100 people : sore throat , runny nose , sudden difficulty breathing , feeling of tightness . this may be a sign of a rash or itching . allergic reaction reporting of side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . the capsules should be used immediately after first opening . store in the original package in order to protect from light .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ) , glycopyrronium ( as bromide ) and mometasone furoate . each inhalation contains 150 mg of ind acétate and 63 mg / ml /ml glucose . the other ingredients are : 63 % indalazine , 50 % glycoprotease and 160 % mtf ( e421 ) in the mouthpiece of the inhaler . 114 % alkaline , 58 % carboxylate and 46 % glutamate , and 136 % of carboxyl , but not all of the active substance in the product are a syringe . this medicine is also used to
the active ingredient clopidogrel acino pharma gmbh belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures that clump together during blood clotting . by preventing this collapsing the platelets form a thicker layer , which is called thrombocytes , forming a clot ( thrombosis ) in the blood , and by reducing the amount of thrombi in hardened blood vessels ( arteries ), resulting in atherothromboisis . these events can be fatal , including stroke , heart attack , or death . if you are not sure , ask your doctor or pharmacist for advice .
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given . - you have a medical condition that is currently causing bleeding ( such as a stomach ulcer or bleeding within the brain ) or severe liver disease . your doctor will tell you exactly what to do . do not stop taking otc if any of these apply to you . you should tell your doctor or nurse if : you have ever had or might have had a problem with your diet or exercise , or you are not sure . it is important that you read the instructions carefully and follow the instructions for use . children and adolescents do not give this medicine to children under 18 years of
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take . do not take more than your doctor tells you to . you may need to take more tablets than you should . if necessary , contact your doctor , pharmacist or nurse straight away . how much to take take : take your tablet with or without food . take the tablet as soon as you remember and then take your next tablet at the usual time . it is recommended that you take a double dose to make up for a forgotten tablet . don ' t take too many tablets at the same time each day , even if it is time for your next dose .
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): rare ( affects 1 to 10 people in 100 people ). rare ( effects 1 , 000 people in 10 or more people in 10,000 people in 1 or 10 000 ). if you notice any of these , contact your doctor immediately : fever , infection , extreme tiredness , rare decrease of some blood cells . liver problems : yellowing of the skin and / or eyes , jaundice . very common : may affect up to 1 in 1000 people in a few cases . tell your doctor , pharmacist or nurse straight away . if any of the side effects gets serious , talk to your doctor or nurse . this
keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister tightly closed in order to protect from light . film - coated tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance in this medicine is called clopd . each tablet contains 75 mg of cloponegrel ( as macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone , a castor oil , hydrogenated film - coating , macrogol 6 - 7000 ethylcellulose ( 462 ) titanium dioxide (e171 ) ( see section 2 ' clopotril '). what the pack looks like and contents of the pack clopionel ambh 75 mg tablets are white to off - white , biconvex , round , oval , 14 , 28 , 30 , 50, 84 , 90 or 100 tablets . not all pack sizes may be marketed .
delstrigo is used to treat hiv ( ' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. doravirine is a non - nucleoside reverse transcriptase inhibitor ( nnrti ) in combination with lamivudine ( a nuclear-derived non  - nuclear - retroviral inhibitor ) and tenofovir disoproxil , also a novel type of nuclear nuclear-- analogue reverse transcriptar - transcriptional inhibitor of n rtis ). what deltrigo looks like and contents of the pack this medicine is intended for use in adults and children aged 18 years and older who have hiv infection . the virus causes aids (' acquired immune deficit syndrome '). the virus
do not take delstrigo : - if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : carbamazepine ( oxcarbazepine ), phenobarbital and phenytoin ( medicines used to treat seizure ) rifampicin and riffapentine . medicines used for tuberculosis include st . john ' s wort and hypericum perforatum ( a herbal remedy used for depression and anxiety ) and products containing mitotretinoin . this medicine is not recommended for use in children and adolescents
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will prescribe a complete regimen for you to take a single tablet to treat hiv infection . it is recommended that you take it at least 1 hour before you start taking certain medicines , such as doravirine and other medicines . you should take this medicine swallow the tablet whole with a glass of water . do not take more than one tablet of this medicine . if your doctor tells you to do so , your doctor may prescribe you a lower dose . how long you need to take your dose , you should wait at least 12 hours after you start your treatment , and at the same time each day to make sure that your doctor prescribes the right dose for you and your doctor decides that you should
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ), headache , dizziness , sleepiness , cough , nasal symptoms , feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( such as pain or stiffness ) and feeling tired . these may be signs of feeling tired or being tired , which may be caused by a combination of symptoms such as : tiredness . uncommon : may affect up to 1 in 1 , 000 people : difficulty in swallowing or swallowing , nausea , constipation , weakness , loss of appetite , increased
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . from a microbiological point of view , the medicine should be used immediately .
what delstrigo contains the active substance is doravirine . each vial contains 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e 468 , hypromellose acetate succinate , magnesium stearate ( e464 ), microcrystalline cellulose e , silica , colloidal anhydrous , sodium stearyl fumarat . a coating material : carnauba wax e903 . the underlying material is a white to off - white , colourless to pale yellow , lactose monohydrate , titanium dioxide e171 , triacetin . film - coating : 776 ml . not all pack sizes
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression by reducing the symptoms of depression such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you are not sure , talk to your doctor , pharmacist or nurse . you may need to take another antidepressant medicine . see section 2 for more information .
do not take spravato : - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have an aneurysm ( a weak spot in a blood vessel wall , which bulges out ) or if bleeding in the brain have recently had a heart attack within 6 weeks . - you have a temporary increase in blood pressure . this can lead to serious complications in these conditions . your doctor may decide to reduce the dose of a small number of patients . you should not take this medicine at the same time each day . it is important that you tell your doctor or nurse if any of these apply to you . tell your doctors if your doctor thinks you may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray you should use the nasal spray device at the same time each day . the usual dose is 1 spray , 2 sprays , 3 nasal spray devices , 1 spray device , 4 sprays and 4 rinses . if your doctor tells you not to use , talk to your doctor , pharmacist or nurse as soon as possible . your doctor will tell you how long you should take this medicine . nausea and vomiting , see section 2 for more information . treatment should be continued for at least 30 days . this medicine should not be used in combination with nasal sprays that contain steroid or decongestant medicines . you should always use a nasal spray during your spruvato treatment . it is important that
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with spravato : very common ( may affect more than 1 in 10 people ): feeling disconnected , feeling feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity in the mouth area , spinning sensation , vertigo , vomiting nausea . common : may affect up to 1 out of 10 people feeling extremely happy , euphoria or feeling agitated . very common , may affect as many as 1 in 100 people feeling very happy . if you notice any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v
what spravato contains - the active substance is esketamine . - each nasal spray device contains a single - use sodium hydrochloride equivalent to 28 mg e - ketamine ( as citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections . the other ingredients are : tablet core : sodium , potassium , magnesium , calcium , and octane , which is a clear , colourless solution for injection . this medicine is supplied as a nasal spray solution . it is supplied in packs containing 1 , 2 , 3 or 6 nasal spray devices , all in a sealed blister . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adults with melanoma that has spread to other parts of the body after surgery . cancer is a type of cancer that has a change ( mutation ) in the cells of the skin , causing it to grow and spread . in a similar way to a normal cell , it targets proteins that are involved in the growth and development of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . symptoms of allergic reactions include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . if any of these apply to you , tell your doctor immediately . allergic reactions are rare . you should tell your pharmacist if : you have allergic reactions while taking the medicine you are taking , have recently taken or might take any symptoms of an allergic reaction , such as : swelling of your face . your doctor may decide to reduce your dose . this will help to reduce the risk of difficulty breathing and / or rash ( fainting sense ) or severe skin redness .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take them . you can take zelboraf with or without food . take the tablet at about the same time each day , usually at least 8 hours apart . do not take more than your doctor tells you to take . it is important that you take your tablet at least 4 hours apart to reduce the risk of side effects during your treatment . swallow the tablet whole with a glass of water . if possible , swallow the tablets whole with some water , with some food , or with some milk . talk to your doctor , pharmacist or nurse straight away . this will help you remember to take the tablets . taking zelloraf
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions , such as swelling of the face , lips or tongue , difficulty breathing rash fainting sensation , have been reported in patients treated with z . if you experience any of the following side effects you should contact your doctor immediately : skin rash , blistering , peeling or discoloration of the skin shortness of breath , or a cleft lip . these may be signs of a reaction to radiation treatment . the most common side effects are : very common : may affect more than 1 in 10 people , including children , adolescents and children . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial tightly closed in order to protect from light .
what zelboraf contains - the active substance is vemurafenib . - each film - coated tablet contains 240 milligrams ( ml ) of v . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica ( e464 ), croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film  - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , and talc and titanium dioxide ( i . debossed with " e171 "). what z . is zeloraf looks like and contents of the pack zelloraf 240 mg film , pinkish white to orange white , aluminium perforated
duoplavin contains the active substance clopidogrel , acetylsalicylic acid ( asa ), which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together to form blood clotting . this clumpeding causes blood vessels to tighten , so that they can ' t clot . in patients who are not sure , antiplatelets medicinal products can help to prevent the forming of blood - called atherothrombosis ( see section 2 ). in patients , duaplavin is used to help prevent the build - - up and / or break down blood blats in hardened arteries , and reduce the risk of atherotrombotic events ( such as stroke , heart attack , or death ).
do not take duoplavin : - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have been told by your doctor that you have a medical condition called asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ). you are currently being treated for , or have had , bleeding , such as a stomach ulcer or bleeding within the brain . you have severe and / or severe brain injuries . your doctor will tell you if this applies to you or your child ' s doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of duoplavin is one tablet once a day . your doctor will tell you how many tablets to take . you should take your medicine at the same time each day , with or without food . do not take more than your doctor tells you to . take your tablet with food , drink or water . if a heart attack occurs , you should contact your doctor , pharmacist or nearest hospital emergency department immediately . bleeding should not be a problem with your treatment . it is important that you take your tablets as soon as you remember . how long to take the tablet , take it at least 12 hours before you start taking it . after 12 hours , skip the tablet and take the next tablet at the usual time . however , if it is
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth . - skin disorders such as rashes , itching and blisters of the surface of an allergic reaction . the following side effects have been reported in patients treated with duoplavin : very common : may affect more than 1 in 10 people , including children , adolescents and children . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if not used immediately , this medicine may be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what duoplavin contains - the active substances are clopidogrel and acetylsalicylic acid ( asa ) 75 mg / ml film - coated tablets . the other ingredients are : tablet core ( e460 ) - active substances : clopd , hydrogen sulphate , mannitol , macrogol ( 6000 ), microcrystalline cellulose , low substituted hydroxypropylcellulose - maize starch - hydrogenated castor oil - see section 2 ' debossed with the word ' desiccant '. - tablet coating : maize - starch and hydrogenated casting oil . not all pack sizes may be marketed in your country .
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . the other ingredients are : salt - containing a group of medicines called carbonic anhydrase inhibitors ( cnir ). - the active substance is a type of medicine called " alpha - 2 adrenergic receptor agonists ", which help to control pressure within the eye . simbr inza is used to treat adults and adolescents ( aged 18 years and older ) with eye conditions such as glaucoma and ocular hypertension ( high pressure in the eyes ).
do not take simbrinza : - if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) or sulphonamides ( medicines used to treat diabetes , infections , diuretics ( water tablets ) that contain a monoamine oxidase ( mao ) inhibitor , or medicines used for depression or parkinson ' s disease . - you are taking certain antidepressants . warnings and precautions talk to your doctor , pharmacist or nurse before taking any antidotepressant medicines if : you have severe kidney problems . you have too much acidity in your blood ( hyperchloraemic acidosis ). you have less than 2 weeks of treatment . children and adolescents this medicine is not recommended for children under 2 years of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop of simbrinza in your eyes . your doctor will tell you how many drops to use . the dose will be given to you by your doctor , pharmacist , or nurse . it is important that you keep the drop in your eyelid closed with a clean finger . there is a ' pocket ' between the eyelid and your eye . if the drop is not working properly , contact your doctor immediately . do not touch the bottle unless your doctor tells you to do so . use it as soon as you remember . drop the medicine with your fingers . keep the bottle tightly closed with your thumb , fingers and your head back . put the bottle back in the back , with an eyelid , using
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : if you experience a reaction to the medicine , tell your doctor immediately . frequency cannot be estimated from the available data . an allergic reaction can cause severe skin reactions , rash , redness and itching all over your body , including your eyes trouble breathing , chest pain , irregular heart beat , or stop taking simbrinza and contact your doctor straight away . extreme tiredness and dizziness have also been reported . other side effects of simbr inza with other medicines may include brinavir . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via your doctor , pharmacist or nurse .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 to 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , the medicine should be used immediately . if you notice any visible signs of infection , you should use a new bottle .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of  - resveratrol . - each vial contains 2 mg / 1 . 3 mg brimoniidine . the other ingredients are benzalkonium chloride ( see section 2 under ' pharmacopoeia '), propylene glycol , carbomer 974p , boric acid , mannitol ( e421 ), sodium chloride and tyloxapol , hydrochloric acid and sodium hydroxide . purified water . not all pack sizes may be marketed .
filgrastim ratiopharm is a medicine that contains the active substance filgra stim , a protein that belongs to a group of proteins called escherichia coli . a natural protein , called granulocyte , is produced by the bone marrow to produce new blood cells . this helps your body produce more blood cells called " white cells ". white cells are important because they help your body fight infection . filgran ratipharm works by reducing the number of white blood cells in your body , and it helps to reduce the amount of syringes in the blood called " eczema - b12 " in a similar way to the anti - analogue of a white blood cell called ' s ' in the cytokines , which help your immune system to fight infection more effectively .
do not take filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to the active substance or to any of the other ingredients ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are taken to the hospital if : you have ever had a cough , fever or difficulty breathing . you have a pulmonary disorder . your doctor may want to monitor you closely for side effects . - you have sickle cell disease 57 you have left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a stomach disorder , which may increase the risk of side effects and may require regular blood tests before and during treatment . the number of neutrophils ( a type of white blood cells ) in your blood will be checked before and after treatment is started . tell your doctor or pharmacist 
filgrastim ratiopharm will be given to you by a doctor or nurse who is experienced in the treatment of your condition . your doctor will decide how long you will be treated for , and how often you will receive , the dose you receive and how long your treatment will last . the recommended dose is one 0 . 5 ml / kg of body surface area ( m2 surface area ) per day . if you are not sure , talk to your doctor , pharmacist or nurse before you are given , or if your doctor has told you to , that you may be given more than once a day , but it may take up to 30 days before your treatment . this is because some disease types may require a higher dose . you may not be able to continue your treatment for at least 14 days . in some cases , your doctor may decide to change the dose
filgrastim ratiopharm is used to treat sickle cell disease in adults and adolescents aged 57 years and older . if you have left upper abdominal pain or pain at the tip of your shoulder , you may have a spleen disorder ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . it is important that you have regular blood tests to check for side effects . your doctor will check your blood for the presence of neutrophils and white blood cells in your blood before and during treatment . other medicines and filgrartim ratioponepharm tell your doctor or pharmacist before taking any other medicines . this includes medicines that are not approved for use in children and adolescents . pregnancy and breast - feeding , it is not recommended to take any medicine with filgraltim relationpharm . do not take any other medicine unless your doctor tell
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if the solution is cloudy , it should be used immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgra . each ml of solution for infusion contains 60 micrograms ( 0 . 5 mg ) of filgrarstim . - each vial ( 30 microgram ) contains 30 microgrammes ( 1 . 6 mg / m2 ). - a single - use solution for injection contains 30 nanograms / milligrams or less . the other ingredients are : water for injections ( 48 microgram infusion ): - sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 ( e553b ) and water for injectings ( see section 2 ). the ingredient sorbitrol is a colourless to pale yellow solution . not all pack sizes may be marketed .
riluzole zentiva is a medicine that contains a substance called glutamate ( a chemical messenger ) that is found in the nervous system . it is used to treat adults with amyotrophic lateral sclerosis , a form of motor neurone disease in which the nerve cells that make up the muscles are damaged . this leads to weakness and muscle waste , which can lead to paralysis . the destruction of nerve cells in motor neurodeath has been linked to the damage caused by the development of a type of motor nerve disease . there is too much glutamates ( an important chemical measurer ) in the brain and spinal cord . if you have any questions on the use of this medicine , ask your doctor or pharmacist .
do not take riluzole zentiva - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have any liver disease . you have increased blood levels of some enzymes of the liver ( transaminases ). - you are pregnant or breast - feeding . if any of these apply to you , tell your doctor or pharmacist . children and adolescents this medicine is not recommended for use in children or adolescents under 18 years of age . your doctor will monitor you closely for any liver problems such as yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or sick , or if your kidneys are not working properly , fever , a low number
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . take the tablets with a glass of water . swallow the tablets whole with some water , with or without food . your doctor will tell you how many tablets to take . do not take more than the recommended daily dose of 12 tablets . riluzole zentiva is for oral use only . contact your doctor , pharmacist or nearest emergency department immediately . you should not take a double dose to make up for a forgotten tablet . don ' t throw away any medicines via wastewater or household waste . ask your doctor for advice before taking this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking riluzole zentiva and contact your doctor immediately if you notice any of the following : - fever ( increase in temperature ) - a decrease in the number of white blood cells . a blood sample should be taken to check for the presence of these cells , which are important for the prevention of infections . tell your doctor straight away if any of these symptoms occur : yellowing of your skin and / or eyes ( jaundice ), itching , feeling sick or being sick ( liver disease ( hepatitis ). - you should have regular blood tests before and during a treatment with rilsule zentiva : cough or difficulties in breathing . these may be signs of cough , difficulty in breathing or difficulty in swallowing .
what riluzole zentiva contains - the active substance in this medicine is rilluzola . - each tablet contains anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460b ), an hydrous colloidal silica , magnesium stearate , croscarmellose sodium - hypromellose , macrogol 6000 , titanium dioxide - free - from irradiation ( see section 2 ). what the tablet looks like and contents of the pack the tablets are white to off - white , round , oval shaped tablets , each containing 50 mg tablet . each tablet is supplied in blisters containing 202 tablets . the other ingredients are : 28 x 56 x 98 x 112 or 168 tablets not all pack sizes may be marketed 
emgality contains the active substance galcanezumab . it is a medicine that blocks the activity of the calcitonin gene ( cgrp ). it is used to treat migraine in adults , adolescents and children aged 4 years and older . the number of migraines in adults is 4 . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may decide to reduce the frequency of migraine headache and improve your quality of life .
do not take emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a serious cardiovascular disease . - you have serious cardiovascular diseases . allergic reactions emmgality can cause serious allergic reactions ( see section 4 ). these reactions may be serious and may affect up to 40 people . it is important that you tell your doctor or pharmacist if any of these reactions are serious . these signs are known as side effects . 4 . children and adolescents this medicine is not recommended for use in children under the age of 18 years . this is because it is not known if it is used in this age group . other medicines and this medicine should not be used in combination with any other medicines 
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg tablet once a day . your doctor will tell you how many tablets to use . you should inject the tablet under your skin ( subcutaneous injection ). your doctor may decide to increase or decrease your dose . if your doctor decides that you need to increase your dose you should receive proper training . do not take more than your doctor tells you to . take a double dose to make up for a forgotten tablet . it is important that you continue to take the tablet at the same time each day , even if it is not working properly . contact your doctor , pharmacist or nurse as soon as you remember . how long to take take the dose you need , and how long you should wait . don ' t stop
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions emgality can cause : rash or itching serious allergic reactions ( may affect up to 1 in 1 , 000 people ) difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects which may affect more than 1 in 10 people , injection site irritation , pain or discomfort at the site of injection , or bruising at the injection site . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . emgality can be stored at room temperature ( up to 7 ) for a maximum of 30 days after first opening of the bottle . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . - each pre - filled pen contains 120 micrograms ( 0 . 5 ml ) of galcanazumabe . each pen contains 1 mg of l - histidine ( e421 ) - its active substance : - hexidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what the pack ' s ' contains the active ingredient is a solution for injection in a clear glass syringe . the solution is clear , colourless to slightly yellow , and the pen is supplied with a single - dose pen . pack sizes of 1 , 2 or 3 single dose pens are available . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease in which the blood vessels in the liver are damaged and blood clots form . this can be caused by medicines taken prior to or after a stem cell transplantation . the active ingredient in defobetide works by slowing down the action of the body ' s natural defences and stopping the flow of blood vessels and preventing the blood from forming . if you are not sure , talk to your doctor , pharmacist or nurse .
do not take defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking other medicines to prevent blood clots ( such as tissue plasminogen activator warnings ). this medicine is used to reduce the risk of bleeding ( heavy bleeding ) and to prevent a blood transfusion after surgery . problems with blood circulation and a constant blood pressure ( see section 1 ). if any of these apply to you , tell your doctor or nurse . other medicines : medicines used to prevent or slow down the clotting ( acetylsalicylic acid ), heparins , warfarin , dabigatran , rivaroxaban and apixaban . 
always take defitelio exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is one tablet once a day . your doctor will tell you how many tablets to take and when to stop the treatment . the treatment is based on stem cells transplantation . it is given into your veins by an ' intravenous infusion ' or drip . this treatment is usually given every 21 days , depending on your symptoms . children and adolescents aged 18 years and over , the dose may be increased if your doctor or nurse tells you to take a double dose to make up for a forgotten tablet . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
like all medicines , defitelio can cause side effects , although not everybody gets them . if you get any of these side effects contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common : may affect up to 1 in 1 , 000 people : bleeding in general bleeding : the nose bleeding , the brain bleeding or the gut vomiting , blood bleeding in the lungs bleeding ; blood in the urine ; the mouth bleeding and the skin coagulopathy ( disturbance of blood clotting ). if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep out of the reach and sight of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the infusion storage times and conditions prior to use are the responsibility of the user . store in a refrigerator ( 2 - 8 ). do not freeze . keep in the original package in order to protect from light . if you notice that the solution is cloudy , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each ml solution contains 2 . 5 mg of 200 mg of defibrotoide , corresponding to one 80 mg solution . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 , " deFITELIO contains sodium ". each vial contains 10 micrograms of concentrate . not all pack sizes may be marketed .
daklinza contains the active ingredient daclatasvir . it is used to treat adults with hepatitis c , an infectious disease that affects the liver and causes it to produce too much of the virus . this medicine works by reducing the amount of this virus in your body . the virus can also be found in your blood , which is important for your immune system to work properly . when you are given daclinza , you will be given other medicines to help control your condition . if you are not sure , talk to your doctor , pharmacist , or nurse . your doctor will tell you how to take the other medicines you are taking . you should not take daklilza unless your doctor tells you to .
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . do not swallow the tablet whole or take it by mouth . the following medicines are used to treat epileptic seizures : phenytoin , carbamazepine , oxcarbazepine and phenobarbital . rifampicin ( e421 ), rfabutin and riffapentine . antibiotics for tuberculosis : dexamethasone ( a steroid used for allergic and inflammatory diseases ) and medicines for st john ' s wort .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . your doctor will tell you how many tablets to take and how long to take them . the usual starting dose is one tablet once daily . do not take more than this if your doctor tells you to . you may have an unpleasant taste . if this applies to you , talk to your doctor , pharmacist or nurse . it is very important that you take the tablet at the same time each day , with or without food . this will help you remember to take your tablets . take these medicines as soon as you remember , and then take them together . taking these medicines , your doctor may decide to increase or decrease the dose , depending on how you respond to the treatment 
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza contains two active substances : sofosbuvir and ribavirin . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache , fatigue . very common : may affect up to 1 in 100 people : difficulty sleeping dizziness , migraine nausea ( feeling sick ) diarrhoea , abdominal pain , joint pain and aching and tender muscles . if you have any of these , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg / ml , containing the other ingredients : tablet core : dihydrochloride , anhydrous lactose , microcrystalline cellulose ( e460 ), croscarmellose sodium , silicon dioxide , magnesium stearate ; tablet coating : hypromellose , titanium dioxide ; macrogol 400 , indigo carmine aluminium lake , yellow iron oxide 51 . what daklonza looks like and contents of the pack 30 tablets are white to off - white , oval shaped , with " bms " debossed on one side and " 30 mm " on the other side . the tablet is a clear , colourless to pale
proquad is a vaccine to protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . the vaccine contains antibodies to protect you against the meases , which are mainly caused by rubella , or by the amplification of a type of varicello virus . when the antibodies are present , diseases caused by these viruses can be prevented . proquade is used to protect people against the two types : a : myeloma - swollen face - infection . it is used in children and adolescents from 9 years of age and older from 9 months of age . national vaccination is not recommended for children .
do not use proquad if you are allergic to any varicella vaccine , measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) neomycin ( a blood disorder or type of cancer that affects the immune system ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this vaccine if : - you have a weakened immune system or a disease ( including aids ), congenital or hereditary immunodeficiency , or lack of immune competence or active untreated tuberculosis . your doctor will monitor your immune system during treatment with medications that weaken your body ' s defences , such as low - dose corticosteroid therapy , asthma or replacement therapy . if your doctor or nurse thinks you
proquad is injected into a muscle , usually under the skin , in the thigh or upper arm area . injections are given to the muscle in the upper part of the tertiary and upper arm areas at the injection site . if you have a blood clotting disorder or low levels of platelets , your doctor will decide if the vaccine is right for you . the vaccine will be injected under your skin to reduce the risk of bleeding from the muscle . your doctor or nurse will determine how long you should wait for the blood vessel to open . you will also be given the vaccine at the same time each day .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives , may occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor immediately . other side effects of proquad may affect up to 1 in 100 people . seizures and a fever may occur ( see section 1 in 1 , 000 people ). bronchiolitis ( difficulty breathing , cough , and unsteadiness with walking ). the following side effects have been reported in patients treated with proquade : very common ( may affect more than 1 in 10 people ): injection site complaints , which may be serious and may be life - threatening . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in append
what proquad contains - the active substances are measles virus1 , edmonston strain ( 3 . 00 %) mumps virus1 ( level b ) strain ( 4 . 30 %) rubella virus2 ( 2 . 1 %) varicella virus3 - merck strain (3 . 99 %) in tissue culture . the other ingredients are : - protein - culture , plate number - formation and recombinant culture of plate numbering units ( pfc1 ), chick embryo cells and fibroblasts ( mrc ). - powder sucrose , hydrolysed gelatin ( e553b ), urea , sodium chloride / sorbitol ( a ), monosodium glutamate / sodium phosphate and sodium bicarbonate 
jylamvo is an anticancer medicine that is used to treat unwanted reactions . it is used in combination with an immunosuppressive agent to produce an anti - inflammatory effect in adults , adolescents and children with rheumatic and skin diseases such as active rhematoid arthritis , polyarthritic forms in the joints , and severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age and older who have not been treated with non . saids . inadequate o severe , disabling psoriasis . treatment with phototherapy , soralen , ultraviolet a radiation ( puva ) therapy .
do not take jylamvo : - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have a severe kidney impairment or a liver impairment . you have blood disorders such as bone marrow hyperplasia , leukopenia or thrombocytopenia ( significant anaemia ). 34 - you suffer from a weakened immune system , a serious infection ( e . g . tuberculosis or hiv ), ulcers in the stomach or intestines , an inflammation of the mucous membrane of the mouth ( mouth ulcers ) or non - oncologic indications . your doctor will monitor you for signs of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jylamvo is one tablet once a day . your doctor will tell you how many tablets to take and how often to take them . do not take more than your doctor tells you to take . you may experience severe side effects , including death , during the treatment of rheumatoid arthritis , severe juvenile idiopathic arthritis or severe psoriasis . if any of the above apply to you , you should contact your doctor immediately . it is important that you follow your doctor ' s instructions on how to take the medicine . children and adolescents , adolescents and adults , who are able to tolerate the medicine for a long - term treatment , will not be given the medicine to
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching . these may affect the whole body . other side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty in breath or chest pain ( fever ), spitting , coughing blood , serious peeling , blistering or blistering . this may affect up to 1 in 10 people . if this happens , stop taking jylamvo and seek medical help immediately . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 100 people ): feeling of sickness - dry - irritating cough - shortness
keep out of the reach and sight of children . do not use jylamvo after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine at room temperature ( up to 25 ). store in the original package in order to protect from light . from a microbiological point of view , the medicine should not be disposed of via wastewater or household waste . any unused medicine or waste material should be discarded . ask your pharmacist how to dispose of cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotrexate , macrogol 400 mg , glycerol , orange flavour , sucralose , epithelium , sodium methyl parahydroxybenzoate ( e421 ), citric acid , tri - sodium citrate , purified water ( see section 2 ' s contents of the pack '). what if you have any further questions on the use of this product , ask your doctor or pharmacist . this medicine is available in a brown glass bottle containing 60 mg of solution , with a child - resistant closure and a bottle adaptor . it is supplied in white dosing syringe . not all pack sizes may be marketed .
what enurev breezhaler is this medicine contains the active substance glycopyrronium bromide . it belongs to a group of medicines called bronchodilators . this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes tightening of the muscles in the lungs , making breathing difficult . if you take this medicine , you may notice that you have tightened these muscles , which makes breathing easier for you . your doctor will tell you if it is time for your next dose . you will be given this medicine to treat copd at the same time each day .
do not use enurev breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have kidney problems , have an eye problem ( narrow - angle glaucoma ) or have difficulty passing urine . treatment with a higher dose of a lower dose may be necessary . if any of these apply to you , tell your doctor or nurse immediately . you may experience tightness of the chest , coughing , wheezing or breathlessness . contact your doctor immediately if this happens . your doctor may decide to lower your dose if it is appropriate for you . do not take a bronchospasm ( difficulties in breathing or swallowing 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation every 24 hours . your doctor will tell you how many capsules to inhale . do not use more than 75 capsules per day . take this medicine as soon as possible after the expiry date which is stated on the carton and on the inhaler label after exp . this medicine is for oral use . it is recommended that you use it every day for as long as you remember . if it is not used immediately , contact your doctor , pharmacist or nurse straight away . inhaling this medicine should not be used unless your doctor tells you to . you should always use enurev breezhaler once a day , with or without food . the capsules ( in blisters )
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention . very common ( may affect more than 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms include excessive thirst , hunger and frequent urination , rash , itching or hives , difficulty breathing or swallowing , dizziness . allergic reaction : swelling mainly of the tongue , lips , face or throat ( angioedema ). other side effects have been reported in patients taking enurev breezhaler . these include : common : may affect up to 1 in 10 people : if you get any of the side effects listed below , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( ml ) of glucose . the other ingredients are : - one inhalation vial of 50 microlitres of glucose ( equivalent to 44 microliters / m2 ) - another inhaler vial containing 0 . 5 mg of glucose per capsule . - a syringe of the inhaling powder contains lactose monohydrate , magnesium stearate . what enterv reeyhaler looks like and contents of the pack eurev breather 44 hard capsules are white to off - white powder . they are supplied in a glass vial with a device containing an inhaled capsules , in blisters
riximyo contains the active substance rituximab . it is a type of protein called a " monoclonal antibody " that attaches to a specific type of white blood cell , called b - lymphocytes . this protein sticks to the surface of the cell and binds to its receptors , causing it to stick to the cells . when a person is given a small number of cells called " b ", the number of b cells in the body , is not known . if you are not sure , talk to your doctor , pharmacist , or nurse . what you need to know about the benefits and limitations of the treatment of non - hodgkin ' s lymphoma ( a disease of the lymph tissue , part of the immune system , which produces a large number of white
do not take riximyo : - if you are allergic to rituximab , other proteins that are present in the blood , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a severe active infection at the moment caused by a weak immune system . you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis or microscopic polyangitis ) or pemphigus vulgaris . if any of these apply to you , tell your doctor or pharmacist before you receive a dose of the medicine . your doctor will tell you how long you should take it . before you start taking the tablet , your doctor may tell you to stop taking r
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much riximyo to take the recommended dose is one tablet once a day . your doctor will tell you how many tablets to take and how often to take them . do not take this treatment unless your doctor tells you to . this medicine will be given to you by a doctor who is experienced in the treatment of non - hodgkin ' s lymphoma . it is important that you do not have any side effects . if any of the above applies to you , you should contact your doctor , nurse or nurse straight away . you should not take more than one tablet per day ( a drip ) or intra - venous infusion . medicines should be given at the same time every day , with or without food 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . they usually disappear after a short period of treatment . reactions have been fatal . infusion reactions may occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the injection site , blisters or itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing . if you notice any of these symptoms , talk to your doctor or nurse straight away . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what riximyo contains - the active substance is rituximab . each ml contains 10 mg or 100 mg / m2 of solution for infusion . the other ingredients are : - 10 mg , 50 mg or 500 mg of ritzimamab in 10 mg and sodium citrate - polysorbate 80 - sodium chloride , sodium hydroxide - hydrochloric acid . see section 2 " ricinopril contains sodium ". - water for injection : water for solution for injection is a clear , colourless to slightly yellowish solution . it is available in packs of 2 or 3 vials containing 1 or 2 vial . not all pack sizes may be marketed .
the active substance topotecan acts as a medicine to treat small cell lung cancer that has spread to other parts of the lung after chemotherapy . it is used to treat advanced cervical cancer after surgery or radiotherapy . in this case the use of to potecan actavis treatment is not possible without the help of other medicines ( e . g ., cisplatin ).
do not take topotecan actavis - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are taken . if your blood cell counts are too low , your doctor may increase your dose . warnings : if any of these apply to you , tell your doctor straight away . you should not take this medicine , unless your doctor tells you otherwise . your doctor will check that you have any kidney problems . before you start taking topotenactavis it is important that you inform your doctor as soon as possible if : you have severe kidney impairment or liver problems , you should contact your doctor or pharmacist before taking to potecan . severe liver impairment or lung inflammation may occur . signs of cough , fever and difficulties in breathing
topotecan actavis will be given to you by a doctor who is experienced in the treatment of the disease . your doctor will do blood tests before and during treatment . treatment in adults small cell lung cancer : 1 . 5 % of body surface area over 5 weeks . this treatment cycle is for adults . for cervical cancer , the usual dose is 0 . 75 mg / m2 body surface space over 3 months . in adult patients with cervical cancer you may be given another anticancer medicines , such as cisplatin . if you are given too much , you may have impaired kidney function , your doctor may want to monitor your kidney function more closely . you may need to have to have a regular check - up with your doctor , pharmacist or nurse . how to potecan actsavis works to help you remember to do your daily routine .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects very common ( may affect more than 1 in 10 people ): fever , which may be a sign of your general condition . local symptoms may include sore throat , burning sensation , severe stomach pain , fever or diarrhoea , bowel inflammation ( neutropenic colitis ). topotecan actavis may increase your ability to fight infections . lung inflammation uncommon ( can affect up to 1 in 1 , 000 people ). difficulty in breathing . very common : may affect as many people . not known : if you experience any of the following : fever or a combination of local symptoms , such as : headache , nausea , vomiting , dizziness , difficulty in swallowing , abdominal pain . uncommon ( cannot be estimated from
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep in the outer carton in order to protect from light . after reconstitution , dilution chemical and physical in - use stability has been demonstrated for 24 hours ( up to 25 ) at 2 - 8 . from a microbiological point of view , the drug product solution should be used immediately . it should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of the medicine product solution . if the solution is discoloured , it should be diluted in solution for infusion ( nacl ) in 0 . 9 % glucose , 5 ml , 4 m
what topotecan actavis contains - the active substance is mannitol . each vial contains 1 mg / 4 mg to potecan ( as hydrochloride ). after reconstitution , 1 ml of solution contains 1 milligram of topotécan . - other ingredients ( e1203 ), are : tablet core : mannitrile ( s ) , tartaric acid , hydrogenic acid and sodium hydroxide ( see section 2 ). what is topotencan actsavis looks like and contents of the pack topoteractavis is a grey bromobutylic stopper and aluminium seals with plastic flip - off . it is supplied in a protective sleeve . pack sizes of 1 , 5 or 1 tablets . not all pack sizes may be marketed .
rivastigmine hexal contains a substance called ' rio '. it contains the active substance - called a ' tricholinesterase inhibitor ' ( csi ). it is used to treat adults with alzheimer' s dementia , dementia or parkinson 's disease . certain nerve cells die in the brain , and the neurotransmitter acetylcholine , which is produced by nerve cells , is not produced by the body . by blocking these enzymes , it works by blocking the enzymes that are needed to make acetelcholine ( acetélcholineserase ) and butyrylcholinesesterase . when these enzyme are not working properly , the effect of the medicine is reduced . this helps to reduce the levels of these chemicals in your brain and reduce the symptoms of
do not take rivastigmine hexal : - if you are allergic to or have recently been treated with any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . - in case of a previous skin reaction ( allergic contact dermatitis ), your doctor may decide that you should not be given a higher or lower dose of the active substance in the medicine ( see section 4 ). if any of these apply to you , tell your doctor or pharmacist . warnings , precautions or precautions your doctor will monitor you closely before and during treatment . children and adolescents do not give this medicine to children or adolescents under the age of 18 years . you should be aware of the following : you have irregular or slow heartbeat , an active stomach ulcer , difficulties in passing
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of rivastigmine hexal is one tablet once a day . your doctor will tell you how much to take and how often to stop treatment . treatment should be started at a low dose . during treatment , the highest dose is 6 . 0 mg once daily , depending on your weight and how well you respond to the medicine . do not take more than three days without talking to your doctor . taking this medicine , take your medicine at the same time each day , with or without food . it is important that you do not change the dose of this medicine until your doctor tells you to . you should not take too many tablets , even if the dose is too high or too low . take the next dose at the usual time 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects while taking your medicine : the side effects listed below are very common ( may affect more than 1 in 10 people ): dizzy loss of appetite stomach problems feeling sick ( nausea ) being sick ( vomiting ) diarrhoea very common , may affect up to 1 in 100 people : anxiety sweating headache heartburn weight loss stomach pain feeling agitated , feeling tired or weak generally feeling unwell trembling . these may be signs of a lack of energy , tiredness or weakness . this may be a sign of an increase in the number of people taking rivastigmine hexal . other side effects may include : common : may affect as many as 1 in 1 , 000 people 
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what rivastigmine hexal contains - the active substance is 64 . - each vial contains the following ingredients : r . the other ingredients are : extractor ( e460 ): hydrromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide , titanium dioxide , shellac . one vial containing 1 . 5 mg / ml of solution , containing 1.5 mg , contains the active ingredient in each raft . each float - able capsule contains 3 floats of 3 g . in each pack , one raft of 4 . 4 g of concentrate . not all pack sizes may be marketed .
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) and liver cancer in adults who do not have a specific anticancer medicine , such as sorafenib ( e421 ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given the medicine . cabrometyre works by blocking the activity of a protein called receptor tyrosine kinases ( rtk ), which are involved in the formation of new blood vessels . these proteins can cause high amounts in cancer cells . your doctor will tell you how to treat you .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . if : you have high blood pressure , have an aneurysm ( enlargement or weakening of a blood vessel wall ) or have a tear in the wall . you have diarrhoea , recently had significant bleeding after surgery in the last month , or have had surgical procedures , including dental surgery , inflammatory bowel disease ( cr ) in your bowel or cr . your doctor will tell you what you need to do to prevent the growth of your blood vessel walls . tell your doctor or pharmacist if any of these apply to you . talk to a doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet once a day . your doctor will tell you how much cabometyx to take and how long you should continue your treatment . if serious side effects occur during treatment , your doctor may decide to reduce the dose . the recommended starting dose is 60 mg / ml . you should take the tablet at least 2 hours before you take it . swallow the tablet whole with a glass of water . do not crush , crush or crush the tablet . take the medicine with or without food , drink or any other medicine . it is important that you do not take more than 1 hour before you start taking the medicine , as this will help you remember to take it as soon as you remember . when to take your tablet 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with cabometyx and with other medicines . your doctor will discuss your side effects with you . if you notice any of these side effects you may need urgent medical treatment . symptoms may include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , or a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . these may include symptoms such as vomiting blood , black tablets , and / or swollen stools . tell your doctor straight away if any of the side effects gets serious . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v
what cabometyx contains - the active substance is cabozantinib ( s ) and malate . each ml of cabômetryx 20 mg / s is a tablet containing either : - one vial ( e421 ) - two vials ( tbsp ) ( a spb ) or a vial of malate ( nm ). each vial contains either 20 mg or 0 . 5 mg cabolinib . the other ingredients are microcrystalline cellulose , lactose anhydrous , and water for injections . - another vial containing : 40 mg ( cbs ). - three vial for injection , the other ingredient being cabozatrib , malate 40 mg and cab
pemetrexed hospira is a medicine used to treat cancer in adults , adolescents and children aged 12 years and older . pemetrexxed hospira is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma ( a type of cancer that affects the lining of the lung ). it is given to you by your doctor if you have previously received prior chemotherapy , or if your doctor tells you to continue with the treatment of your child ' s doctor , pharmacist or nurse , who will decide whether to continue on with the initial treatment of adult patients with advanced stage of lung cancer , if it is clear that you have lung cancer due to the severity of your disease . your doctor will decide if initial chemotherapy is not suitable for you . if pemetre
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . do not breast - feed unless your doctor tells you to . - in case you are breastfeeding , your doctor may decide to increase your dose . warnings : your doctor will decide how long you should continue to receive treatment . you should not be treated with pemetrexxed as this medicine is a vaccine against yellow fever . it is important to tell your doctor as soon as possible if any of these apply to you . your doctor should tell you that you have problems with your kidneys . before you are given the medicine , you will be monitored by a doctor or nurse . infusion of pemetre
the recommended dose of pemetrexed hospira is 500 mg / m2 of your body ' s surface area , based on your height and weight . this body surface area will be measured by your doctor , pharmacist or nurse . treatment will depend on your blood cell counts and on how well you respond to treatment . the dose you receive depends on how your blood cells are working . you will be given a dose of 9 ml / kg of sodium chloride solution . your doctor will decide the dose that is right for you . if you are given more doses than you should , your doctor may decide to increase your dose , depending on your condition , and on your level of blood cells . mixed the pemetreexed aspira powder into a glass vial ( 9 mg ) and a solution of 9 mg water for infusion . pe
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : fever , signs of infection , a temperature of at least 30 oc , sweating , sign of infection and a lower number of white blood cells than normal . infection ( sepsis ) can lead to death . chest pain with a fast heart rate , pain , redness , swelling , sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever . skin reactions may include death , nausea , vomiting , diarrhoea , chills , itching , cough , abdominal pain . uncommon : may affect up to 1 in 100 people . if this happens , contact your doctor immediately 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . this medicine does not require any special temperature storage conditions . infusion solution : the product should be used immediately after reconstituted infusion solutions of pemetrexed for at least 24 hours after reconstitution . parenteral medicines : store in the original package in order to protect from light . any unused solution should be disposed of in accordance with local requirements . if you notice discolouration prior to administration of this medicine , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pemetrexed hospira contains each ml of solution for injection contains - the active substance , - phenomenal . each vial contains 100 micrograms ( ph - 100 ). - each millilitre of solution is a single - use sachet . - one vial containing 100 microgrammes is one , two , three , four , five , six , seven , eight , nine , 10 , 15 , 20 , 30 , 40 , 50 , 60 , 70 , 80 , 90 , 120 , 1 , 000 iu / m2 , 100 uu , one - time solution . the other ingredients are mannitol , hydrochloric acid , water for injections .
ganfort contains two active substances called bimatoprost and timolol . they work together to reduce pressure in the eye . the active substances are part of a group of medicines called prostamides , which are a prostaglandin analogue , and a type of medicines known as beta - blockers . a clear , watery liquid is injected into the eye and is absorbed by the body . this helps the eye to clear and clear . it is used to treat glaucoma in adults , adolescents and children whose eye drops are used to lower the pressure of the eye in adults who have been diagnosed with glausoma . your doctor has prescribed ganfordt eye drops to reduce high pressure in your eye , thereby preventing the development of the disease .
do not use ganfort eye drops if you are allergic to bimatoprost , timolol or beta - blockers . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease , wheeziness or difficulty in breathing , or long - standing cough . you have heart problems , such as low heart rate or heart block , heart failure warnings or precautions . this medicine is not recommended for use in patients with coronary heart disease ( symptoms include chest pain ) or if any of the above applies to you . tell your doctor or pharmacist if your doctor thinks you may be at risk . your doctor may need to adjust the dose of this medicine to suit your condition . if
always use ganfort exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one glass of water per eye . treatment should be started at the same time each day . use the bottle at the end of your neck ( see section 5 ). use in children and adolescents 1 . do not touch your hands or head . 2 . open the eyelid with a small pocket . 3 . remove the eye from the bottle . 4 . close the lid of the eye 5 . gently close the eye with your finger . this will allow you to see the light coming through the eye , preferably through your nose . 5 - touch the eye using your fingers . - use the eye through the nose , nose and / or ear . your doctor will tell you what you need to do to make sure that
like all medicines , ganfort can cause side effects , although not everybody gets them . stop taking the drops and see a doctor straight away if you notice any of the side effects listed below . if any of these occur , contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ) are : the eye redness . uncommon side effects may affect up to 1 in 9 or 100 people . the eye burning , itching , or stinging , irritation of the conjunctiva ( the white part of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes and feeling of something in the eye ( small break in the lens ). these may be signs of a rash , redness or redness of the eyes . other side effects include : fainting or tingling of the skin 
keep out of the reach and sight of children . do not use ganfort after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . if not used immediately , the product should be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol ( as 5 mg / m2 ). - each tablet contains tibiol maleate equivalent to 6 . 8 mg benzalkonium chloride ( a preserver ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e421 ), purified water , hydrochloric acid , and sodium hydroxide . the colour may be slightly yellow . what you need to know about the colour of the eye . it is supplied in a plastic bottle , with each pack contains 1 , 3 or 4 bottles . not all pack sizes may be marketed .
gefitinib mylan contains the active substance gefitib . this protein is a type of protein that is produced by the body ' s natural defences . it works by blocking the activity of this protein in cancer cells , preventing them from growing . gefiteinib melan is used to treat adults with non - small cell lung cancer , which affects more than one part of the lung , but is also a disease in which malignant ( cancer ) cells spread to other parts of the body ( e . g ., the lungs ) and in the brain .
do not take gefitinib mylan - if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should tell your doctor or nurse if : you have any other lung problems . some lung problems may be serious . - you have been told that you may need to stop taking the medicine , or that you have problems with your liver . do not stop taking gefithinib melan if any of these apply to you . children and adolescents this medicine is not recommended for use in children or adolescents under 18 years of age . it is not known if this applies to you or your child ' s doctor will tell you to take other medicines . tell your child or pharmacist if your child is taking , have recently taken
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take antacids with or without food . swallow the tablet whole with a glass of water . your doctor will tell you how much gefitinib mylan to take and how often you should take it . take the tablet at the same time each day and take it at least 2 hours apart . do not take more than 1 tablet . how much to take : - if your child has trouble swallowing , or if he or she has taken any other liquids , the recommended daily dose is 20 ml . - do not crush , crush or chew the tablet , as this may affect the way your child is swallowing the tablet and the way the tablet works .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction . symptoms may include swollen face , lips , tongue or throat , difficulty to swallow , hives or nettle rash . difficulty breathing , serious breathlessness , sudden worsening breathlessness or a cough or fever . this may be a sign of an inflammation of the lungs ( called ' interstitial lung disease '). very common ( may affect more than 1 in 100 people ) when gefitinib mylan is given : severe skin reactions affecting the entire body . if this happens , contact your doctor immediately . these may be signs of a reaction to gefit
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 milligrams ( mg ). - other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide , red iron oxide ( e171 ), yellow iron oxide [ e172 ]). what ge fitinia mylan looks like and contents of the pack gefit inib melan tablets are white to off - white , round , biconvex film with a diameter of 11 . 1 x 5 . 6 mm , each containing 250 tablets
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ) in adult patients with many different blood and bone marrow disorders where red blood cells become abnormal . this can lead to signs and symptoms of a low red blood cell count ( anaemia ), which can be caused by a lack of redblood cell transfusions . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the medicine , as a preventative measure to reduce the risk of anaemic , which can occur when a person with a type of m - ds has had to have a high level of red blood platelet count ( erythropoietin therapies ) and beta - lassaemia ( thalassaemia
do not take reblozyl : - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children under the age of 6 years . if this applies to you , it is important that you tell your doctor as soon as possible . pregnancy and breast - feeding . this medicine may cause thalassaemia . your spleen removed to prevent a blood clot . you may need hormone replacement therapy to prevent the formation of a previous blood coagulation . preventive measures and medicines should be taken to reduce the risk of the occurrence of the risk . high blood pressure your doctor will monitor your blood pressure regularly . before you are given re , your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will do blood tests before you are given reblozyl . how much to use the recommended dose is one ml / kg of body weight . the injections are given as a single injection under the skin . it is important that you weigh at least 1 . 0 kg . this dose will depend on your blood pressure . in patients with myelodysplastic syndromes , the maximum single dose is 1.75 mg / m2 of bodyweight . for patients with beta - thalassaemia the maximum simple dose is 1 , 25 mg , depending on the body weight you will receive . you should continue to use re - this medicine for at least 3 weeks . do not stop using this medicine unless your doctor tell
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects include : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or other parts of the body , blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face . lips , mouth , tongue , throat allergic reactions such as rashes , sores , itching , redness or tingling in the skin . this may be a sign of an allergic reaction . if you notice any of these , talk to your doctor or pharmacist as soon as possible . you may also experience redness in the eyes or lips or tongue . other possible side effects are : very common 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored for up to 8 hours at room temperature ( up to 25 ) for 24 hours at 2 to 8 . if not used immediately , any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg ( equivalent to 75 mg ) dextromethorphan . after reconstitution , a single dose of 50 mg dexterophosphate ( e421 ) is given . - excipients : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide , and water for the treatment of the syringe . the other ingredients are sodium , potassium , calcium , magnesium , manganese , iron , zinc , copper , cobalt - free , white powder for solution for injections . what retinol looks like and contents of the pack rembozy
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . it is used to treat the cancer by reducing the number of cancer cells and allowing the body ' s immune system to produce new blood vessels . in adults with advanced kidney cancer , other treatments may be needed , such as alpha or interleukin - 2 , depending on the severity of your disease .
do not take fotivda : - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . - the active substances are john ' s wort , hypericum perforatum , a herbal remedy used to treat depression and anxiety . do not use fotiva if : you have high blood pressure . your doctor will monitor your blood pressure regularly . you may need to take a medicine to reduce your dose . it is important that you follow the advice given to you by your doctor or nurse . this is to make sure that you are taking a dose that is right for you . when you are not sure , ask your doctor for advice before you are given fotivdea . tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda for adults is 1340 mg once a day for 21 days . your doctor will tell you how many capsules to take and how often to take them . you will be given 7 capsules of 1 capsule per day for 4 weeks . if your doctor decides that you should take more than one capsule , your doctor may decide to increase your dose . do not take more fotiv dada than your doctor tells you to . severe side effects may occur during or after a period of time . it is important that you follow the advice of your doctor , pharmacist or nurse . this is to prevent unacceptable side effects from occurring . patients who have been treated for a long time have been told that they are at risk of serious side effects during fotiv
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). if you notice any of the following side effect , stop taking fotivda and contact your doctor immediately : - you may have high or severe blood pressure . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will check your blood pressure regularly . if this happens , you may need to take a medicine to treat your high bloodpressure . you should not take more than a few tablets of this medicine . it is important that you tell your doctor as soon as possible if any of these side effects get serious . talk to your doctor , pharmacist or nurse .
what fotivda contains - the active substance is tivozanib . each tablet contains 890 micrograms ( 0 . 5 ml ) of tivazib in a single - use solution . the other ingredients in the tablet core are : tablet core : tivonib hydrochloride monohydrate , equivalent to 890 milligrams / millilitre . - tablets - ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine , yellow iron oxide [ e172 ), propylene glycol ( for strong ammonia solution ), titanium dioxide , tartrazine aluminium lake , shellac , propanolone ( for strength ammonium solution ) and indiga carmine aluminiu
stribild contains the active substance elvitegravir . it is an antiretroviral medicine that contains an integrase inhibitor cobicistat , which acts as a booster ( pharmacokinetic enhancer ) for the immune system . the other ingredients are : a syringe ( e . g ., emtricitabine ) and a single tablet regimen ( st ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . you will be given strebild in combination with a nucleoside reverse transcriptaser inhibitor ( nrti ) or with tenofovir disoproxil . this is a type of antibiotic that works by reducing the number of transcriptases in the genome . what
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir . your doctor may prescribe a different dose for you , depending on how you respond to treatment . tell your doctor , pharmacist or nurse before taking this medicine . warnings and precautions talk to your doctor or pharmacist before you are given this medicine ( see section 6 ) before treatment with any medicine containing tenovir disoproxil . this medicine may affect your kidney function . these medicines may be used together with alfuzosin ( used to treat an enlarged prostate gland ), amiodarone or quinidine ( used for irregular heartbeats ), 47 dabigatran , used to prevent blood clots , carbamazepine ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 12 mg once a day for adults aged 18 years and over . your doctor will tell you how much stribild to take and how often to take it . take the tablet with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . you should take your medicine by mouth . it is important that you take it at the same time each day . this will help to control the effects of the treatment . medicines containing oral supplements ( antacids ), laxatives containing minerals ( e . g . magnesium , aluminium , calcium , iron , zinc ) will be given to you at least 4 hours before or after meals . see section 4 for more information
stribild is used to treat hiv therapy with an increase in weight and in levels of blood lipids and glucose . this is linked to a reduction in the amount of fat in the blood . like all medicines , this medicine can cause side effects , although not everybody gets them . hiv infection is a very common , but unwanted effect . if you are not sure , talk to your doctor , pharmacist or nurse immediately . serious side effects tell your doctor immediately : lactic acidosis , which occurs when there is excess lactic acids in the body . it can be a serious side effect of some hiv medicines to reduce the risk of lactic acidosis in people who are overweight or have liver disease . in patients with severe , deep , rapid , and often sudden , lactic ketosis can occur in people with liver disease where lactic
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each film - coated tablet contains : 150 mg / ml : the other ingredients are : tablet core : e . g . tablets containing 150 mg and 150 mg each . tablet coating : cobicitat 200 mg : each tablet contains 200 mg and emmtricit abine 245 mg , respectively , in combination . the other ingredient is a combination of 300 mg . in combination with the combination of tenovir diproxil fumarate and 136 mg t . debossed with ' m ' on one side and ' the other side , the active substance is croscar
zyprexa contains the active substance olanzapine . zy prexa belongs to a group of medicines called antipsychotics . it is used to treat schizophrenia , a disease with symptoms such as hearing , seeing or sensing things that are not there . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria , may be signs of recurrence of these symptoms in patients with bipolar disorder . manic episode is a rare but potentially life - threatening episode , even if it is not treated .
do not take zyprexa : - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zypresa . if any of these apply to you , tell your doctor immediately . signs of an allergic reaction may include a rash , itching , swollen face , swelling of lips , shortness of breath , eye problems such as glaucoma ( increased pressure in the eye ). your doctor may need to adjust your dose . your doctor will tell you how long you need to take . children and adolescents do not give this medicine to children under the age of 18 years . you should not use this medicine in children under 18 years who have dementia . serious side effects may occur when medicines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa is one tablet a day . your doctor will tell you how many tablets to take . the usual starting dose for adults is one 5 mg tablet , followed by one 20 mg tablet each day , depending on your symptoms . if your doctor tells you to stop taking zy prexa , your doctor may change your dose . you should take your tablets as soon as you remember . do not take them with or without food . swallow the tablets whole with a glass of water . it is important that you take the tablet with some water , with some milk . take the tablets with some fruit juice . this will help to reduce the amount of sugar in your blood . however , you should not take more zy
like all medicines , this medicine can cause side effects , although not everybody gets them . unusual movement is a common side effect ( may affect up to 1 in 10 people ) in the face or tongue . blood clots in the veins are a possible side effect . this side effect has been reported in more than 1 in 100 people in the legs . symptoms include : swelling , pain or redness in the leg , which can damage blood vessels in the lungs , chest pain and difficulty in breathing . if you notice any of these symptoms , contact your doctor immediately . tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . zyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . - each zypresa tablet contains 2 . 5 mg , 5 ml of solution , 7 . 50 mg or 10 mg . the other ingredients are : tablet core : hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate ( e460 ), hypromellose . tablet coating : titanium dioxide , carnauba wax . which of the different zy prexa tablet strengths are available in pack sizes containing : two tablets each containing one tablet . each tablet contains two tablets . one tablet is available in packs containing two tablet sizes : one tablet in each pack . two tablets are available , each with a different strength , the other being a tablet containing either 2 
prolia contains denosumab , which is a protein ( monoclonal antibody ) that attaches to another protein . it is used to reduce the amount of bone loss caused by osteoporosis in adults . after treatment , your doctor will decide if you should continue to receive treatment . the benefits of using prolaia are obvious : it makes your bone stronger and helps your body make more oestrogen . your body ' s ability to make its own hormone , and it helps to make your bones stronger . this happens when the menopause occurs , when your body starts to produce more hormones , making your bones thinner and fragile . osteoparosis is caused by a combination of testosterone and glucocorticoids . in osteoporosis , the body produces more testosterone , causing symptoms of osteo
do not use prolia - if you have low calcium levels in the blood ( hypocalcaemia ). - you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . before you start using , tell your doctor or nurse if : you have a skin infection with symptoms such as a swollen , red area of skin on one side of your leg that feels hot or tender . cellulitis . these symptoms may be signs of an allergy to latex . the needle in the pre - filled syringe contains a derivative of latex which contains calcium . it is important that you read the instructions carefully before you use it . this is to make sure that it is clear and colourless .
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe containing 60 mg / 6 ml . you will receive a single injection under the skin ( subcutaneous ) in your thighs , abdomen or upper arm . your doctor will tell you exactly how much to inject . stickers and tablets contain calcium and vitamin d supplements . how much and how often to inject prolaa tell your doctor , pharmacist or nurse if any of the above applies to you or your child ' s doctor or nurse tells you to do so . do not inject more than once a day . it is important that you read the instructions for use in this leaflet and follow the instructions of the package leaflet . if your child has any further questions on the use
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can cause skin infections such as cellulitis . if you get any of these symptoms , stop taking the medicine and contact your doctor immediately . you may feel swollen , red area of skin on one side of your leg that feels hot and tender . symptoms may include fever , which may be accompanied by pain in the mouth and / or jaw , swelling , non - healing of sores in the jaw or discharge , numbness or feeling of heaviness , loosening of a tooth , bone damage in the face , neck , shoulders , back , arms , legs , ankles or feet . these may be symptoms of osteoporosis . tell your doctor straight away if any of the side effects gets serious
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , the injection can be stored at room temperature ( up to 25 ) for a single period of up to 30 days . if not used immediately , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . 1 ml of solution contains 60 mg of denosomab in 60 mg . the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e421 ), polysorbate 20 and water for injections . what prolaia looks like and contents of the pack prollia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard . not all pack sizes may be marketed .
ambirix is a type of vaccine that can be given to children and adolescents from 1 to 15 years of age . it is used to treat two diseases called hepatitis a and a . infection , caused by a virus called ' h1n1 ', occurs when the liver becomes swollen or inflamed . if the virus gets into an infected person , the virus can be spread through faeces , serum or saliva . symptoms of infection may last 3 to 6 weeks . you may feel sick , have a fever , aches and pains , or are very sensitive to light touch . this is especially important if you have very sensitive skin or skin . your doctor will tell you how long you should stay in contact with your doctor , pharmacist or nurse . the most common signs of infection are : -
do not use ambirix : - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine . - in case of an allergic reaction such as itchy skin rash , shortness of breath or swelling of your face or tongue , tell your doctor or nurse immediately . this may be a sign of an allergy reaction to any vaccine used to treat hepatitis a or b diseases . you have a severe infection with a high temperature . the vaccine is not recommended for use in children and adolescents . your doctor may decide to reduce the dose to a minor infection ( such as a cold ). do not give ambirx to children under 6 years of age . do not stop the use unless your doctor tells you otherwise
always use ambirix exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection per day into a muscle , usually in the upper arm . your doctor will tell you how many injections to give . you will be given ambirx via a vein . after the injection , the injection will be injected into the thigh muscle . a total of two injections are given within 12 months of the first injection and the second injection is given within 6 and 12 months after the first one . it is recommended that you do not need extra doses to avoid future booster dosing . do not give more than one injection at the same time each day to prevent the diseases from getting worse . however , if your doctor tells you otherwise , your doctor may decide to give you two more injections . this will help to
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing or a sudden drop in blood pressure , and loss of consciousness . other side effects reported in clinical trials with ambirix include : very common ( may affect more than 1 in 10 people ) headache loss of appetite , tired , irritable pain . these may be signs of an allergic reaction . if these occur , contact your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml contains 720 elisa units . the other ingredients are : human diploid ( mrc ) surface antigen , 20 , human diaspora ( hdl ) cells , aluminium hydroxide , hydrated ( 0 . 05 %), saccharomyces cerevisiae ( scc ), aluminium phosphate (0 . 4 %) , sodium chloride ( e1520 ) and water for injections . what amburix looks like and contents of the pack suspension for injection is a pre - filled syringe . each pack contains a white , slightly milky liquid . it is supplied as a clear , colourless to slightly opalescent
bexsero contains the active substance neisseria meningitidis group b . it belongs to a group of vaccines known as ' meningococcal ' which is used to protect against disease caused by the non - mesotheliobacteria meringitidedis type b bacteria . these bacteria can cause infections , such as : meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by preventing the disease from spreading .
do not use bexsero - if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are vaccinated . if : you have a severe infection with a high temperature after vaccination . you have had a minor infection ( such as a cold ). if this applies to you , tell your doctor immediately . your doctor will decide if vaccination is right for you . do not give this vaccine to patients with haemophilia or any other problem that could prevent your blood from clotting properly . blood thinners ( anticoagulants ) may be used during treatment to prevent your immune system ( eculizumab ) to prevent you from getting vaccinate yourself . children and adolescents this vaccine is not recommended for children under 28 years of
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg injection into a muscle , usually in the thigh or upper arm . your doctor will tell you how many injections to give . you will receive 2 to 5 injections , followed by three injections of the vaccine . if necessary , your doctor may decide to give you an additional injection ( booster ) at the beginning of the first injection ( 2 to 2 months ). the interval between injections is usually 1 month , after which the injection is given , and at least 2 months after a booster is given 12 to 15 or 6 months after the injection . after the booster has been given 24 to 24 hours after the initial injection , the booster will be given to you by your doctor . it is important that you follow the instructions for
like all vaccines , this vaccine can cause side effects , although not everybody gets them . the following side effects have been reported with bexsero : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin , injection site and swelling of the surface of the injection area , hardness in the skin and injection site side effects of this vaccine may be more serious . very common : may affect up to 1 in 100 people : fever , loss of appetite , nausea , vomiting , diarrhoea , abdominal pain , indigestion , muscle spasms . this is usually mild , but may be mild . if this happens , contact your doctor immediately . these may be signs of a possible side effects not listed in this leaflet . you can also report
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each ml contains 1 , 2 , 3 , 50 micrograms . the other ingredients are : - total protein from the pora p , 1 - 2 and 3 - 50 mmol . - transient protein from rna - a , b and c fusion proteins from a single source , one 50 - milligram / m2 , two 50 kilo , three 50 ub , four 50 iu , five 50 omv , and one outer membrane vesicles ( ommv ) from dna ( nas ). 
nitisinone mdk is a medicine that contains the active substance nitric acid . this medicine is used to treat a rare disease called hereditary tyrosinemia ( a condition that affects more than 1 in 10 people ). this disease affects your body . it causes your body to produce less of the amino acid toyrosine ( amino acids ) that your body produces . by reducing the amount of tirosine in the body , it reduces the harmful substances that are present in this medicine . if you are not sure , talk to your doctor , pharmacist , or nurse . you should take this medicine exactly as your doctor has told you . your doctor will work out how to make sure that you are getting enough of the beneficial substances in the diet and exercise you have been given . in this way , a low amount of
do not take nitisinone mdk : - if you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding , and breastfeeding , the use of nitric oxide ( e . g . the active substance in this medicine is oesophagus ) is not recommended . you should tell your doctor or pharmacist if any of these apply to you . children and adolescents this medicine should not be used in children or adolescents under 18 years of age . your doctor will monitor your eyes after you start . during the first few weeks after starting treatment , you may experience red eyes . contact your doctor immediately for an eye examination . eye problems may be caused by inadequate dietary
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one capsule once a day . your doctor will tell you how many capsules to take . treatment with this medicine will be started by a doctor experienced in the diagnosis and treatment of the disease ( hereditary tyrosinemia type ). the usual dose is 1 capsule per kg of body weight . the recommended daily dose is 20 capsules per day for this patient population . swallowing the capsules with a small amount of water or formula diet . do not take more nitisinone mdk than you should if your doctor tells you to . you should not take a double dose to make up for a forgotten dose . if it is time for your next dose , take it as soon as you remember 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , nitisinone mdk can be stored at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nitric acid . each capsule contains 2 mg / ml ( 0 . 5 mg ). - one capsule ( 2 - 3 mg ) contains 2 g /ml . - another capsule ( 3 - 4 mg ), containing 5 mg or 5 mg ( 00 % ) nitsinone the other ingredients are : - capsules : 10 mg or 10 mg , each containing 10 mg of the active ingredient : gelatin , titanium dioxide , black iron oxide ( e171 ), shellac glaze , and water for injections , containing the active component : 1 . 7 mg - hard gelatin capsules with the word " ' ' on one side and the word ' " on the other side 
docetaxel accord contains the active substance ' sd ' docetaxil '. docetacil belongs to a group of anti - cancer medicines called taxoids . the other ingredients are : - breast cancer , lung cancer and non - small cell lung cancer . - prostate cancer and gastric cancer ; - head and neck cancer ( mainly affecting the neck ); - advanced breast cancer where the active substances are doxorubicin , trastuzumab , capecitabine , and - early breast cancer in patients with lymphoma - forming lymphoblastic leukopenia . this is a type of cancer that has spread to other parts of the body .
docetaxel accord must not be used : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of docetaxil accord ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given this medicine . - in case you do not have enough white blood cells , or have a severe liver disease . your doctor will do blood tests to check that you have enough blood cells to support your liver . warnings , precautions do not take docetal accord if any of these apply to you , tell your doctor , pharmacist or nurse immediately if : you have problems with white blood cell disturbances such as fever or infections . you should contact your doctor immediately for abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of docetaxel accord is based on your weight and your general condition . your doctor will tell you how many doses to give . method of administration docetaxil accord will be given as an infusion into one of your veins . you will receive the infusion for one hour . this will be repeated every 3 weeks , depending on how well you respond to your infusion . if your doctor decides that you should continue to receive this medicine , your doctor may decide to reduce your dose if necessary . it is important that you follow your doctor ' s instructions for how long you need to stay on the same day each week . do not change your dose more than once a day , unless your doctor tells you to . however ,
like all medicines , this medicine can cause side effects , although not everybody gets them . stop your treatment and tell your doctor straight away if you notice any of the following adverse reactions : docetaxel accord reduces the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . these may be signs of adverse events that may occur while you are receiving the infusion . allergic reactions common ( may affect more than 1 in 10 people ): flushing , tingling , or swelling of the face , lips , tongue or throat . this may be a sign of allergic reactions . very common : may affect up to 1 in 100 people . flushing may occur more frequently in children and adolescents . if this happens , contact your doctor immediately . you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep in the original package in order to protect from light . from a microbiological point of view , docetaxel accord can be stored at room temperature ( up to 25 ) for a single period of up to six months . after dilution , the medicine may be stored in the infusion bag for up to 6 months at a maximum of 25 days . once the solution is ready for infusion , it should be used immediately . if not used within 48 hours , in - use storage times and conditions prior to use are the responsibility of the user and should not be longer than 48 hours at 2 to 8 . before use ,
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetax . - each vial of 1 vial ( s ) of concentrate contains : 20 mg docetastel in 4 vials . the other ingredients are ethanol anhydrous , water for injection , polysorbate 80 ( e421 ), ethanol anionhydrous ( see section 2 ), citric acid anion . what does docettaxel accord looks like and contents of the pack does not contain alcohol . it is a clear pale yellow to brownish - colourless to pale yellow - yellow concentrate . for solution of infusion , it is supplied in a glass vial , containing either : ethanol - 80 - 160 mg or 80 mg .
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . it is used to treat adults who are impulsive or hyperactive when taking this medicine . adults with this medicine have ' attention deficit hyperactivity disorder ' ( adhd ). adhd is caused by a lack of current stimulant medication . current medication can cause adhd symptoms . the medicine is given in combination with a treatment programme that includes psychological therapy , educational therapy and social therapy . 38 adults with adhd have been shown to have adhd more often than not . if you have any questions about how to treat adhd you should ask your doctor or pharmacist .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low or high blood pressure . you have heart problems . - you have recently fainted , had thoughts or feelings of suicide , or had any other psychiatric conditions . withdrawal symptoms may include increased heart rate , which may increase the risk that your heart does not work as well as it should . this medicine is not recommended for use in children and adolescents under 18 years of age . your doctor may prescribe this medicine for you if any of these problems occur . children under the age of 6 years and adolescents this medicine should not be used in children below 18 years . the recommended dose is 6 mg /
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . this medicine is for oral use only . the recommended dose of your treatment is 1 mg once a day . if your doctor decides that you need more intuniv than you should , your doctor will adjust your dose based on your body weight . you will be given a dose of 0 . 06 . 12 mg once per day , depending on bodyweight . treatment is for 1 to 7 mg once daily . it is recommended that your doctor adjusts your dose at least every 7 days . how long you should take intunev , this medicine should not be taken with fatty foods . swallow the tablet whole with a glass of water
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and contact your doctor immediately . serious side effects tell your doctor straight away if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of consciousness ( syncope ), a serious withdrawal side effect , high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). other side effects include : very common ( may affect more than 1 in 10 people ): dizziness ( numbness ), difficulty sleeping , difficulty sleeping ( sleepiness ) or feeling unwell ( systolic syndrome ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the tablets in the blister pack in order to protect from light .
what intuniv contains - the active substance is guanfacine hydrochloride . each tablet contains 1 mg / 0 . 5 ml of solution for injection . the other ingredients are : - one tablet of 1 g / 100 m2 of solution . - another tablet of 2 g/ 00 m3 of solution ( acetate ) for injection ( bcl ). - two tablets of 2g/ml : the other ingredient in intunev is the gcl ( e421 ). the other component in the tablet of 3g/100 mbc ( dbc ): the second ingredient in the product name is gdc , the third ingredient in gtc . one tablet contains the dcl of dgc containing the gu
ecalta contains the active substance anidulafungin . it is used to treat adults , adolescents and children aged 1 to 18 years with fungal infection that affects the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida . echinocandins have been shown to reduce the number of these medicines . serious fungal infections are caused by a lack of healthy fungal cell walls . when you are given , your doctor will tell you if you have a problem with your skin , hair , nails or other parts of your body that are damaged or have incomplete or defective cell walls which make them fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins or caspofungine acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . do not stop using ecalcta until your doctor tells you to . if any of these apply to you , tell your doctor or nurse . your doctor will monitor your liver function and if there are signs of liver problems . during your treatment , your doctor may prescribe anaesthetics , but your treatment may be stopped . before you have been given the medicine , you should contact your doctor immediately . you may experience an allergic reaction such as itching , wheezing , or blotchy skin .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of ecalta is 200 mg once a day . your doctor will tell you how much to give the patient . you will be given one 100 mg infusion ( 1 ml / kg ). the usual dose for adults is 3 . 0 mg twice a week . for children and adolescents from 1 year of age , your doctor may prescribe a higher or lower dose of 200 mg to 1 . 5 mg to 100 mg per kg of body weight . depending on your child ' s weight , the patient will receive the medicine as a slow infusion via a drip into a vein . this will take approximately 1 , 5 mg or 3 mg of bodyweight , depending on the loading dose . it will be determined by the patient
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common side effects ( may affect more than 1 in 10 people ) difficulty breathing , wheezing or an existing rash . ecalta can cause serious side effects such as convulsion ( seizure ) flushing , rash ( pruritis ), itching , hot flush , or hives , sudden contraction of the muscles such as whezing . coughing or difficulty of breathing other side effects are very common . they may affect up to 1 in 100 people . very rare side effects have been reported in children and adolescents . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the reconstituted solution in the outer carton in order to protect from light . after reconstitution , the infusion solution should be used immediately . ecalta can be stored at room temperature ( up to 24 hours ) for up to 48 hours .
what ecalta contains - the active substance is anidulafungin . each ml of powder contains 100 mg of anidülafungine . the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and water for injections . - each vial contains 30 mg of concentrate for solution for infusion in a box containing 1 vial of 100 mg concentrate for concentrate for injection . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
adynovi contains the active substance rurioctocog alfa pegol , a type of pegylated human coagulation factor viii . a doctor or nurse will prescribe a dose that is right for you . this medicine is used to treat patients with a lack of a particular type of factor ii in the blood to prevent clots and stop bleedings . in patients with haemophilia a , the amount of human factor ixii is not known . it is used for the treatment of bleeding in adults and adolescents 12 years of age and older , who have a form of haemorrhagia b , an inherited bleeding disorder caused by lack of factor vii ' s function .
do not take adynovi : - if you are allergic to rurioctocog alfa pegol , or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or nurse immediately . you may be allergic to the active substances listed in this leaflet . children and adolescents 6 years of age and above , the risk of being allergic , is not known . allergic reactions are : an anaphylactic reaction ( a severe , sudden allergic reaction ). your doctor will tell you how to treat allergic reactions such as rash , 95 hives or wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing or tight
treatment with adynovi will be started by a doctor who is experienced in the treatment of haemophilia . your doctor will decide on the best dose for you . how much to take the recommended dose is one tablet once a day . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment . bleeding : if your doctor decides to stop treatment , your doctor may decide to stop the replacement therapy . you will be given a , or you may be given the medicine as a life - long treatment with this medicine to reduce the risk of bleeding . the usual starting dose of the tablet is 40 mg / 50 mg once daily for 2 weeks , depending on your body weight , the factor viii levels you are taking . this will be determined by your doctor depending on the severity of the bleeding , and appropriate laboratory tests
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) have been reported in patients receiving the injection . early symptoms of allergic reactions include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing or wheezing , tightness in the chest , feeling of being unwell , dizziness , loss of consciousness . severe symptoms may include difficulty in breath or fainting . prompt emergency treatment may be needed if previous treatment has failed to work properly . if you notice any of the above , contact your doctor immediately . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep in the outer carton in order to protect from light . the powder vial should be used within 30 days after first opening . if not used within 3 days , this medicine may be stored at room temperature ( up to 3 ) for a single period not exceeding 3 months . once adynovi has been used , the powder must be disposed of via wastewater or household waste . ask your pharmacist how to dispose of the medicine . these measures will help protect the environment .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu / ml ( i . e . one vial containing one g /ml ). the solvent vial is supplied in sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate and histidine , glutathion , sodium chloride , calcium chloride dihydrate , tris ( hydroxymethyl ) aminomethane , polysorbate 80 , and sterile . not all pack sizes may be marketed .
rekovelle contains the active substance follitropin delta . it belongs to a group of hormones called gonadotrophins . gonadotropins are hormones produced by the body . they are used to prevent female infertility in women who are not able to have a baby . assisted reproduction programmes ( such as in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ) are used in women whose ovaries are damaged or have many egg sacs in their eggs .
do not use rekovelle - if you have any of the following : - your fertility problems - you are allergic to follicle stimulating hormone ( fsh ) or any other ingredients of this medicine ( listed in section 6 ) - the presence of a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus ( enlarged ovary ), cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina , an early menopause , or malformations of the sexual organs ( e . g . in women ) during pregnancy , fibroids of the utorhinalgia ( ovulation syndrome ) in women who have recently been treated with gonadotropins . warnings and precautions
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by a doctor or nurse . your first treatment cycle will be based on your response to anti - mullerian hormone ( hcg ) in your ovaries . after stimulation with gonadotropins , your doctor will test your blood and your body weight . a blood sample will be taken over the last 12 months . you will be monitored for the duration of treatment , depending on your bodyweight , during the 12 months of treatment and how long you will receive treatment . this will be determined by your doctor . how long will you be treated , how often you should be given , and how much you should receive , will depend on how well you respond to treatment and what you need to take .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects may be caused by hormones that can cause infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . these symptoms may be signs of a side effect common ( may affect up to 1 in 10 people ): headache and nausea . in women , rekovelle may cause an increase in the number of menopause . if you notice any of these symptoms , talk to your doctor or pharmacist straight away . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , rekovelle should be used immediately . after first opening , the solution may be stored at room temperature ( up to 25 ) for a maximum of 3 days . if not used within 3 months , it must be used within 28 days and not above 25 . during the treatment any unused solution should be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 millilitres of recombinant solution for injection . - each cartridge contains 0 . 36 ml of solution , equivalent to 33 . 3 mg / m2 dna . the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid and sodium hydroxide , and water for injections ( see section 2 ). what reticulant looks like and contents of the pack recovelle is a clear and colourless solution . it is supplied in a carton containing 1 cartridge and 3 pen injection needles .
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each ml contains : the active substance is fluticanol , 92 mg / m2 . the other ingredients are vilantrol and 22 mg . - each vial contains the same amount of fluticaloate as 184 mg , while the other two are 22 mg and 92 / 22 mg respectively . it is used in adults with chronic obstructive pulmonary disease ( copd ) and asthma . adults with asthma , children and adolescents 12 years and older , the usual dose is 184 m3 or 22 mg of m4 . in adult patients with asthma who are 12 years of age and older are 12 months of age or older are the same dose twice a day . these two dose
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking rev int y . do not eat , drink or take any other medicines not listed in this leaflet . if this applies to you , tell your doctor or pharmacist . talk to a doctor if : you have liver disease . you may experience side effects in patients who have moderate or severe liver disease and the lower strength of rev in t 92 / 22 you have heart problems such as high blood pressure , tuberculosis ( tb ) of the lung , any long standing or untreated infections , diabetes , high blood sugar , thyroid gland problems 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . asthma the recommended dose for asthma is fluticasone furoate ( 22 mg / ml ) in combination with vilanterol . for severe asthma , the higher strength inhaler should be used . the dose should be adjusted by your doctor , pharmacist or nurse . in copd , your doctor will prescribe a dose that is right for you : - if your doctor tells you to use ellipta . your doctor may prescribe the dose you need to take . - in case you have been told that you have copd for which you are using , it is important that you use the same dose twice a day . this will help you remember to use the dose . you will be given revinty ellimta
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking revinty ellpa , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling of the face and mouth ( angioedema ). you may feel very wheezy , coughing , difficulty in breathing , feeling weak or light headed . if this happens , tell your doctor as soon as possible . you may also experience feeling weak , light headed or irritable . this may be a sign that you have a feeling of weakness . your doctor may decide to reduce the dose of this medicine . it is important that you take it exactly as your doctor
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each 92 mg inhalation contains 92 micrograms ( ml ) of the active substance . - each 22 - mg inhaled dose contains a total of 92 milligrams / m2 dna ( e421 ). - one 184 mbddd containing 184 millilitres ( 1 0 . 5 %) of the corresponding dose , which is equivalent to 22 milliliters , respectively . the other ingredients are : - a dose of 184 microgram ( g ., fluticsone fumoate ) and vicanterol ( triglycerides ), trifenatate , lactose
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine ( a nuclear-mediated non  - nuclear - retrotranslational inhibitor ) and tenofovir , which is also a nanolooper - recombinant nucleotide reverse transcriptionaser inhibitor . these active substances are found in antiretroviral medicines . they work by reducing the amount of an enzyme ( reverse transcriptarse ) that binds to the virus , and thus improves the quality of life . atriplage is used as a treatment for human immune deficience virus ( hv ), hi
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken with or without food . swallow the tablet whole with a glass of water . your doctor will tell you how many tablets to take and how often to take them . do not take more than your doctor tells you to take . you should take your tablet with food , drink or juice . take it as soon as you remember . this will help you remember to take it at least 1 hour before or 2 hours before you take it . some side effects may include dizziness or drowsiness . talk to your doctor , pharmacist , or nurse if any of the above apply to you , as you may need to take the tablet . it is important that you take atrip
during hiv therapy , there may be an increase in weight and in levels of blood lipids and glucose . this is linked to a reduction in the amount of fat in the blood . as with all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects include lactic acidosis , which is caused by excess lactic acids in the body . it can affect up to 1 in 1 , 000 people . if you get any of the following serious side effect , talk to your doctor , pharmacist or nurse . other possible side effects are : - deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ) and stomach pain . you should contact your doctor immediately if any of these side effects gets serious . atripla is used to treat hiv patients who have been treated for hiv 
what atripla contains - the active substances are efavirenz , emtricitabine and tenofovir disoproxil . - each atripla film - coated tablet contains 600 mg / ml of e . the other ingredients are : - tablet core : 200 mg e. g . tablet coating : 245 mg enovir ( as fumarate ), croscarmellose sodium ; hyprolose ; magnesium stearate and microcrystalline cellulose ; sodium laurilsulfate . see section 2 for more information on the contents of the pack . atriplase contains sodium , and the tablet film coating contains iron oxide black ( e172 ) and iron oxide red . not all pack sizes may be marketed in your country .
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . gnrh regulates the release of a hormone called follicle stimulating hormone ( fsh ). gsh is a type of hormone that helps to stimulate the growth and development of new - born , adult - onset - stage - 1 - type i egg cells . these are small round sacs in which the egg cells are produced . they help to release the mature egg cells into the ovaries , allowing them to form a new type of egg in the womb , which helps to produce new , mature eggs , and thereby allowing the egg to grow and reproduce in a way that the eggs are mature . in vitro fertilisation ( ivf ) and other
do not take orgalutran : - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking : you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to any other form of ganrh analogue . you have a moderate or severe kidney or liver disease or are pregnant . if any of these apply to you , tell your doctor or pharmacist before taking orgallutran allergic reactions . your doctor may need additional monitoring and treatment . allergic reactions are generally generalised , including hives ( urticaria ), swelling of the face , lips tongue and / or throat , difficulty in breathing or swallowing ( angioedema ), or anaphylaxis .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of orgalutran is one injection a day . the treatment is carried out using assisted reproduction techniques ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin , on day 2 or 3 of pregnancy . your doctor will tell you how to inject the medicine under the skin . children and adolescents from 5 to 6 years of age , your doctor may decide to change the dose based on your child ' s age . if your child is not sure about the correct dose , talk to your doctor , pharmacist or nurse . what to do if the child does not respond to the treatment , the doctor or nurse will explain the preparations , different injection sites and
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect that is not listed in this leaflet , please tell your doctor immediately . very common ( may affect more than 1 in 10 people ): local skin reactions ( redness , swelling ). the local reaction disappears within 4 hours . uncommon : may affect up to 1 in 100 people : headache , nausea , malaise . rare : might affect upto 1 in 1 , 000 people allergic reactions : rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat . difficulty in breathing or swallowing ( numbness ) rash skin reactions , redness or swelling . these may occur for up to 4 weeks or longer . they may occur in up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , orgalutran is a clear , particle - free solution .
what orgalutran contains the active substance is ganirelix . each ml contains 0 . 5 mg of acetic acid . the other ingredients are mannitol , water for injections and ph - control , sodium hydroxide ( e421 ) and aqueous solution for injection . what or galutran looks like and contents of the pack orgalutran is presented as a clear , colourless , solution for subcutaneous administration . it is supplied in a glass vial with the needle , dry natural rubber / latex , and syringe . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
blitzima contains the active substance " rituximab ", which is a " monoclonal antibody " that attaches to a specific type of white blood cell . when this type of antibody sticks to the surface of a cell , the activity of ritsuximabab sticks to it . this helps to protect the cells from damage . what dna tests are used to test the effectiveness of the medicine , and how well it works . if you have a history of non - hodgkin ' s lymphoma ( a disease of the lymph tissue , part of the immune system , which produces white blood cells called b - lymphocytes ) your doctor may decide to increase the number of these cells . your doctor will tell you how long you will be treated with the treatment . you may be given b
do not take blitzima : - if you are allergic to rituximab , other proteins that are present in the blood , or to any of the other ingredients of this medicine ( listed in section 6 ) if : you have a severe active infection caused by a weak immune system , severe heart failure or severe uncontrolled heart disease , such as granulomatosis , polyangiitis or microscopic polyangitis ( pemphigus vulgaris ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor or pharmacist . you should not be exposed to the active substance . your doctor will check that you are at risk of developing a hepatitis infection . before you start taking the medicine , you should
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much blitzima to use the recommended dose is one tablet once a day . your doctor will tell you how many tablets to use and how long you should continue to use them . you will be given this treatment with or without food . do not take this medicine unless your doctor tells you to . this will help to reduce the risk of any side effects . the usual starting dose is a drip ( intravenous infusion ). your doctor may prescribe medicines for you based on your condition . if your doctor decides to give you one or two tablets at the same time each day , you may be given one or more tablets together with other medicines ( pre - medication ) to prevent side effects during your treatment . in the case of non - hodgkin
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . they usually disappear after a short period of treatment . reactions have been fatal . infusion reactions may occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the injection site , blisters or itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing . if you notice any of the side effects above , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains - the active substance is rituximab . each vial contains 10 mg or 100 mg / ml ( corresponding to 10 mg ) - each sachet contains 50 mg , 500 mg e . g . the other ingredients are : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what the pack contains the active ingredient is a clear , colourless solution for infusion . pack sizes of 2 vials containing 50 or 1 vial . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody , called interleukin - 6 . this is a protein that attaches to a specific protein in your body . it stops the activity of this protein and slows down the inflammation in the body , thus reducing the risk of a condition called rheumatoid arthritis ( an autoimmune disease ). it is used to treat patients with previous therapies that have not worked well enough , such as methotrexate , to prevent symptoms such as pain and swelling in your joints . if you are not sure , ask your doctor , pharmacist or nurse .
do not use roactemra : - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if this applies to you , tell your doctor immediately . you may have an active , severe infection during or after the infusion . your doctor will monitor you closely for signs of allergic reactions , such as chest tightness , wheezing or severe dizziness or light - headedness . swelling of the lips or skin rash . during and after the injection , you may experience signs of infection . infections should be treated immediately , unless your doctor tells you to feel unwell . do not take the medicine until your doctor has told you that your body ' s ability to fight infections
roactemra is given into a vein by a nurse . during the intravenous infusion , the patient will be given the treatment . the usual starting dose is 8 mg / ml given once a day for 4 hours . if you are given more than 8 hours of treatment , your doctor may decide to increase your dose . your doctor will decide on the dose you need . depending on how you respond to the treatment you should be given , you may be given up to 8 hours after you have been given a single dose , or 4 hours after a drip in the vein ( intravenous infusions ) every 2 hours for up to 2 hours , depending on your body weight . you may also be given 30 hours after the first dose and a further 12 hours after your first dose of 30 mg every 8 hours based on your response to the dose 
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): allergic reactions ( difficulty with breathing , chest tightness , light - headedness ), rash , itching or hives , swelling of the lips , tongue or face , serious infections ( fever , chills , mouth , nose , throat , sinuses ). these may be signs of serious infections such as fever and chills in the mouth . other possible side effects are listed below . very common : may affect up to 1 in 100 people allergic reactions . these may include : headache , diarrhoea , nausea , vomiting , diarrhea , stomach pain , constipation , cough , abdominal pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what roactemra contains - the active substance is tocilizumab . each vial contains 4 mg / 80 mg . - each ml of concentrate contains 20 mg or 10 mg or 200 mg , each containing 20 mg and 20 mg of concentrate . the other ingredients are : sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphorectide dihydrate and water for injections which are not listed in this leaflet . what the pack r - 1 - 2 - 3 solution for infusion is a clear , colourless to pale yellow to pale pink concentrate for concentrate for solution for forfusion . it is available in packs containing 4 , 10 or 20 vials .
onbrez breezhaler contains the active substance indacaterol , which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles that attach to the walls of the small air passages in the lungs , making breathing easier . this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd is a condition where the muscles in your breathing are not working properly . if you have copd and your breathing is difficult , this medicine relaxes the muscles of your lungs and makes breathing easier for you .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using oncb . if any of these apply to you , tell your doctor or nurse immediately . do not take the medicine if : you have asthma . you have been told by your doctor that you may need to stop using the medicine because you have heart problems such as epilepsy , thyroid gland problems ( thyrotoxicosis ) or diabetes . your doctor will monitor you closely during treatment with oncc . when using onvc , contact your doctor immediately : - tightness of the chest , coughing , wheezing or breathlessness . immediately - the medicine should not be used 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 150 microgram capsule once a day . your doctor will tell you how much to inhale and how many capsules to use . you will be given a dose of either 150 or 300 micrograms per day depending on how you respond to the treatment . if your inhaler is not working properly , contact your doctor immediately . use within 24 hours of using onbrez breezhaler . it is recommended that you use an inhalation and capsules ( in blisters ) should be used . how to use the medicine , the capsules should not be swallowed whole with water . do not crush , split , or split . inhaling the medicine should be diluted with water or powder . when using the on
what onbrez breezhaler contains the active substance is indacaterol . each inhaler 150 mg / ml capsule contains 150 mg of indecaterol ( as in daviderol maleate ). the other ingredients are lactose and the capsule is coated in gelatin . the capsules are supplied in a glass vial with a syringe containing a 300 mg dose ( equivalent to 300 mg ) of indalafil , indelafil maleate and lactoses . they are also supplied in capsules containing capsules in blisters , which contain a white powder for inhalation . one vial contains a clear , colourless to pale yellow , round , oval - shaped capsule , each containing one 150 mg capsule and one 300 mg capsule . not all pack sizes may be 
clopidogrel hcs belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets that form in these structures , the body ' s natural defences prevents this clumpeding . antiplatelets medicinal products help to prevent the forming of blood - clots ( a process called thrombosis ) in patients who have not been able to take their medicine , as well as prevent the formation of thrombi in hardened blood vessels ( arteries ), which can lead to atherothrombosis ( e . g . stroke , heart attack , or death ). when a patient has been given a medicine containing clops , clo
do not take clopidogrel hcs - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , you should contact your doctor immediately . talk to a doctor if this applies to you or your child ' s doctor before you are given this medicine : - you have been told by your doctor that you are at risk of bleeding . it is important that you tell your doctor as soon as possible if your doctor tells you to . this is because there is no information available on the safety and efficacy of 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . you should take clopidogrel hcs for a condition called ' atrial fibrillation ' ( an irregular heartbeat ). your doctor will tell you how many tablets to take . your doctor may decide to increase your dose if necessary . if this applies to you , your dose may be increased by up to 75 mg once daily . do not take more than the recommended daily dose . severe chest pain ( unstable angina ) or heart attack , the doctor may prescribe a lower dose of 300 mg / m2 per day ( see section " warnings and precautions "). the usual starting dose is 75 mg per day , depending on how you respond to treatment . 75 mg 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel hcs and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells . - signs of liver problems , such as yellowing of the skin and / or the eyes ( jaundice ), bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth ( signs of skin disorders such as rashes , itching , blisters of skin ). this is a sign of an allergic reaction . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , nausea ,
what clopidogrel hcs contains - the active substance in each film - coated tablet , contains 75 milligrams of clopd ( as hydrochloride ). the other ingredients are : tablet core : 2 mg / ml . - tablet coating : hydrogenated castor oil , microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated casting oil ( see section 2 ). - polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide and talc , macrogol 3000 tablets . not all pack sizes may be marketed .
fetcroja contains the active substance cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help to fight bacteria that cause infections . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine , as it is used to treat infections caused by bacteria , other antibiotics , or other bacteria .
do not take fetcroja : - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your doctor thinks you may be allergic to other antibiotics such as cephalosporins , you may have a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). - severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , or difficulty swallowing or breathing . your doctor will monitor you closely for any allergic reaction . you should not take any other antibiotic and tell your doctor or pharmacist if : you have recently taken , have had or might take any of these . it is important that you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . fetcroja is given as an infusion ( a drip ) into a vein . it should be given every 3 weeks for 2 weeks . your doctor will decide how long you should receive . you will be monitored closely for signs of infection , if your infection gets worse or if there is any pain . the doctor will tell you how long your doctor is going to give you , and how often you should be treated . kidney problems your doctor may decide that you should not be given a higher or lower dose , depending on your kidney problems . how long should you be given this medicine , your doctor should tell you to take it as soon as possible . do not take your dose of this medicine without talking to your doctor , pharmacist or nurse before you are given 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash , or other severe skin reactions , difficulty swallowing or breathing . this reaction may include diarrhoea or stools , blood or mucus . treatment may be interrupted by medicines to slow bowel movement . if any of these side effects gets serious , talk to your doctor or pharmacist . the most common side effects are : very common : may affect more than 1 in 10 people fetcroja has been associated with an increased risk of having these effects . you should contact your doctor as soon as possible to discuss the possible side effects with your doctor
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ceferocol ( as sucrose ), sodium chloride , sodium hydroxide and water for injections ( see section 2 ). what the other ingredients are : the powder for concentrate for solution for infusion is white to off - white . pack size 10 vials . not all pack sizes may be marketed .
depocyte is used to treat lymphomatous meningitis ( a condition in which tumour cells attach to membranes in the brain and spinal cord . debocyte works by reducing the number of lymphoma tumour cells in the body .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . - in case you have a meningeal infection . severe neurological side effects have been reported with depcyto . symptoms of the nervous system may include convulsions , pain , numbness or tingling , blindness or visual disturbances . these symptoms may be serious . your doctor may prescribe any dexamethasone tablets to treat unwanted effects . tell your doctor or nurse immediately if your side effects get worse . you may also get any new side effects while you are taking other medicines , such as medicines used to treat pregnancy , breast - feeding , or to prevent pregnancy .
always use depocyte exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one vial of lumber sac per day . your doctor will tell you how many doses to inject and how often to inject . injections of 1 ml contain 5 mg dexamethasone , which is 5 mg / kg / m2 of body surface area . if necessary , your doctor may adjust the dose based on the side effects . how much to inject your doctor or nurse will advise you on the correct dose . do not inject yourself unless your doctor tells you otherwise . you should inject yourself at the same time each day , with or without food . it is important to inject yourself as soon as you remember . this is to make sure that the dose is right for you and that it is safe to inject
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects while you are being treated with depocyte : very common ( may affect more than 1 in 10 people ): very rarely , the number of side effects is not known ( frequency cannot be estimated from the available data ). the frequency of the side effects depends on how you respond to your treatment . if any of these side effects occur , contact your doctor or pharmacist . the most common side effects are : - nausea , vomiting weakness , confusion , fever headaches , diarrhoea - dizziness , numbness or tingling sensations in the hands or feet - difficulty in breathing or swallowing - pain in the arms or legs - bruising - swelling of the skin -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep depocyte in the original package in order to protect from light . after first opening , it should be used within 4 hours of opening . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this medicine if you notice severe discolouration , a changed appearance or a defective container , or if it is not used immediately . if the product contains cytarabine , do not throw away any medicines via wastewater . these measures will help protect the environment .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cysteine . one vial contains 5 mg / 50 mg . the other ingredients are : cholesterol , trolein , dioleoylphosphatidylcholine ( e421 ), dipalmitoyllphosphatidicylglycerol , sodium chloride and water for injections . what dodepocyte looks like and contents of the pack despocyte is a clear , colourless to pale yellow solution for injection . it is available in packs containing 5 vials in a single injection or a bottle . not all pack sizes may be marketed .
what bemrist breezhaler contains - the active substances are indacaterol and mometasone furoate . both of these substances belong to a group of medicines called bronchodilators . they work by stimulating the muscles in the lungs , which help to open the airways . what do you need to know before you use bemresh breezehaler ? bemmris brerezhaler is used to treat adults with asthma .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you have heart problems such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , low level of potassium in your blood , severe liver problems or tuberculosis ( tb ) of the lung , or any long - standing or untreated infections . if any of these apply to you , tell your doctor or pharmacist before you start treatment with bemmrrist brozhaler and before starting treatment with this medicine you may experience tightness of the chest , coughing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules are for inhalation only . the medicine should be inhaled by a doctor experienced in the treatment of your asthma and your symptoms . how much to use the inhaler and capsules the instructions for use are the same as for the capsules . your doctor will tell you exactly how many capsules to inhale and how to use them . do not use more than once a day . if your doctor tells you to use , tell your doctor , pharmacist , or nurse . take the medicine as soon as possible , with or without food . it is important that you use the medicine at the same time each day , and that you do not have to change the dose of the medicine . you should use the
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching , hives . allergic reaction common : may affect up to 1 in 100 people : swelling in the tongue and / or lips or face or throat , angioedema . other side effects include : nausea , vomiting , diarrhoea , abdominal pain , stomach ache , constipation , difficulty sleeping , pain in the legs , back , arms , legs or legs . uncommon : might affect upto 1 in 1 , 000 patients : a feeling of a sense of smell , feeling sick 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . keep the capsules in the original blister in order to protect from light .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler containing 125 mg / 62 . 5 ml of solution contains 173 micrograms of ind - catechol - 2 - methyl - methacrylate ( e421 ). each 150 mg vial contains 150 microgram s , corresponding to a total of 80 mg of mome - catalase . the other ingredients are in the mouthpiece of the inhalers : 125 microgram ( mmol ) indda caterol / 72 . 0 mg syringe contains 2 , 5 mg of mtm / 1 - molecular weight ( mm ) or mome
zyllt contains the active substance clopidogrel , which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together during blood clotting . by preventing this clumpeding from forming , antiplatelets medicinal products reduce the risk of blood - clots forming ( thrombosis ) in the arteries . in patients who have not been previously treated , it reduces the chance that blood , called thrombi , are forming in hardened blood vessels ( arteries ( atherothromboses ), which can lead to atherotrombotic events ( such as stroke , heart attack , or death ). in patients treated with zylt , the risk is reduced if they do not get enough of these severe forms of bleeding . this is because
do not take zyllt : - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . - in case you have a medical condition that is currently causing bleeding ( such as a stomach ulcer or bleeding within the brain ) or severe liver disease . before you start taking the medicine , tell your doctor or pharmacist if any of these apply to you . your doctor will discuss with you the possible risks and benefits of taking the tablet . you should also tell the doctor if : you have been told by your doctor that you may be at increased risk of bleeding . this is because you are at high risk of having a medicine that can cause internal bleeding ( for example , if your stomach ulcer is a blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . zyllt is for use in adults with a condition called ' atrial fibrillation ' ( an irregular heartbeat ). your doctor will tell you how many tablets to take . your doctor may decide to increase your dose if necessary . do not take more than your doctor tells you to . take the tablet at the same time every day , unless you have severe chest pain ( unstable angina ) or heart attack . you will be given 300 mg of the tablet once every day until your next dose . however , the recommended starting dose is 75 mg twice daily . during treatment , you will only be given 75 mg . it is important that you continue to take your dose as prescribed by your doctor 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth . - skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . the most common side effects of zyllt are : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , indigestion , constipation , abdominal pain , dizziness . very common : may affect
what zyllt contains - the active substance is clopidogrel . - each film - coated tablet contains 75 mg / ml ( equivalent to the other ingredients ) - lactose ( see section 2 under ' zyillt contains lacto '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil , hypromellose , titanium dioxide , red iron oxide ( e171 ), talc and propylene glycol in the film coating . what the pack the film- coated tablets are white to off - white , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 tablets are available . not all pack sizes may be marketed .
lamivudine teva is an antiviral medicine that blocks the growth of the hepatitis b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrti ). it is used to treat adults with long term ( chronic ) infection with liver damage . if you have a problem with your liver , you may be more prone to compensated liver disease . your doctor will decide how long you should continue to receive treatment with this medicine , and how long it will take for you to continue to treat your body .
do not take lamivudine teva : - if you are allergic to leucine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 if your doctor thinks you may be allergic , ask your doctor , pharmacist or nurse for advice . if this applies to you , tell your doctor or pharmacist . warnings , precautions and information 28 - lamivine and other similar medicines can cause serious side effects , including liver disease , hepatitis c . you are overweight . your doctor may ask you to have blood tests before and during treatment with your medication . see section 4 ' possible side effects and warnings for use '. - your doctor will tell you how long you will be treated . talk to your doctor and pharmacist before taking this medicine if : you have 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . lamivudine teva will be given to you by a doctor who is experienced in the treatment of your hepatitis b infection . your doctor will tell you how much to take and how often to take it . if your infection does not go away , your doctor may decide to reduce your dose . do not take more than your doctor tells you to . you may need to take your medicine at the same time each day . it is important that you do not have to take too many tablets at once . the dose you take will depend on how you respond to the medicine you are taking . how long to take , how long you need , and how long your doctor prescribes it , depending on the severity of your illness . when to take la
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva : - other conditions associated with hepatitis b . if you notice any of the side effects listed below , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in section 6 ' warnings and precautions '. the number of side effects that have been observed during therapy for ' treatment of ' therapy for the treatment or prevention of the treatment of the condition ' has not been established . other side effects reported in the clinical trials were tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting , diarrho
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance in each film - coated tablet , contains 100 milligrams ( 0 . 5 ml ) dextrose . - tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow and iron oxide red . how to prepare the tablet the tablet is orange , biconvex film , engraved with " 32 " on one side and " nvr " on the other side . the tablets are supplied in aluminium blisters containing 28 , 30 or 84 tablets each containing 100 tablets . not all pack sizes may be marketed .
nespo is an anti - anaemic . it is used to treat your anaemia , which is a condition in which your blood does not contain enough red blood cells . this causes the symptoms of fatigue , weakness and shortness of breath . the natural hormone erythropoietin is produced by your kidneys , your bone marrow , and your body ' s natural defence system , where it is produced , to increase the number of red blood cell . darbepoetine alfa is used for the treatment of chronic renal failure , a type of symptomatic anemia . chronic renal fail is also known as kidney failure . kidney failure occurs when your kidney does not produce enough of the natural hormonal erythropoinetin . if you have an ailment , tell your doctor 
do not take nespo - if you have high blood pressure or are taking other medicines . if any of the above applies to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine : - you are allergic to the active substances in r - hoepo ( rbepoetin alfa ) or to any of its derivatives . you are taking medicines to treat sickle cell anaemia ( epileptic fits ( seizures ), convulsions and seizures ) you have liver disease . your doctor may need to change your dose of drugs to reduce the risk of anaemic patients . this is because you have an allergy to latex . the needle of the pre - filled sujede contains a derivative of latex which can cause symptoms such as unusual tiredness and
always use nespo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you are given the medicine . the recommended dose is : your haemoglobin level should not exceed 10 mg once a day . if your doctor tells you to increase your dose , your doctor may prescribe a higher dose based on your age , weight and body surface area . it is important that you use the pre - filled syringe in a vein ( intravenous ) to treat chronic renal failure . you will receive a single injection under the skin or a catheter . this will be given to you by a doctor , nurse or nurse . depending on your anaemia , the dose you receive will depend on your body weight ( 0 . 75 kg ) or 
like all medicines , nespo can cause side effects , although not everybody gets them . the most serious side effects are listed below : 471 very common ( may affect more than 10 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( affects 1 to 100 people ), blood clots ( thrombosis ), pain in the area injected rash , redness and swelling of the skin rare , may affect up to 1 in 10 , 000 people , serious allergic reactions , including sudden life - threatening allergic reactions ( anaphylaxis ), swelling of face , lips , mouth , tongue or throat , difficulty in swallowing or breathing ( angioedemo ). if you notice any of the following symptoms , talk to your doctor or pharmacist . this includes any possible side effects not
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the original package in order to protect from light . after re - opening , you should use a single dose . if you have any further questions on the matter , ask your pharmacist , pharmacist or nurse . these measures will help to protect the environment .
what nespo contains the active substance is darbepoetin alfa . each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 , 500 micrograms . the other ingredients are : water for injections : sodium phosphate monobasic ( e421 ) sodium chloride , polysorbate 80 - 80 ml solution for injection in a clear , colourless to slightly pearly liquid , cloudy solution . pack sizes : 1 , 4 or 4 pre – filled . all pack sizes may be marketed .
macugen is a solution for the treatment of macular degeneration ( amd ). this disease can cause vision loss or damage to a part of the retina called the macula , which is located in the back of the eye . maculia is the backbone of an eye that is damaged by amd and causes abnormal blood vessels grow in the retina , causing the eye to become damaged . these new blood vessels in the eye can be damaged if they are not working properly . what are the benefits of using macunigen , it is used to treat the following conditions : - if you are not sure , talk to your doctor , pharmacist , or nurse . this medicine works by blocking the effects of pegaptanib and preventing abnormal formation and the formation of new blood vessel in the eyes . - when used alone , the treatment is not effective , mac
do not use macugen - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - you have an active or suspected infection in your eye . - your doctor will tell you how to use macugagen if any of these apply to you . the injection may cause an infection or bleeding in the eye , so you should contact your doctor immediately . symptoms include eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , and increased sensitivity to light . small particles in your vision may be injected into your eye during the injection . you may experience the injection serious allergic reactions and the symptoms are usually mild to moderate . children and adolescents this medicine is not recommended for children under 4 years of age
macugen will be given to you by a doctor or nurse who is experienced in the use of injections . the recommended dose is a single injection into the eye . children and adolescents from 6 months of age to 9 years of age , the injection will be injected into a vitreous ( i . e . your eye ). if you are not sure , ask your doctor , pharmacist or nurse for advice . you should not be given antibiotic eye drops directly into your eyes . some local anaesthetic ( numbing medicine ) will be used to relieve any pain caused by the injection . do not give the injection to children or adolescents under the age of 18 years , as antibiotic treatment may increase the risk of eye infection . it is important that you tell your doctor as soon as possible .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting or rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . frequency cannot be estimated from the available data . these side effects may be due to an infection in the internal portion of the eye . during macugen treatment , the symptoms may get worse . see section 2 for more information . if you notice any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the original package in order to protect from light .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 ml of solution for injection . the other ingredients are : sodium chloride ( e421 ), monobasic sodium phosphate monohydrate , dibasic so - known as sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macugegen solution is supplied as a single dose pack in a pouch . it is supplied in two different sizes : - a pre . filled . - 0.25 or . 27 micrograms , with an elastomeric plunger stopper , a pr - attached plunger rod and a plastic clip .
kepivance contains the active substance palifermin . it belongs to a group of medicines called escherichia coli ( esk ) . elk are epithelial cells that attach to the mouth , digestive tract , and tissues under the skin . when a patient is given paliferance , it is used to treat oral mucositis ( soreness , dryness ) and inflammation of the mouth ( a common side effect of treatments to treat your blood cancer ). your doctor may decide to reduce the number of cells in your body . your doctor will decide whether to give you treatment for your cancer if you are undergoing chemotherapy , radiotherapy , autologous hematopoietic stem cell transplantation .
do not take kepivance : - if you are allergic to palifermin or escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children under 18 years of age . tell your doctor or pharmacist if this applies to you . other medicines you may be taking , have recently taken , or might take any other medicines . talk to a doctor if any of these apply to you or you are taking heparin . your doctor may need to adjust the dose . pregnancy , breast - feeding , and breast feeding are not recommended . pregnant women are not advised to breast feed . it is not known whether you are pregnant , are planning to have a baby 
kepivance will be given to you by a doctor or nurse who is experienced in cancer treatment . the recommended dose is 60 mg / kg . your doctor will give you the dose you need as an intravenous injection into a vein . how much to give the doctor will tell you how long you will receive . you will then be given three days of chemotherapy and radiotherapy . if you are given more than three weeks of chemotherapy or radiotherapy than you should be given chemotherapy and radiation therapy within 24 to 48 hours , depending on how you respond to the chemotherapy , radiotherapy or radiation therapy , the chemotherapy will last for a short period of time . it is important that you follow your doctor ' s instructions for how to give it to your child . do not give more than 48 hours after the chemotherapy is given . however , if it is given too much , your doctor may decide
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) side effects skin rash , itching , redness , pruritus , erythaema , an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever , and aching joints ( arthralgia ) altered taste , lipase and amylase levels . if you notice any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliffermin in the other ingredients : mannitol , sucrose , l - histidine , polysorbate 20 ( e421 ) and diluted hydrochloric acid . what kespivaze looks like and contents of the pack ketivance is a white to off - white powder . it is available in packs containing 6 vials .
the active ingredient cinacalcet accordpharma contains calcium and phosphorous . it is used to treat problems with organs called parathyroid glands , which are four small glands in the neck that connect the thyroid gland to the body . the purpose of the medicine is to prevent secondary hyperparathyroidism in patients with serious kidney disease who are on dialysis . this medicine contains waste products that contain calcium in the blood ( hypercalcaemia ). this is the same as in patients who suffer from parathyroid cancer . cinacaca accordpharma is used in adults and children 3 years of age and above . secondary hyperparhyroidisis is a condition where removal of the gland is not possible . in adults , the use of cinacaucaccordpharma is not recommended in children and adolescents under 18 years . there are no data available on the prevalence and severity of secondary hyper parathyroid
do not take cinacalcet accordpharma - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking , if : - you have low levels of calcium in your blood . your doctor will check your blood calcium levels before you start taking the medicine . do not stop taking cinacacalcet acordpharma . if any of these apply to you , tell your doctor straight away . you may experience seizures , convulsions or seizures . these may be signs of liver problems or heart failure . take special care when you are taking this medicine to reduce calcium levels . this can lead to life threatening events or fatal outcomes . low calcium levels ( hypocalcaemia ) can be fatal . contact your doctor immediately if your doctor tells you to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet of cinacalcet accordpharma per day . the tablets should be swallowed whole with a glass of water . your doctor will take regular blood samples during treatment for secondary hyperparathyroidism . you should not take more than 30 tablets a day , unless your doctor tells you to . children and adolescents 3 to 18 years of age , the dose should not exceed 0 . 20 mg per day for three days or more . take the tablet with or without food . if possible , take it as soon as you remember . do not swallow the tablet whole with water , as it may take longer than the recommended daily dose . it is important that you do not stop taking this medicine without talking to your doctor 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps , or seizures . your calcium levels may be too low ( hypocalcaemia ). swelling of the face , lips , mouth, tongue or throat , difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea or vomiting . these side effects may affect up to 1 in 100 people : dizziness . uncommon ( may effect up to 2 in 1 , 000 people ), which may be a sign of a feeling of weakness , weakness or weakness . if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet
what cinacalcet accordpharma contains - the active substance in each film - coated tablet is cinacacet . each tablet contains 30 mg , 60 mg or 90 mg cinacalcet ( as hydrochloride ), cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminium lake , iron oxide yellow ( 8 . 1 mm / ml ). what ccc has to do with the name of the product is a clear , colourless to light green colored , oval shaped , 9 . 65 x 6 . 00 x - rectangular , biconvex , film . not all pack sizes may be marketed .
jentadueto contains the active substance linagliptin . it is used in combination with metformin to treat diabetes . the other ingredients in this medicine are : linodiptin belongs to a group of medicines called dpp - 4 inhibitors , dipeptidyl peptidase -4 inhibitors ( dp - 5 ), lupus , biguanides , which help to control blood sugar levels in adults with diabetes , called ' type 2 diabetes mellitus '. this medicine works by lowering the amount of sugar in your blood . this is because this medicine does not work as well as insulin . you should not take this medicine with certain other medicines for diabetes such as sulphonylureas or empagliflozin ( a type of insulin ) to treat type 2
do not take jentadueto : - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have severely reduced kidney function , you have uncontrolled diabetes , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis , ketoacidosis . if this applies to you , tell your doctor as soon as possible . your doctor may decide to reduce your dose . you should not be treated if your doctor thinks you may be at risk of developing a condition called ' ketone bodies ' which can lead to diabetic pre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of jentadueto is one tablet once a day . your doctor will tell you how many tablets to take . you will be given the tablet with or without food . currently taking metformin , your doctor may prescribe individual tablets of linagliptin . this medicine is for oral use . taking this medicine can cause an upset stomach . the usual starting dose is 5 mg linguipta , or 2 , 000 mg metformine hydrochloride . if your doctor decides to change your dose , you may need to take more tablets than you should . it is important that you continue to take it as long as your blood sugar is controlled with this medicine . do not take more than the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may require immediate medical attention . stop taking jentadueto and tell your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) - trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion . this is a very common ( may affect up to 1 in 10 people ). this side effect is common . if this happens , you should contact your doctor or go to the nearest hospital straight away . you may experience the following side effect : - not known : frequency not known ( frequency cannot be estimated from the available data ): very common : may affect more than 1 in 100 people . the most common side effect with j
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light and moisture . from time to time , this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what jentadueto contains the active substances are linagliptin and metformin hydrochloride . a single tablet contains 2 . 5 mg / 850 mg , corresponding to two 2.5 mg doses : a tablet containing one ml / 1 , 000 mg : one 2.5 mg tablet contains one 0 . 50 mg dose of the active substance . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous hypromellose , titanium dioxide ( e171 ), talc , propylene glycol , and water for injections . each jenteduet is available in packs containing 2 , 5 mg tablet for injection , which contains one vial . one via
edurant contains the active substance rilpivirine , which is used to treat human immunodeficiency virus ( hiv ) infection in adults . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrti ). it is used in adults and children 12 years of age and older who are infected with hiv and who are not taking hiv medicines . if you are not sure , talk to your doctor , pharmacist or nurse .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . - in case you are not sure , ask your doctor or pharmacist for advice . the recommended dose is one tablet once a day . take the tablet with a glass of water . do not swallow the tablet whole , as it may cause a reaction to the tablet . you may need to take the following medicines : carbamazepine ( oxcarbazepine ), phenobarbital , phenytoin ( medicines used to treat epilepsy and seizures ) rifampicin ( equilibrium ) and riffapentine , ( medicines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . children and adolescents ( aged 18 years and over ) edurant contains the active substance rifabutin . this is a medicine used to treat some bacterial infections . your doctor will tell you how many tablets to take . you should not take more than one tablet per day , unless your doctor tells you to do so . do not take two tablets at the same time each day ( see section 2 ). the other ingredients are : - an antacid . - another medicine used for the treatment of diseases caused by the acid in the stomach , such as aluminium / magnesium hydroxide , calcium carbonate , magnesium carbonate or acetic acid . it is important to take the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : headache , nausea , difficulty falling asleep , insomnia , dizziness . your routine liver tests may show an increase in transaminase , increase in cholesterol , pancreatic amylase in your blood , abnormal dreams , rash , stomach pain . these may be signs of depression , tiredness ( vomiting ), drowsiness , decreased appetite , sleep disorders such as stomach discomfort , depressed mood . this may be a sign of sleep disorders , including stomach discomfort and depression . edurant is used to treat a wide range of conditions . the following side effects have been reported in patients treated with this medicine : very common : may affect more than 1 in 10 people :
what edurant contains - the active substance is rilpivirine . - each film - coated tablet contains a single - use tablet containing rillpiviine hydrochloride equivalent to 25 mg / ml . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose 2910 ( e461 ), titanium dioxide , macrogol 3000 , triacetin . not all pack sizes may be marketed .
avandamet tablets contain two different medicines , rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . in adults , the body does not make enough insulin to control blood sugar levels . insulin - containing substances , such as the two tablets , work together to control the level of sugar in your blood . both tablets work together by reducing the amount of sugar that your body makes . the insulin you are given is called " sulphonylurea " ( a type of diabetes drug used for the treatment of diabetes ).
do not take avandamet - if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of the medicine ( listed in section 6 ). - have had a heart attack , severe angina or heart failure . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - heart failure in the past . - severe breathing difficulties , liver disease , diabetic ketoacidosis ( a complication of diabetes , such as rapid weight loss , nausea or vomiting ) - kidney disease 107 - are very dehydrated , thirsty or thirsty . tell your doctor or pharmacist if any of these apply to you . your doctor will tell you how long you need to take the tablet . you should not take it unless your doctor tells
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone , 1000 mg metformin , once a day . this dose is 1 to 8 mg / ml . your doctor may increase the dose to a maximum of 4 mg or a lower dose . if your doctor decides to increase your dose , your doctor will tell you how many tablets to take . you should take this dose at least 2 hours before or 2 hours after your meal . swallow the tablets whole with a glass of water , with or without food . take your tablets at the same time each day to make up for any problems with your stomach , including indigestion , nausea , vomiting and diarrhoea . do not take more tablets than your
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur when a patient is given a lot of the following : - raised and itchy rash ( hives ) swelling of the face and mouth ( angioedema ) and difficulty in breathing collapse . if you experience any of these symptoms , stop taking the medicine and contact your doctor immediately . you may experience lactic acidosis ( a build - up of lactic acids in the blood ( lactic ketosis ). this is a side effect of metformin . severe kidney disease . symptoms associated with lactic acidosis include rapid breathing and cold . these may be signs of rapid breathing , cold and flu . your doctor may decide to reduce your dose . this side effect may be more serious and may require immediate medical attention 
keep this medicine out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains one tablet containing one ml of both ingredients : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate . the other ingredients are : water for injections : - 1 tablet - one tablet ( containing 1 mg / m2 ) - two tablets ( 1 mg and 500 mg ) for injection , with one or two tablets , each containing 500 mg of metformine . - 2 tablets containing two tablets each , the other containing 1000 mg , and one tablet for injection with one , two , three , or four tablets - containing both of these , one or both of them , respectively , in combination with one tablet of 
clopidogrel mylan belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets that form in these structures , the body ' s natural defences prevents this clumpeding , and by preventing the clots from forming ( a process called thrombosis ) from accumulating in the arteries ( thrombi ), which form in hardened blood vessels ( arteries ) and thus reduces the risk of atherothrombosis and reduces , or prevents atheothrombotic events ( such as stroke , heart attack or death ) that occur after a long period of time , by lowering the number of the medicines that are used to help prevent blood 
do not take clopidogrel mylan 31 : - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , tell your doctor straight away . do not give this medicine to children and adolescents under the age of 18 years . your doctor will tell you how to treat bleeding . this is because you may be at risk of bleeding if your doctor has told you to . it is important that you tell the doctor immediately if this applies to you or your child ' s doctor is able to tell you to stop . the risk of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . you should take clopidogrel mylan for the treatment of a condition called ' atrial fibrillation ' ( an irregular heartbeat ). your doctor will tell you how many tablets to take . your doctor may prescribe a lower dose of 75 mg . take the tablet with or without food . if your doctor tells you otherwise , you may take a higher dose . severe chest pain ( unstable angina ) or heart attack , the usual starting dose is 300 mg / ml . however , in rare cases , your doctor might decide to increase your dose to 75 mg per day , depending on your response to treatment . it is recommended that you take 75 mg of clo
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel mylan and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '), swelling in the mouth , skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . if this happens , tell your doctor or pharmacist immediately . this may be a sign of skin disorders , including rash or itching ( signs of a skin disorder ), such as red spots , swollen skin or red spots on the skin
what clopidogrel mylan contains - the active substance in each film - coated tablet , contains 75 milligrams of clopdr , the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 under " cdr "). - tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide [ e172 ), talc , macrogol 3000 , and water for injections . not all pack sizes may be marketed in your country and / or country . what odours and contents of the pack the film- coated tablets are white to off - white , colourless to pale
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelt is used in adults with chronic liver disease with low platelet count ( a condition known as thrombocytopenia ), which is a medical procedure used to prevent bleeding by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and prevent bleeding .
doptelet should not be used : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . blood clots may form in your veins or arteries . this can increase the risk of blood coagulations . if this applies to you , tell your doctor or nurse straight away . do not use doptelt if any of these apply to you or your child ' s doctor will check that you are not able to prevent blood stains from forming . your doctor may also check whether you have a higher risk of developing , or have been , a lower risk of , any other medicines you are taking . pregnancy and breast - feeding if your doctor has told you to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 5 mg tablet once a day . your doctor will tell you how much doptelet to take and how often to take it . the usual starting dose is 8 mg once daily . do not take more than your doctor tells you to take . take your tablet at the same time each day , with or without food . if your doctor decides to change your dose , your doctor may prescribe a higher or lower dose based on your platelet counts . this will depend on how you respond to your planned medical procedure . swallow the tablet whole with a glass of water . don ' t take a double dose to make up for a forgotten tablet . it is important that you keep taking this medicine to make sure that you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired . very common : may affect up to 1 in 100 people : low red blood cell count ( anaemia ) - blood clot in the portal vein ( a blood vessel that connects the liver and intestines ). - upper abdominal pain - swelling bone pain , muscle aches and fever . reporting of side effects click here to help provide more information on the safety of this medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide additional information .
what doptelet contains - the active substance is avatrombopag maleate . each film - coated tablet contains 20 mg of avatombopag . the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e421 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol ( e460 ), talc , macrogol 3350 , titanium dioxide ( iodine ) and iron oxide yellow ( oblong ). what dopet looks like and contents of the pack dopelet 20 mg tablets are white to off - white , pale yellow , round , and rounded , with 20 mm in diameter . they are packed in one aluminium blister .
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the flow of blood through the heart arteries , which increases heart rate , and relaxes the muscles in your heart . rapiscan is used to perform a heart scan ( ' myocardial perfusion imaging '). the scan contains a radioactive substance called a ' radiopharmaceutical ' . these images are taken using a treadmill to work out how your heart works . when you have a scan , you will be given a small amount of radio pharmaceutical product injected into your body through a vein . it is important that you check how well your heart is working .
do not use rapiscan - if you have a slow heart rate or high degree heart block ( sinus node disease ). if your doctor has prescribed a pacemaker for chest pain ( unstable angina ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given treatment . low blood pressure ( hypotension ), heart failure , are allergic to regadenoson , or any of the other ingredients of this medicine ( listed in section 6 ). talk to a doctor or pharmacist before you start taking the medicine . if any of these apply to you , tell your doctor straight away . you should not take the tablet if : you have recently had a serious heart problem , such as a heart attack , have abnormal heart rhythms . your doctor will tell you how often your heart beat is very fast or uneven . it is very important that you
rapiscan will be given to you by a doctor who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein using 400 micrograms of a 5 ml solution . the injection should be given at least 5 times a day , depending on your weight . if you are given an injection of sodium chloride 9 mg , the dose may be increased to 9 mg or increased to 5 mg . this is a radioactive substance ( radiopharmaceutical ). your doctor will test your heart rate . your doctor may also check how well you are doing and how much you are taking . you will be monitored by your doctor , pharmacist or nurse if necessary . how long , how often and how often you are being given the injection , it is important that you continue to follow the instructions for the injection and the instructions given in this leaflet 
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually resolve within 30 minutes of the rapiscan injection . if you experience any of the following : sudden stopping of the heart ( a sign of damage to the heart ), heart block , or rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak , talk to your doctor , pharmacist or nurse before you are given the medicine . warnings and precautions talk to a doctor or nurse if : you have a stroke or a cerebrovascular accident . you have an allergic reaction , such as rash , wheals / weals . your doctor may decide to stop any treatment . other side effects include : very common ( may affect more than 1 in
viagra contains the active substance sildenafil . it belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . they work by blocking the activity of a protein in the blood vessels in the penis . when this happens , your penis is enlarged . viagra is used to help you get an erection . if you are sexually stimulated , viagra is a treatment for erectile dysfunction ( impotence ), a condition in which you cannot get , or keep , a rect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking viagra . - you are taking medicines containing nitrates , which can cause a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). - the medicines are given by nitric oxide donors , such as amyl nutritrite , that can lead to a dangerous fall in the blood pressure when taken together with riociguat . this drug is used for the treatment of pulmonary arterial hypertension ( high blood pressure in the lungs ) or chronic thromboembolic pulmonary hypertension , a condition that causes excessive blood pressure to form blood 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 50 mg tablet of viagra once a day . viagra film - coated tablets : viagra orodispersible tablets: swallow the tablet whole with a glass of water . you can take viagra with or without food . your doctor will tell you how many tablets of viagra you need to get an erection when you are sexually stimulated . it is very important that you take viagra at the same time each day , so that you can get the best results . if it is not possible to get a sexually stimulating person , you should not take more viagra than your doctor tells you to . do not stop taking viagra without talking to your doctor , pharmacist or nurse before you start taking viagra . this will help you to achieve an erect 
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects may be serious . stop taking viagra and tell your doctor straight away if you notice any of the following side effects while you are taking viagra : an allergic reaction common ( may affect up to 1 in 100 people ) symptoms may include sudden wheeziness , difficulty in breathing , dizziness or swelling of the eyelids , face , lips or throat . chest pains may occur when you are in a semi - sitting position . your doctor may prescribe nitrates to relieve your chest pain . prolonged and sometimes painful erections may affect more than 1 in 1 , 000 people . you may have a problem with having an erectile dysfunction , which may take up to 4 hours . if this happens , you should contact your doctor immediately .
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of silenafil ( as the citrate salt ). - other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake . what viagra looks like and contents of the pack viagra film - coated tablets are a rounded - diamond shape with 25 mg . the tablets are supplied in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole . it belongs to a group of medicines called dopamine agonists . they work in the brain by blocking the receptors that control nerve impulses , causing the symptoms of primary parkinson ' s disease . if levodopa is not effective , it can be used alone or in combination with other medicines . the treatment of parkinsons ' disease is used to treat the symptoms associated with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . - you have any medical conditions that may cause symptoms of kidney disease such as hallucinations ( seeing , hearing or feeling things that are not there ) or if any of these occur . most hallucinosia are caused by dyskinesia ( abnormal , uncontrolled movements of the limbs ) in patients with advanced parkinson ' s disease who have been treated with levodopa . this is because of the increased risk of dyskineia in patients treated with sunlessrol . dystonia ( inability of keeping your body and neck straight and upright ) is caused by the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 mg once a day for the first week of the month . your doctor will tell you how many tablets to take and how often to take them . you will start with 0 . 088 mg / ml on day 1 , and then on day 2 , if your doctor tells you not to take . if this applies to you , your doctor may prescribe a lower dose . this will be based on your symptoms . it is important that you take tablets at the same time each day . for 1 week , the usual starting dose is : - the usual dose is 1 tablet , which is a single dose , followed by a maximum of 0
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects has been carried out on a regular basis . very common ( may affect more than 1 in 10 people ): very common : may affect up to 1 out of 10 people very rare ( may effect up to 10 out of 100 people ), uncommon ( may impact up to 100 out of 1 , 000 people , uncommon (1 out of 10,000 people ). parkinson ' s disease side effects include dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ), confusion , tiredness . other possible side effects are : diarrhoea , constipation , vomiting ,
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 ml of solution , corresponding to 0.35 mg / kg ( equivalent to 0. 7 . 7 mg ). - a tablet containing the other ingredients are : - tablet core : pre - prepared tablets - pre pre prepared - made tablets : 1 . 125 mg . 25 mg ; - tablets containing 1 mg pre pre reconstituted tablets , one tablet of 1 mg pramipexole dihydrochloride monohydrate , including mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what the pack looks like and contents of the pack sunlessrol is a
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . it is used to treat allergic conditions that affect the eye . the allergic reaction is caused by the presence of some materials ( allergens ). allergic reactions include itching , redness and swelling on the surface of your eye , which may make you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents ( aged 3 years and above ) benzalkonium chloride may be present in the solution of the tablet . - in clinical trials , the effect of the active substance has not been established . warnings , precautions or safety precautions : if any of these apply to you , tell your doctor or pharmacist . clinical trials have not been conducted in patients treated for kidney or liver problems . you should not take , have recently taken or might take any other medicines . other eye drops should not be used after the expiry date which is stated on the label . pregnancy and breast feeding , expectant mothers and breast 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 3 drops in one eye . do not open the bottle unless your doctor tells you to do so . your doctor will tell you how much emadine to use and how often to use it . if the dose is too high or too low , contact your doctor , pharmacist or nurse straight away . the usual dose is one drop in the eye once a day . this will help to keep your eyes open . see section 3 for more information . use in children and adolescents 1 - 2 years of age and older , see section 1 , ' how to use '. how to drop the drop in your child 's doctor ' s hand - wash the bottle with soap and water . keep the bottle in the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the following : common side effects ( may affect more than 10 people ) in the eye : eye pain , itchy eye , eye redness uncommon side effects that may affect up to 1 in 100 people eye problems : corneal disorder , abnormal eye sensation , increased tear production , tired eyes eye irritation , blurred vision , corneal staining . these effects are usually mild to moderate , but can be serious and can be life - threatening . the most commonly reported side effects are : - eye inflammation , redness , tingling , dry skin , skin rash , dark circles , yellowing of the eyes , swelling of the eyelids , decreased redness of the skin
keep this medicine out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and moisture . after first opening , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains - the active substance is e madastine . each ml contains 0 . 5 mg of difumarate , containing benzalkonium chloride , trometamol , sodium chloride ( e421 ), hypromellose , purified water , hydrochloric acid and sodium hydroxide ( for acidity levels and ph levels ). what amadine looks like and contents of the pack emmadine is a liquid ( a solution ) and is supplied in a 5 or 10 mg plastic ( drop - container ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam actavis is an antiepileptic medicine . it is a medicine used to treat seizures in epilepsy in adults and adolescents 16 years of age and older with newly diagnosed epileptic syndrome . if you have been diagnosed with a form of epilepsia , you may be more at risk of developing a condition called repeated fits ( seizures ). your doctor will decide if this is appropriate for you . your doctor may decide to increase your dose , depending on your condition . levetiractam actsavis works by reducing the amount of fits in your brain . the epileptia may affect both sides of the brain ( partial onset seizure with or without secondary generalisation ). you will be given levetiacetam in combination with other antiepic medicines to treat a group of partially onset seizures ( myoclonic seizures 
do not take levetiracetam actavis : - if you are allergic to the active substances listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . you should tell your doctor or nurse if : you have kidney problems , any slow down in the growth or puberty . - you are being treated with anti - epileptics . your doctor will tell you how to take and how long you should be taking the medicine , if any of the above apply to you . this is especially important , because levetiractam actsavis can cause you to have thoughts of harming or killing themselves . it is important that you tell your child ' s doctor immediately if they have any symptoms of depression or suicidal ideation . other side effects include abnormal thoughts , feeling irritable or react
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose 16 mg / ml : the usual starting dose is 1 , 000 mg once a day . your doctor will prescribe the appropriate dose based on your condition . the usual dose is 3 . 000 mg twice a week . if your doctor prescribes a higher or lower dose , your doctor may prescribe a lower or higher dose . you should take the tablet at least 2 weeks before you start to take it . therapy dose 17 mg or greater : if the dose is less than 1 - kilometres , you will be given a maximum of 50 mg once per day , followed by a
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately or go to your nearest emergency department if you notice any of the following : weakness , feeling light - headed , dizzy or having difficulty breathing . this may be a sign of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms , a rash on the face or an extended rash with a high temperature , increased levels of liver enzymes in blood tests . increase in the number of white blood cell 56 ( eosinophilia ) or enlarged lymph nodes ( drug reaction ). if this happens , contact your doctor or pharmacist .
what levetiracetam actavis contains - the active substance is a type of medicine called ' crospovidon '. - each 250 mg tablet contains 250 mg / 0 . 5 ml of  - l . the other ingredients are : - tablet core : the  500 mg tablet core: the 500 mg tablets are a mixture of two different concentrations of a particular type of molecule , namely 1 .  1 , 000 mg of ' 1 . 000 mg ' in each tablet , which contains a total of one tablet containing one tablet each , and a maximum of one dose of the other , each tablet contains one tablet of the same type , called a syringe , in addition to the other two other ingredients , both of which are described in section 2 
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that affects the lining of the lungs . it causes breathing difficulties and difficulties in breathing due to tightening of the muscles in the airways . the use of this medicine can help to reduce the tightness of these muscles in your lungs and reduce your breathing difficulties . if you suffer from copd you should stop taking ellipta and contact a doctor immediately . you may experience a sudden attack of breathlessness or wheezing . your doctor will tell you how long you should stay in hospital .
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if this applies to you , tell your doctor immediately . use in children and adolescents this medicine should not be used in children or adolescents under the age of 18 years . do not inhale in your child ' s womb . children under 18 years have asthma , heart problems , an eye problem ( narrow - angle glaucoma ), an enlarged prostate , difficulty passing urine , or a blockage in your bladder . severe liver problems . immediate breathing difficulties , such as tightness of the chest , coughing , wheezing or breathlessness . contact your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every 24 hours . incruse ellipta should only be used once a day . your doctor will tell you how many inhalations to use . do not use more than your doctor tells you to take . how much to inhale in the morning and evening . use in the evening , the dose may be increased or decreased depending on how you respond to this medicine . symptoms of this medicine may include a sudden attack of breathlessness or wheezing . if this happens , your doctor may prescribe a quick - acting reliever inhaler ( such as salbutamol ). if your doctor decides to change your dose , contact your doctor , pharmacist or nurse as soon as possible .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may affect up to 1 in 100 people . tell your doctor straight away if you notice any of the following symptoms while taking incruse ellipta : itching skin rash , hives , redness 29 common side effects ( may affect more than 1 in 10 people ): faster heart beat painful , frequent urination ( a urinary tract infection ). common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead , inflammation of the lungs . these may be signs of a rash and / or redness of the skin . other possible side effects are listed below : very common : may affect as many as 1 in 1 , 000 people : fast heart beat painful ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the sealed tray in order to protect from light . after first inhaling the medicine , it should be used within 6 hours . if not used within 30 days , the inhaled cartridge must be used immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what incruse ellipta contains - the active substance is umeclidinium bromide . each inhalation dose contains 55 micrograms ( i . e , umeclinium ) and is equivalent to a dose for adults of 65 years and over . the other ingredients are : lactose monohydrate ( see section 2 under ' inhalations containing lactoses '), magnesium stearate . what the incruseta looks like and contents of the pack the inhaler is a white to off - white powder , with a grey plastic body and a light green mouthpiece cover . it is supplied in a dosing counter , a foil laminate tray , which has a peelable foil lid . there is also a desiccant packet in the packaging . one inhal
nucala contains mepolizumab , a monoclonal antibody , which is a type of protein that is involved in the treatment of severe asthma in adults , adolescents and children aged 6 years and older . severe asthma is caused by the presence of many eosinophils , the type of white blood cell that attaches to the airways in the lungs . this type of asthma is also known as e . g . asthma nucala is used to treat asthma attacks when you are given medicines or high dose inhalers to treat your asthma . these medicines can be used in combination with medicines called oral corticosteroids . when used together , your doctor will tell you how to treat it . your doctor may also tell you to take other medicines , such as medicines that are not listed in this leaflet . you will also be given nucal
do not use nucala - if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have asthma - related side effects affecting their asthma . if this applies to you , tell your doctor immediately . your doctor may decide to reduce your dose of nucalal if your asthma is not controlled or stopped . you may be allergic to other injection site reactions medicines of this type ( monoclonal antibodies ). severe allergic reactions may occur in the body ( see section 4 ) if any of these apply to you or your child , or you are not sure . the risk of side effects may be increased by a similar reaction . it is important that you inform your doctor or nurse immediately if
always use nucala exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection under the skin ( subcutaneous injection ) every 12 hours . your doctor will give you a dose of 100 mg per 1 ml of the pre - filled pen once a day . you will be given the medicine at the same time each day , with or without food . it is important that you continue to receive treatment at the usual time . do not change the dose without talking to your doctor , pharmacist or nurse . if your doctor tells you otherwise , your doctor may decide to change your dose . treatment with nucalal is to be continued for as long as the treatment is effective and you should continue with the treatment . however , you may need to continue with your asthma symptoms , such as attacks , and to reduce your asthma
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ) when the injection is given . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness or feeling lightheaded ( a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash . contact your doctor immediately if you notice any of the following : - a reaction to a similar reaction to the injection . - not known ( frequency cannot be estimated from the available data ): very common : may affect more than 1 in 1 , 000 people allergic reactions , which may be serious . these are usually mild to moderate .
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and the pre - filled pen after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the nucala pen in the outer carton in order to protect from light . if not used immediately , the pen should be used within 7 days after first opening .
what nucala contains - the active substance is mepolizumab . each vial contains 1 mg or 100 mg / ml . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e460 ), polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucale 1 mg is supplied as a pack containing 1 or a multipack containing 3 vials of 1 .
ninlaro is a cancer medicine that contains the active substance ixazomib , also known as a ' proteasome inhibitor '. it is used in adults to treat a type of cancer of the bone marrow called multiple myeloma , in which the immune system ( the body ' s natural defence system ) does not work well enough . it works by inhibiting the activity of a number of proteins that are involved in cell survival . myelama cells have a lot of proteins called proteasoms , which are important in preventing them from working properly . what are the benefits of taking a dose of dna / ml , and how long will it take for you to take , the benefits will depend on how well your immune system works . if you are given a combination of n
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are taken . if any of these apply to you , tell your doctor or nurse . do not give this medicine to children and adolescents under 18 years of age . talk to a doctor or pharmacist before taking n in case of bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , liver or kidney problems . your doctor will tell you how long you will be treated . before starting treatment , your doctor may ask you to have blood tests to check that you have enough blood cells . it is important that you do not
ninlaro is used to treat multiple myeloma in adults . this medicine is for oral use only . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will prescribe a dose that is right for you . how much to take the recommended dose is lenalidomide , a medicine that contains the active substance dexamethasone , which is an anti - inflammatory medicine , and it is important that you take the tablets at the same time each day . it is recommended that you have a daily dose of lenalomide and a combination of both , once a week , on the same day of the week . in the first 3 weeks , the first 4 weeks of treatment will be based on the dose you have taken . you will be given len
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds , easily bruise nausea , vomiting , diarrhoea , numbness or tingling , burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet , peripheral oedema ) skin rash , itchy all over the body . rare side effects may affect up to 1 in 1 , 000 people . ninlaro can cause a variety of symptoms . these include : - redness , redness and / or itchy areas of the body that are not normally clear , but may be mild to moderate . this includes any possible side effects not listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 to 8 ). do not freeze . keep the blister in the original package in order to protect from light . if not used immediately , the capsule may be stored at room temperature ( up to 30 ) for a single period of up to one year . the capsule should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains - the active substance is ixazomib . each 2 . 3 mg capsule contains 2 , 3 mg of xazomimib in 3 . 4 ml of solution . the other ingredients are : capsule core : microcrystalline cellulose , magnesium stearate , talc . capsule shell : gelatin , titanium dioxide , red iron oxide ( e171 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]). if you have any questions about the contents of the pack , ask your doctor or pharmacist . - each capsule contains 3 capsules containing one capsule containing three capsules ( each capsule is filled with one capsule of one containing the other containing two capsules of one of each containing four capsules
do not take palforzia - if you are allergic to peanuts ( arachis hypogaea ). warnings and precautions talk to your doctor , pharmacist or nurse before taking palforizia . children and adolescents aged 4 months to 17 years of age are at increased risk of developing treatment for peanut allergy . peanut ( desensitisation ) is not recommended . if any of the above applies to you , tell your doctor or pharmacist . allergic reactions are rare . you should not be treated with palfordzia in patients with food allergies . your doctor will tell you how long you should stay on the tablet . it is important that you read the leaflets carefully before you are given the tablets . this is to make sure that you are aware of the effects of the product .
do not take palforzia - if you are allergic to severe asthma or any of the other ingredients of your asthma ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your asthma has a problem swallowing , you may have long term problems with your digestive system , a severe mast cell disorder ( severe or life - saving anaphylaxis ). if this happens for more than 60 days , your doctor may decide to stop treatment . your doctor will monitor you closely during treatment with palfrazia to check the symptoms of peanut allergy . you should tell your doctor immediately if : you have ever had an allergic reaction to the medicine , or you have been told by your doctor that you have a history of allergic reactions . it is important that you inform your doctor as soon as possible if pal
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . allergic reactions ( anaphylaxis ) may occur within 3 weeks of starting treatment with palforzia . initial dose escalation : these treatment phases will be repeated during the initial dose up - dosing phases . your doctor will decide how much to take and how long to take . if your doctor decides to change the dose , your doctor may decide to increase or decrease your dose . this will depend on how long you need to take the first day of treatment . you will need to continue to take your tablet at the same time each day , with or without food . it is very important that you continue to receive the first dose as prescribed by your doctor . however , you will be given palfor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions . tell your doctor straight away if you notice any of the following symptoms while you are taking the medicine : trouble breathing , throat tightness , feeling of fulness , trouble swallowing , speaking - changes in voice , dizziness - fainting - severe stomach cramps , pain , vomiting - diarrhoea , severe flushing and itching of the skin palforizia may cause problems with the stomach and digestive system . if this happens , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice any hard lumps of powder , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains - the active substance is 0 . 5 mg / ml . each capsule contains 1 , 10 or 20 mg microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforizia 100 mg oral powder in capsules , opening microscopic cellulose ( e421 ), colloidal amylase ( type a ) and magnesium st . 300 mg oral powder in sachet microcrystalline cephalosporin , co - containing colloidal naphthalic acid . e553b . the other ingredients in the powder are : - beige oral powder . initial dose escalation ( see section 3 ), 13 or 5 single - dose blisters containing 0.5 mg . not all pack sizes may be marketed .
zerene contains the active substance benzodiazepine , which belongs to a group of medicinal products called hypnotic actions . it is used to treat sleeping problems after treatment . treatment should be stopped if you have problems sleeping .
do not take zerene - if you have hypersensitivity ( an allergy ) to zaleplon , or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . - in case you have been told by your doctor or nurse that you have a history of zeene sleep apnoea syndrome ( short periods of sleep ) or severe kidney or liver problems , such as myasthenia gravis ( very weak , tired muscles , severe breathing , chest problems ). children and adolescents ( below 18 years of age and older ) the use of this medicine can cause undesirable effects . you should not take any medicine or any medicines that may cause physical dependence during treatment . withdrawal symptoms may include headaches , muscle pain , extreme anxiety or tension . your
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day to help you fall asleep . children and adolescents ( aged 65 years and over ) adults with mild to moderate liver problems the usual dose is 5 mg once daily . for adults aged 65 and over the age of 65 , if the dose is too high , your doctor may prescribe a lower dose . if your doctor prescribes a higher dose , you may become increasingly drowsy , which may lead to a coma . your doctor will tell you how long you will be treated . you should continue to take zeene until your original sleeplessness is resolved . symptoms include mood changes , anxiety and restlessness . tell your doctor immediately if any of these symptoms occur . do not stop taking
like all medicines , zerene can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any other changes in your health . frequency of side effects 36 common : may affect up to 1 in 10 people , may affect more than 1 in 100 people . uncommon : might affect 1 out of 10 people 1 , 000 people 1 out - 10 people 10 - 10,000 people 0 out of 1 10 people 10,000 people all medicines have side effects that may be serious . tell your doctor , pharmacist or nurse if any of the following side effects occur : drowsiness , memory difficulties , sensations like tingling in the extremities . these may be mild to moderate . the frequency of the side effects is not known . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side
what zerene contains the active substance is zaleplon . each tablet contains 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( type a ), titanium dioxide , gelatin , titanium dioxide [ e172 ] , red iron oxide , yellow iron oxide and black iron oxide (  e132 ) and sodium lacuryl Sulphate ( see section 2 , " zerene contains silicon dioxide - 13050 "), shellac , lecithin , simethicone ( yellow iron dioxide ). what zeene looks like and contents of the pack zeroene is a clear , colourless to pale
